0001493152-23-029306.txt : 20230817 0001493152-23-029306.hdr.sgml : 20230817 20230817160555 ACCESSION NUMBER: 0001493152-23-029306 CONFORMED SUBMISSION TYPE: 6-K/A PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230817 DATE AS OF CHANGE: 20230817 FILER: COMPANY DATA: COMPANY CONFORMED NAME: A2Z Smart Technologies Corp CENTRAL INDEX KEY: 0001866030 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40472 FILM NUMBER: 231181899 BUSINESS ADDRESS: STREET 1: 559 BRIAR HILL AVENUE, CITY: TORONTO STATE: A6 ZIP: M5N 1N1 BUSINESS PHONE: 1 647 558 5564 MAIL ADDRESS: STREET 1: 559 BRIAR HILL AVENUE, CITY: TORONTO STATE: A6 ZIP: M5N 1N1 6-K/A 1 form6-ka.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K/A

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2023

 

Commission File Number: 001-40472

 

A2Z SMART TECHNOLOGIES CORP.

(Registrant)

 

1600-609 Granville Street

Vancouver, British Columbia V7Y 1C3 Canada

(Address of Principal Executive Offices)

 

Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

 

This Amendment No. 1 (“Amendment No. 1”) to the Report on Form 6-K originally filed with the U.S. Securities and Exchange on August 14, 2023 (the “Original 6-K”) is being filed solely to provide the Company’s Unaudited Condensed Interim Consolidated Financial Statements for the six month period ended June 30, 2023 formatted in Inline eXtensible Business Reporting Language (“iXBRL”), in accordance with Rule 405 of Regulation S-T and paragraph C.(6) of the General Instructions to Form 6-K, attached hereto as Exhibit 99.1. Such Unaudited Condensed Interim Consolidated Financial Statements were previously filed without iXBRL as Exhibit 99.1 to the Original 6-K.

 

Except as described above, this Amendment No. 1 speaks as of the original filing date of the Original 6-K and does not amend, update or restate any information set forth in the Original 6-K or reflect any events that occurred subsequent to the original filing date of the Original 6-K.

 

The information contained in this Amendment No. 1, including Exhibit 99.1, is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333- 271226).

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  A2Z SMART TECHNOLOGIES CORP.
  (Registrant)
     
Date August 17, 2023 By /s/ Joseph Bentsur
    Joseph Bentsur
    Chief Executive Officer

 

 

 

 

EXHIBIT INDEX

 

Exhibit   Description of Exhibit
     
99.1   Unaudited Condensed Interim Consolidated Financial Statements for the six months period ended June 30, 2023 formatted in Inline XBRL

 

 

EX-99.1 2 ex99-1.htm
0001866030 true 6-K/A Q2 --12-31 Amendment No. 1 A2Z SMART TECHNOLOGIES CORP 0001866030 2023-01-01 2023-06-30 0001866030 2023-06-30 0001866030 2022-12-31 0001866030 2023-04-01 2023-06-30 0001866030 2022-04-01 2022-06-30 0001866030 2022-01-01 2022-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-12-31 0001866030 ifrs-full:CapitalReserveMember 2022-12-31 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001866030 ifrs-full:RetainedEarningsMember 2022-12-31 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001866030 ifrs-full:IssuedCapitalMember 2021-12-31 0001866030 ifrs-full:CapitalReserveMember 2021-12-31 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001866030 ifrs-full:RetainedEarningsMember 2021-12-31 0001866030 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001866030 2021-12-31 0001866030 ifrs-full:IssuedCapitalMember 2023-01-01 2023-06-30 0001866030 ifrs-full:CapitalReserveMember 2023-01-01 2023-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001866030 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-01-01 2022-06-30 0001866030 ifrs-full:CapitalReserveMember 2022-01-01 2022-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001866030 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-06-30 0001866030 ifrs-full:IssuedCapitalMember 2023-06-30 0001866030 ifrs-full:CapitalReserveMember 2023-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001866030 ifrs-full:RetainedEarningsMember 2023-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2023-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-06-30 0001866030 ifrs-full:CapitalReserveMember 2022-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001866030 ifrs-full:RetainedEarningsMember 2022-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-06-30 0001866030 2022-06-30 0001866030 AZ:Cust2MateLtdMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedAutomotiveInnovationsIncMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-15 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-15 2023-06-15 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-20 2023-06-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-20 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-04-01 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-01-01 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-04-01 2022-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-01-01 2022-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-11-02 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-11-02 2022-11-02 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-04-01 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-01-01 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoWarrantsMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2022-12-31 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-12-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-01-01 2023-03-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2021-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-01-01 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-01-01 2023-03-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-03-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-06-30 0001866030 AZ:IsramatLtdMember 2022-02-03 0001866030 2022-02-03 0001866030 2022-02-11 0001866030 AZ:RestrictedStockUnitsMember 2023-06-30 0001866030 AZ:RestrictedStockUnitsMember 2023-01-01 2023-06-30 0001866030 2023-03-20 2023-03-20 0001866030 2023-03-20 0001866030 AZ:WarrantsMember 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember 2023-03-20 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember 2023-03-20 0001866030 2023-06-20 2023-06-20 0001866030 2023-06-20 0001866030 AZ:WarrantsMember 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember 2023-06-20 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember 2023-06-20 0001866030 AZ:NonregisteredWarrantsMember 2023-06-20 0001866030 2022-01-01 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementMember 2022-01-01 2022-12-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsMember 2023-06-30 0001866030 AZ:WarrantsMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsTwoMember 2023-06-30 0001866030 AZ:WarrantsTwoMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsThreeMember 2023-06-30 0001866030 AZ:WarrantsThreeMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsFourMember 2023-06-30 0001866030 AZ:WarrantsFourMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsFiveMember 2023-06-30 0001866030 AZ:WarrantsFiveMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsSixMember 2023-06-30 0001866030 AZ:WarrantsSixMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsSevenMember 2023-06-30 0001866030 AZ:WarrantsSevenMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-03-27 0001866030 AZ:WarrantsOneMember 2023-03-27 2023-03-27 0001866030 AZ:WarrantsTwoMember 2023-03-27 0001866030 AZ:WarrantsTwoMember 2023-03-27 2023-03-27 0001866030 AZ:WarrantsTwoMember AZ:WarrantHoldersMember 2021-03-31 0001866030 AZ:WarrantsThreeMember AZ:WarrantHoldersMember 2021-06-30 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-01-04 2023-01-04 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-01-04 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-02-08 2023-02-08 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-02-08 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-04-18 2023-04-18 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-04-18 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-06-28 2023-06-28 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-06-28 0001866030 AZ:StockOptionOneMember 2023-06-30 0001866030 AZ:StockOptionOneMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionTwoMember 2023-06-30 0001866030 AZ:StockOptionTwoMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionThreeMember 2023-06-30 0001866030 AZ:StockOptionThreeMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionFourMember 2023-06-30 0001866030 AZ:StockOptionFourMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionFiveMember 2023-06-30 0001866030 AZ:StockOptionFiveMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionSixMember 2023-06-30 0001866030 AZ:StockOptionSixMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionSevenMember 2023-06-30 0001866030 AZ:StockOptionSevenMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionEightMember 2023-06-30 0001866030 AZ:StockOptionEightMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionNineMember 2023-06-30 0001866030 AZ:StockOptionNineMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionTenMember 2023-06-30 0001866030 AZ:StockOptionTenMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionElevenMember 2023-06-30 0001866030 AZ:StockOptionElevenMember 2023-01-01 2023-06-30 0001866030 AZ:RestrictedStockUnitsMember AZ:DirectorsOfficersAndAdvisersMember 2022-08-04 2022-08-04 0001866030 AZ:RestrictedStockUnitsMember AZ:ExecutivesAndDirectorsMember 2022-08-04 2022-08-04 0001866030 AZ:RestrictedStockUnitsMember 2022-08-04 2022-08-04 0001866030 AZ:RestrictedStockUnitsMember AZ:DirectorsOfficersAndAdvisersMember 2023-01-04 2023-01-04 0001866030 AZ:RestrictedStockUnitsMember AZ:ExecutivesAndDirectorsMember 2023-01-04 2023-01-04 0001866030 AZ:RestrictedStockUnitsMember 2023-01-04 2023-01-04 0001866030 AZ:RestrictedStockUnitsMember AZ:EmployeesMember 2023-04-18 2023-04-18 0001866030 AZ:RestrictedStockUnitsMember 2023-04-18 2023-04-18 0001866030 AZ:RestrictedStockUnitsMember AZ:OfficersMember 2023-06-28 2023-06-28 0001866030 AZ:RestrictedStockUnitsMember 2023-06-28 2023-06-28 0001866030 AZ:RestrictedStockUnitsMember 2022-12-31 0001866030 AZ:RestrictedStockUnitsMember 2022-01-01 2022-06-30 0001866030 AZ:RestrictedStockUnitsMember 2021-12-31 0001866030 AZ:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001866030 AZ:RevenuesFromServicesMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromServicesMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromServicesMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromServicesMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromLeasingMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromLeasingMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromLeasingMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromLeasingMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember 2023-04-01 2023-06-30 0001866030 AZ:ExternalMember 2022-04-01 2022-06-30 0001866030 AZ:ExternalMember 2023-01-01 2023-06-30 0001866030 AZ:ExternalMember 2022-01-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:ExternalMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:ExternalMember 2023-01-01 2023-06-30 0001866030 AZ:SmartCartsMember AZ:ExternalMember 2023-01-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:InterSegmentMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:InterSegmentMember 2023-01-01 2023-06-30 0001866030 AZ:SmartCartsMember AZ:InterSegmentMember 2023-01-01 2023-06-30 0001866030 AZ:InterSegmentMember 2023-01-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember 2023-01-01 2023-06-30 0001866030 AZ:SmartCartsMember 2023-01-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:ExternalMember 2022-01-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:ExternalMember 2022-01-01 2022-06-30 0001866030 AZ:SmartCartsMember AZ:ExternalMember 2022-01-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:InterSegmentMember 2022-01-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:InterSegmentMember 2022-01-01 2022-06-30 0001866030 AZ:SmartCartsMember AZ:InterSegmentMember 2022-01-01 2022-06-30 0001866030 AZ:InterSegmentMember 2022-01-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember 2022-01-01 2022-06-30 0001866030 AZ:SmartCartsMember 2022-01-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:ExternalMember 2023-04-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:ExternalMember 2023-04-01 2023-06-30 0001866030 AZ:SmartCartsMember AZ:ExternalMember 2023-04-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:InterSegmentMember 2023-04-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:InterSegmentMember 2023-04-01 2023-06-30 0001866030 AZ:SmartCartsMember AZ:InterSegmentMember 2023-04-01 2023-06-30 0001866030 AZ:InterSegmentMember 2023-04-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember 2023-04-01 2023-06-30 0001866030 AZ:SmartCartsMember 2023-04-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:ExternalMember 2022-04-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:ExternalMember 2022-04-01 2022-06-30 0001866030 AZ:SmartCartsMember AZ:ExternalMember 2022-04-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember AZ:InterSegmentMember 2022-04-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember AZ:InterSegmentMember 2022-04-01 2022-06-30 0001866030 AZ:SmartCartsMember AZ:InterSegmentMember 2022-04-01 2022-06-30 0001866030 AZ:InterSegmentMember 2022-04-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember 2022-04-01 2022-06-30 0001866030 AZ:SmartCartsMember 2022-04-01 2022-06-30 0001866030 AZ:NonadjustingEventMember 2023-07-31 0001866030 AZ:NonadjustingEventMember 2023-07-01 2023-07-31 0001866030 AZ:NonadjustingEventMember 2023-08-31 0001866030 AZ:NonadjustingEventMember 2023-08-01 2023-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD iso4217:CAD xbrli:shares AZ:Segment iso4217:ILS iso4217:ILS xbrli:shares

 

Exhibit 99.1

 

A2Z Smart Technologies Corp.

 

CONDENSED INTERIM CONSOLIDATED

FINANCIAL STATEMENTS

 

FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2023

 

(Unaudited)

(Expressed in US Dollars)

 

 

 

A2Z SMART TECHNOLOGIES CORP.

 

 

 

 

 

 

A2Z SMART TECHNOLOGIES CORP.

 

CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

 

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023

 

(Unaudited)

(Expressed in US Dollars)

 

INDEX

 

  Page
   
Condensed Interim Consolidated Statements of Financial Position 3
   
Condensed Interim Consolidated Statements of Loss and Comprehensive Loss 4
   
Condensed Interim Consolidated Statements of Changes in Equity (Deficit) 5
   
Condensed Interim Consolidated Statements of Cash Flows 6-7
   
Notes to the Condensed Interim Consolidated Financial Statements 8- 19

 

2

 

 

A2Z SMART TECHNOLOGIES CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

(Unaudited)

(Expressed in Thousands of US Dollars)

 

           
  

As at

June 30, 2023

  

As at

December 31, 2022

 
ASSETS          
Current assets          
Cash and cash equivalents   5,671    2,616 
Restricted cash   -    8 
Inventories   621    375 
Trade receivables, net   1,547    1,373 
Other accounts receivable   1,566    2,570 
Total current assets   9,405    6,942 
Intangible asset - patent, net   2,115    2,207 
Goodwill   1,188    1,188 
Property, plant and equipment, net   2,059    2,357 
Total non-current assets   5,362    5,752 
           
Total Assets   14,767    12,694 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities          
Short term loan and current portion of long-term loans   1,155    1,403 
Lease liability   257    281 
Trade payables   2,692    2,224 
Deferred revenues   -    1,373 
Other accounts payable   840    956 
Total current liabilities   4,944    6,237 
Lease liability   447    605 
Long term loans   289    341 
Provisions   1,466    1,447 
Warrant Liability (note 3)   6,249    1,142 
Severance payment, net   31    33 
Total non-current liabilities   8,482    3,568 
Total liabilities   13,426    9,805 
Shareholders’ equity (note 4)          
Share capital and additional paid in capital   52,944    43,452 
Warrant Reserve   30,863    30,863 
Accumulated other comprehensive income   (1,409)   (1,634)
Accumulated deficit   (77,936)   (67,395)
Total equity including non-controlling interest   4,462    5,286 
Non-controlling interest   (3,121)   (2,397)
Total shareholders’ equity   1,341    2,889 
Total liabilities and shareholders’ equity   14,767    12,694 

 

August 14, 2023   “Yonathan De Yonge”   “Joseph Bentsur”
Date of approval of the financial statements   Yonathan De Yonge - Director  

Joseph Bentsur

President and

Chief Executive Officer

 

The accompanying notes are an integral part of these Condensed Interim Consolidated financial statements.

 

3

 

 

A2Z SMART TECHNOLOGIES CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS

(Unaudited)

(Expressed in Thousands of US Dollars, except per share data)

 

                     
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
                 
Revenues (note 7)   2,860    1,430    7,468    2,876 
Cost of revenues   2,222    1,219    5,809    2,389 
Gross profit   638    211    1,659    487 
                     
Expenses:                    
Research and development costs   1,220    1,106    2,243    2,171 
Sales and marketing costs   359    199    482    282 
General and administration expenses   3,797    2,276    7,702    4,122 
Operating loss   (4,738)   (3,370)   (8,768)   (6,088)
                     
Loss on revaluation of warrant liability (note 4)   2,749    -    2,344    - 
Loss on sale of property, plant and equipment   -    -    -    16 
Financial (income) expense   (65)   (5)   153    (7)
Loss before taxes on income   (7,422)   (3,365)   (11,265)   (6,097)
Income tax expense   -    -    -    - 
Net loss for the period   (7,422)   (3,365)   (11,265)   (6,097)
                     
Less: Net loss attributable to non-controlling interests   (454)   (416)   (724)   (795)
Net loss attributable to controlling shareholders   (6,968)   (2,949)   (10,541)   (5,302)
Net loss for the period   (7,422)   (3,365)   (11,265)   (6,097)
Other comprehensive income (loss)                    
Item that will not be reclassified to profit or loss:                    
Adjustments arising from translating of financial statements to presentation currency   574    (425)   225    (997)
Other comprehensive income (loss)   574    (425)   225    (997)
                     
Total comprehensive loss for the period   (6,848)   (3,790)   (11,040)   (7,094)
                     
Less: Comprehensive loss attributable to non-controlling interests   (454)   (410)   (724)   (795)
Comprehensive loss attributable to controlling shareholders   (6,394)   (2,955)   (10,316)   (6,298)
Basic and diluted loss per share   (0.19)   (0.11)   (0.34)   (0.23)
Weighted average number of shares outstanding   33,386,071    27,261,525    32,349,810    27,049,715 

 

The accompanying notes are an integral part of these Condensed Interim Consolidated financial statements.

 

4

 

 

A2Z SMART TECHNOLOGIES CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

(Unaudited)

(Expressed in Thousands of US Dollars)

 

                                    
   Ordinary share capital       Accumulated             
   Number of shares   Additional paid in capital   Warrant reserve   Other Comprehensive Income   Accumulated deficit   Non-controlling interest   Total Equity 
Balance - January 1, 2023   30,945,322   $43,452   $30,863   $(1,634)  $(67,395)  $(2,397)  $2,889 
Net loss for the period   -    -    -    -    (10,541)   (724)   (11,265)
Adjustments arising from translating financial statements of foreign operations   -    -    -    225    -    -    225 
Net comprehensive loss for the period   -    -    -    225    (10,541)   (724)   (11,040)
Issuance of shares in respect of private placement   1,783,561    2,233    -    -    -    -    2,233 
Issuance of shares in respect of registered direct offering   3,818,275    4,193    -    -    -    -    4,193 
Exercise of RSU’s   30,000    -    -    -    -    -    - 
Exercise of warrants   65,000    99    -    -    -    -    99 
Share based compensation   -    2,967    -    -    -    -    2,967 
Balance - June 30, 2023   36,642,158    52,944   $30,863    (1,409)   (77,936)   (3,121)   1,341 

 

   Ordinary share capital       Accumulated             
   Number of shares   Additional paid in capital   Warrant reserve   Other Comprehensive Income   Accumulated deficit   Non-controlling interest   Total Equity 
Balance - January 1, 2022   26,326,488   $28,297   $34,763   $(708)  $(50,838)  $(607)  $10,907 
Net loss for the period   -    -    -    -    (5,302)   (795)   (6,097)
Adjustments arising from translating financial statements of foreign operations   -    -    -    (997)   -    (12)   (997)
Net comprehensive loss for the period   -    -    -    (997)   (5,302)   (795)   (7,094)
Issuance of shares in respect of crowd funding   74,895    -    -    -    -    -    - 
Exercise of warrants   584,207    4,072    (2,795)   -    -    -    1,277 
Issuance of shares in respect of Isramat deal (note 3)   273,774    2,089    -    -    -    -    2,089 
Exercise of options   16,667    20    -    -    -    -    20 
Expiration of warrants   -    51    -    -    -    -    51 
Share based compensation   -    111    -    -    -    -    111 
Balance - June 30, 2022   27,276,031    34,640   $31,968    (1,705)   (56,140)   (1,402)   7,361 

 

The accompanying notes are an integral part of these Condensed Interim Consolidated financial statements.

 

5

 

 

A2Z SMART TECHNOLOGIES CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Expressed in Thousands of US Dollars)

 

           
   Six months ended 
   June 30 
   2023   2022 
         
Cash flows from operating activities          
Net loss for the period   (11,265)   (6,097)
Adjustments to reconcile net loss to net cash provided by operating activities:          
Amortization and depreciation   547    303 
Share based compensation   2,967    111 
Loss on revaluation of warrant liability   2,344    - 
Loss on revaluation of contingent liability   19    - 
Change in severance liability   (2)   (21)
Change in inventory   (246)   (64)
Change in trade receivables   (174)   367 
Change in other account receivables   1,005    (2,211)
Accrued interest on loans and leases   (10)   1 
Loss from sale of property, plant and equipment   -    16 
Change in accounts payable   468    (151)
Changes in deferred revenues   (1,373)   1,236 
Change in other accounts payable   (116)   45 
Cash flow from operating activities   (5,836)   (6,465)
Cash flows from investing activities          
Restricted deposits   8    (14)
Newly consolidated subsidiary (see Appendix B)   -    (879)
Purchase of property, plant and equipment   (157)   (209)
Cash flow used in investing activities   (149)   (1,102)
           
Cash flows from financing activities          
Issuance of shares and warrants, net   9,188    - 
Exercise of options   -    20 
Exercise of warrants   99    1,277 
Lease payments   (172)   (47)
Repayment of loans   (394)   (282)
Proceeds from receipt of loans   94    429 
Cash flows from financing activities   8,815    1,398 
           
Increase (decrease) in cash and cash equivalents   2,830    (6,169)
Effect of changes in foreign exchange rates   225    (639)
Cash and cash equivalents at beginning of period   2,616    8,470 
           
Cash and cash equivalents at end of period   5,671    1,662 
           
Interest paid during the period   57    6 
           
APPENDIX A: NON-CASH ACTIVITIES          
Issuance of shares in respect of Isramat deal   -    2,089 

 

6

 

 

A2Z SMART TECHNOLOGIES CORP.

CONDENSED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(Expressed in Thousands of US Dollars)

 

APPENDIX B: INVESTMENT IN NEWLY CONSOLIDATED SUBSIDIARIES

 

   Six months ended 
   June 30 
   2023   2022 
         
Issuance of the Company’s ordinary shares   -    2,089 
Working capital other than cash and cash equivalents   -    (878)
Liability for severance pay fund, net   -    35 
Provision for vacation leave   -    49 
Property, plant and equipment   -    (636)
Goodwill   -    (1,538)
Total cash and cash equivalents paid   -    (879)

 

The accompanying notes are an integral part of these Condensed Interim Consolidated financial statements.

 

7

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 1 – NATURE AND CONTINUANCE OF OPERATIONS

 

A2Z SMART TECHNOLOGIES CORP. (the “Company” or “A2ZST”) was incorporated on January 15, 2018 under the laws of British Columbia. The head office is located at 1600 – 609 Granville Street, Vancouver, British Columbia V7Y 1C3, and the records and registered office is located at 2200 HSBC Building 885 West Georgia Street, British Columbia, V6C 3E8.

 

The Company was listed on the NASDAQ Stock Market LLC (“Nasdaq”) starting January 22, 2022, and trades under the symbol “AZ” and on the TSX Venture Exchange (“TSX Venture”) and trades under the symbol “AZ.V”.

 

The Company owns 76.78% of the common shares of Cust2Mate Ltd (“Cust2Mate”), a technology company focused on providing retail automation solutions, in particular for large grocery stores and supermarkets. The Company’s primary product is the Cust2Mate system which incorporates a “smart cart” which automatically calculates the value of the customers purchases in their smart cart, without having to unload and reload their purchases at a customer checkout point.

 

The Cust2Mate system offers various features for shoppers and retailers such as product information and location, an on-cart scale to weigh items and automatically calculate costs, bar-code scanner and on-board payment system to bypass checkout lines. In addition, the product includes big data smart algorithms and computer vision capabilities, allowing for customer specific targeted advertising. (“The Cust2Mate Platform”).

 

The Cust2Mate Platform is being rolled out in Israel and is being marketed throughout the world, with pilot programs in North and South America, Europe and in the Middle East.

 

The Company’s other activities include the provision of services in the field of services to the military and security markets as well as the development of related products for the civilian markets. Such services include providing maintenance services and container leasing. The Company also provides maintenance services for complex electronic systems and products.

 

On February 3, 2022, the Company announced the closing of acquisition of Isramat Ltd. This strategic acquisition vertically integrates certain manufacturing capabilities for the production of A2Z’s Cust2Mate smart cart while complementing existing contract manufacturing partnerships to support anticipated worldwide growth.

 

The Company, through its 80% owned subsidiary, Advanced Automotive Innovations Inc., (“AAI”) continues the development of a product for the automotive market - the FTICS or Fuel Tank Inertia Capsule System which activates automatically in the event of a vehicle collision. This eliminates the danger of fuel tank combustion thereby saving lives and reducing damage.

 

As of June 30, 2023, the Company had four key subsidiaries, all of which are companies incorporated under the laws of Israel: (1) Cust2mate Ltd. (“Cust2mate”); (2) A2Z Advanced Military Solutions Ltd (“A2Z MS”); (3) A2Z Advanced Solutions Ltd. (“A2Z AS”); and (4) Isramat Ltd., the “Subsidiaries”).

 

The Company had a net loss of approximately $11.3 million for the six months ended June 30, 2023, and $6.1 million for the six months ended June 30, 2022. The Company has an accumulated deficit of $78 million as of June 30, 2023. The Company has incurred negative cash from operations and net losses for the current and recent periods. The Company financed its operation up to date by issuance of shares and warrants. The Company does not have any material financial cash obligations as of the balance date. The company believes that it has sufficient resources to operate in the foreseeable future with the support of its directors and officers.

 

These Condensed Interim Consolidated financial statements were authorized for issue by the Board of Directors on August 14, 2023.

 

8

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 2 – BASIS OF PREPARATION

 

1.Significant accounting policy

 

Statement of Compliance

 

These unaudited Condensed Interim Consolidated financial statements of the Company are as of June 30, 2023, and presented in US dollars, which is not the functional currency. The functional currency is the NIS. These unaudited interim condensed consolidated financial statements have been prepared in accordance with the requirements of International Accounting Standard IAS 34 “Interim Financial Reporting” as issued by the IASB. They do not include all the information required in annual financial statements in accordance with IFRS and should be read in conjunction with the financial statements of the Company for the year ended December 31, 2022.

 

The policies applied in these Condensed Interim Consolidated financial statements are based on IFRS effective as of June 30, 2023, and are consistent with those included in the Company’s annual financial statements for the year ended December 31, 2022.

 

Basis of Consolidation

 

The financial results of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Intercompany balances and transactions and any unrealized income and expenses arising from such transactions are eliminated upon consolidation.

 

Basis of measurement

 

These consolidated financial statements have been prepared on a going concern basis, under the historical cost basis, except for financial instruments which have been measured at fair value.

 

2.Critical Estimates and Assumptions

 

The preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these estimates. The Company’s financial statements include estimates which, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the Company’s financial statements and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and also in future periods when the revision affects both current and future periods.

 

9

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

The functional currency for each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates; the Company has determined the functional currency of each entity to be the New Israeli Shekel. Such determination involves certain judgements to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions which determine the primary economic environment. During there three and six months ended June 30, 2023, there have been not such changes. The Company’s presentation currency is the U.S. dollar.

 

The critical judgments and significant estimates in applying accounting policies that have the most significant effect on the amounts recognized in the financial statements are the same as at December 31, 2022:

 

  a) The useful life of property and equipment

 

Property and equipment are amortized or depreciated over their useful lives. Useful lives are based on management’s estimates of the period that the assets will generate revenue, which are periodically reviewed for continued appropriateness. Changes to estimates can result in significant variations in the amounts charged to the consolidated statement of comprehensive income in specific periods.

 

  b) Determining the fair value of share-based payment transactions

 

The fair value of share-based payment transactions is determined upon initial recognition by the Binomial model. The Binomial model is based on share price and exercise price and assumptions regarding expected volatility, term of share option, dividend yield and risk-free interest rate.

 

  c) Intangible assets and goodwill

 

Intangible assets and goodwill are tested for impairment annually or more frequently if three is an indication of impairment. The carrying value of intangibles with definite lives is reviewed each reporting period to determine whether there is any indication of impairment. If there are indications of impairment the impairment analysis is completed and if the carrying amount of an asset exceeds its recoverable amount, the asset is impaired and impairment loss is recognized.

 

  d) Derivative liability – Warrants

 

The Company uses the Black-Scholes option-pricing model to estimate fair value at each reporting date. The key assumptions used in the model are the expected future volatility in the price of the Company’s Common Shares and the expected life of the warrants.

 

  e) Going concern

 

In order to assess whether it is appropriate for the Company to continue as going concern, management is required to apply judgements and make estimates with regards to future cash flow projections. In arriving at this judgement there were several assumptions and estimates involved in calculating the future cash flow projections. These includes making estimates regarding the timing and amounts of future expenditures and the ability and timing to raising additional financing.

 

3.New Accounting Standards

 

A number of amended standards became applicable for the current reporting period. The Company and its subsidiaries did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amended standards:

 

1.IFRS 17 Insurance Contracts

2.Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2

3.Definition of Accounting Estimates – Amendments to IAS 8

4.Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12

 

10

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 3 – WARRANT LIABILITY

 

  a)

June 2023 Warrants

 

On June 15 and on June 20, 2023, the Company issued an aggregate of 1,909,134 June 2023 Registered Direct Offerings Warrants (as defined below) as part of registered direct offerings (see also note 5(g)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.93) rather than the functional currency of the Company – New Israeli Shekels (NIS). The June 2023 Registered Direct Offerings Warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 99% using the historical prices of the Company, risk-free interest rate of 4.45%, expected life of 2.00 years and share price of CAD2.99.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2023  $- 
Issuance of June 2023 Registered Direct Offerings Warrants   2,333 
      
Balance at June 30, 2023  $2,333 

 

  b)

March 2023 Warrants

 

On March 20, 2023, the Company issued an aggregate of 891,778 March 2023 Warrants (as defined below) as part of a private placement (see also note 5(f)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.35) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 93% using the historical prices of the Company, risk-free interest rate of 3.62%, expected life of 2.00 years and share price of CAD1.74.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2023  $- 
Issuance of March 2023 Warrants   496 
      
Balance at March 31, 2023  $496 
Revaluation at June 30, 2023   1,004 
      
Balance at June 30, 2023  $1,500 

 

11

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 3 – WARRANT LIABILITY (CONTINUED)

 

For the three- and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the March 2023 warrant liability in the amount of $1,004 and $1,004, respectively (for the three- and six-month period ended June 30, 2022 - $nil and $nil, respectively).

 

  c)

November 2022 Warrants

 

On November 2, 2022, the Company issued an aggregate of 1,489,166 warrants (November 2022 Warrants) as part of a private placement. The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.35) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 110% using the historical prices of the Company, risk-free interest rate of 3.94%, expected life of 2.00 years and share price of CAD1.56.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2022  $- 
Issuance of November 2022 Warrants   894 
Revaluation at December 31,2022   248 
      
Balance at December 31, 2022  $1,142 
Revaluation at March 31, 2023  $(405)
      
Balance at March 31, 2023  $737 
Warrant exercises (note 4(d))  $(66)
Revaluation at June 30, 2023   1,745 
Balance at June 30, 2023  $2,416 

 

For the three-and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the November 2022 warrant liability in the amount of $1,745 and $1,362, respectively (for the three- and six-month period ended June 30, 2022 - $nil and $nil, respectively).

 

12

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 4 - SHAREHOLDERS EQUITY

 

  a) During the six months ended June 30, 2022, the Company issued 584,207 shares in respect of 584,207 warrants that were exercised for gross proceeds of $1,277 (note 5 (a)).
     
  b) On February 3, 2022, the Company issued the shareholders of Isramat 273,774 common shares in the capital of the Company in respect of the acquisition of Isramat. Total value of the shares issued was $2,089.
     
  c) On February 11, 2022, the Company issued 74,985 shares to a trustee in respect of a crowd funding transaction that was completed in 2019, for which shares were not immediately issued until the completion of an Israeli tax ruling which was only finalized in late 2021.
     
  d)

During the six months ended June 30, 2023, the Company issued 65,000 shares in respect of 65,000 warrants that were exercised for gross proceeds of $99 (note 3 (c) and note 5 (a)).

     

e) During the six months ended June 30, 2023, the Company issued 30,000 shares in respect of 30,000 RSU’s that were exercised (note 5 (c)).
   
  f) On March 20, 2023, the Company closed a private placement for gross proceeds of $2,604 through the issuance of 1,783,561 units (“Units”) at a price per Unit of US$1.46 (CAD$1.95). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of 891,778 Warrants were issued with an exercise price of CAD$2.35 (US$1.75) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional 891,778 common shares (“March 2023 Private Placement Warrants”). A finder’s fee of $208 (CAD$290) was paid and 142,685 March 2023 Private Placement Warrants were issued in connection with the private placement.
     
  g) On June 15 and on June 20, 2023, the Company closed registered direct offerings for gross proceeds of $6,873 through the issuance of 3,818,275 units (“Units”) at a price per Unit of US$1.80 (CAD$2.41). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of 1,909,134 Warrants were issued with an exercise price of CAD$2.93 (US$2.20) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional 1,909,134 common shares (“June 2023 Registered Direct Offerings Warrants”). A finder’s fee of $550 (CAD$733) was paid and 305,462 non-registered warrants were issued in connection with the Registered Direct Offerings.

 

13

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 5 - WARRANTS AND OPTIONS

 

a) Warrants

 

  (i) Warrant transactions for the six months ended June 30, 2023 and for the year ended December 31, 2022 are as follows:

   Number   Weighted Average
Exercise Price
 
Balance, January 1, 2022   5,966,204   $3.55 
Expiration of warrants   (5,437)     
Exercise of warrants   (630,161)     
Warrants issued in the November 2022 Private Placement   1,726,366      
Balance, December 31, 2022   7,056,972   $3.07 
Warrants issued in the March 2023 Private Placement   1,034,463      
Exercise of warrants (*)   (65,000)     
Warrants issued in the June 2023 Registered Direct Offerings   2,214,596      
Balance, June 30, 2023   10,241,031   $2.67 

 

(*)During the six months ended June 30, 2023, the Company issued 65,000 shares in respect of 65,000 warrants that were exercised for gross proceeds of $99. All exercised warrants were warrants classified as a liability prior to their exercise.

 

14

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)

 

a) Warrants (continued)

 

As at June 30, 2023, the Company had outstanding warrants, enabling the holders to acquire common shares as follows:

June 30, 2023   Expiry date  Exercise price   Exercise price (USD) 
 2,658,313   November 10, 2025    ILS7.1418(1)  $1.93 
 1,366,631   December 24, 2025    ILS7.1418(1)  $1.93 
 221,100   April 22, 2026    ILS29.025(2)  $7.84 
 1,084,562   May 6, 2026    ILS29.025(2)  $7.84 
 1,661,366   November 8, 2024    CAD2.04   $1.60 
 1,034,463   March 13, 2025    CAD2.35   $1.75 
 2,214,596   June 15, 2025    CAD2.93   $2.20 
 10,241,031                

 

  1. On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant.
     
  2. On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026.

 

b) Stock Options

 

Stock option transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number   Weighted
Average
Exercise Price
(CAD)
   Weighted
Average
Exercise Price
(USD)
 
Balance January 1, 2022   820,010   $2.26   $1.78 
Options granted   1,200,000    3.67      
Exercise of options   (116,667)   2.27      
Expiry of options   (20,000)   1.50      
Balance December 31, 2022   1,883,343   $3.17   $2.45 
Options granted (i-iv)   1,585,250    1.78    1.34 
Balance June 30, 2023   3,468,593   $2.53   $1.91 

 

  (i)

On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.

 

  (ii) On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
     
  (iii) On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
     
  (iii) On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.

 

15

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)

 

b) Stock Options (continued)

 

As at June 30, 2023, the Company had outstanding stock options, enabling the holders to acquire common shares as follows:

Outstanding as
of June 30,
2023
   Exercisable as
of June 30,
2023
   Expiry date  Exercise price (CAD)   Exercise price (USD) 
 543,333    510,000   August 20, 2025  CAD 1.50   $1.11 
 40,000    40,000   September 1, 2025  CAD 2.25   $1.66 
 33,333    33,333   January 28, 2025  CAD 3.00   $2.21 
 50,000    33,333   June 3, 2026  CAD 8.40   $6.20 
 16,677    11,118   October 28, 2026  CAD 8.00   $5.90 
 900,000    337,500   August 2, 2032  CAD 3.56   $2.63 
 300,000    300,000   August 21, 2032  CAD 4.00   $2.95 
 816,500    802,063   January 4, 2033  CAD 1.65   $1.22 
 100,000    25,000   November 25, 2027  CAD 2.01   $1.48 
 423,750    -   April 18, 2033  CAD 1.60   $1.21 
 245,000    -   June 28, 2028  CAD 2.45   $1.85 
 3,468,593    2,117,347               

 

Share-based compensation expense is recognized over the vesting period of options. During the six months ended June 30, 2022, share-based compensation of $2,547 was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $111).

 

c) RSU’s

 

On August 4, 2022, the Company granted 1,265,000 Restricted Share Units (“RSUs”) to directors, officers and advisers, of which 590,000 RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no-par value in the Company (“Common Shares”).

 

On January 4, 2023, the Company granted 1,027,000 Restricted Share Units (“RSUs”) to directors, officers and advisers, of which 260,000 RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,027,000 common shares of no-par value in the Company (“Common Shares”).

 

On April 18, 2023, the Company granted 116,250 Restricted Share Units (“RSUs”) to employees, pursuant to the Company’s RSU Plan. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 116,250 common shares of no-par value in the Company (“Common Shares”).

 

On June 28, 2023, the Company granted 165,000 Restricted Share Units (“RSUs”) to officers pursuant to the Company’s RSU Plan. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 165,000 common shares of no-par value in the Company (“Common Shares”).

 

RSU’s transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number 
Balance, January 1, 2022   - 
RSU’s granted   1,265,000 
Exercise of RSU’s   (545,000)
Balance, December 31, 2022   720,000 
RSU’s granted   1,308,250 
Exercise of RSU’s   (30,000)
Expiry of RSU’s   (66,667)
Balance, June 30, 2023   1,931,583 

 

Total exercisable RSU’s as at June 30, 2023, are 585,333 (December 31, 2022 – 225,832). During the six months ended June 30, 2023, share-based compensation of $420 was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $nil).

 

16

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 6 - REVENUES:

 

Revenue streams:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
                 
Revenues from services:                    
Revenues from services   618    301    1,149    638 
Revenues from leasing   154    75    287    159 
                     
Precision metal parts:                    
Revenues from sales of precision metal parts   795    1,054    1,612    1,872 
Smart Carts:                    
Revenues from smart carts project   1,574    -    4,701    207 
Revenues   3,141    1,430    7,749    2,876 

 

NOTE 7 – OPERATING SEGMENTS:

 

The Company and its subsidiaries are engaged in the following three segments:

 

  a. Services to the military/security markets as well as development of related products for the civilian and retail markets. (“Services”)
     
  b. Retail automation solutions – Smart Carts (“Smart Carts”)
     
  c. Manufacturing and selling of precision metal parts – “Precision Metal Parts”

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,612   $1,436   $4,701   $7,749 
Inter-segment   -    (281)   -    (281)
Total   1,612    1,155    4,701    7,468 
                     
Segment loss (gain)   548    (56)   8,276    8,768 
Loss on revaluation of warrant liability                  2,344 
Finance expense, net                  153 
Tax expenses                  - 
Loss                 $11,265 

 

17

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,872   $797   $207   $2,876 
Inter-segment   -    -    -    - 
Total   1,872    797    207    2,876 
                     
Segment loss   199    492    5,397    6,088 
Loss on sale of fixed asset                  16 
Finance expense, net                  (7)
Tax expenses                  - 
Loss                 $6,097 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $795   $772   $1,575   $3,141 
Inter-segment   -    (281)   -    (281)
Total   795    491    1,575    2,860 
                     
Segment loss (gain)   277    122    4,339    4,738 
Loss on revaluation of warrant liability                  2,749 
Finance expense, net                  (65)
Tax expenses                  - 
Loss                 $7,422 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,054   $376   $-   $1,430 
Inter-segment   -    -    -    - 
Total   1,054    376    -    1,430 
                     
Segment loss   137    210    3,023    3,370 
Loss on sale of fixed asset                  - 
Finance expense, net                  (5)
Tax expenses                  - 
Loss                 $3,365 

 

18

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 8 - FINANCIAL RISK FACTORS:

 

ECL and their measurement

 

ECL are measured as the unbiased probability-weighted present value of all cash shortfalls over the expected life of each financial asset. For receivables from financial services, ECL are mainly calculated with a statistical model using three major risk parameters: probability of default, loss given default and exposure at default. The estimation of these risk parameters incorporates all available relevant information, not only historical and current loss data, but also reasonable and supportable forward-looking information reflected by the future expectation factors. This information includes macroeconomic factors (e.g., gross domestic product growth, unemployment rate, cost performance index) and forecasts of future economic conditions. For receivables from financial services, these forecasts are performed using a scenario analysis (base case, adverse and optimistic scenarios).

 

As of June 30, 2023, and December 31, 2022, ECL for trade and other account receivables are not material, and as such are not disclosed, in accordance IFRS 9.

 

NOTE 9 – SUBSEQUENT EVENTS

 

  a) During July 2023, the Company issued 100,000 shares in respect of 100,000 RSU’s that were exercised.
     
  b) During August 2023, the Company issued 2,000 shares in respect of 2,000 warrants that were exercised for gross proceeds of $3.

 

19

 

EX-101.SCH 3 az-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - BASIS OF PREPARATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - WARRANT LIABILITY link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SHAREHOLDERS EQUITY link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - WARRANTS AND OPTIONS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - REVENUES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - OPERATING SEGMENTS link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - FINANCIAL RISK FACTORS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - WARRANT LIABILITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - WARRANTS AND OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - REVENUES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - OPERATING SEGMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - WARRANT LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SHAREHOLDERS EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - SCHEDULE OF RSU’S TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - WARRANTS AND OPTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - SCHEDULE OF REVENUE FROM SERVICES (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - OPERATING SEGMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 az-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 5 az-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 6 az-20230630_lab.xml XBRL LABEL FILE Components of equity [axis] Issued capital [member] Capital reserve [member] Accumulated other comprehensive income [member] Retained earnings [member] Non-controlling interests [member] Associates [axis] Cust2Mate Ltd [member] Subsidiaries [axis] Advanced Automotive Innovations Inc. [member] Types of Warrants [Axis] June 2023 registered direct offerings [member] March 2023 private placements [member] November 2022 warrants [member] November 2022 warrants [member] Business combinations [axis] Isramat Ltd [member] Types of share-based payment arrangements [axis] RSU's [member] Warrants [member] March 2023 private placement warrants [member] June 2023 registered direct offerings warrants [member] Non-registered Warrants [Member] Subsidiary Sale of Stocks [Axis] November 2022 private placement [member] March 2023 private placement [member] Warrants one [member] Warrants two [member] Warrants three [member] Warrants four [member] Warrants five [member] Warrants six [Member] Warrants seven [member] Counterparties [axis] Warrant holders [member] Stock option one [member] Consultant [member] Stock option two [member] Stock option three [member] Stock option four [member] Stock option five [member] Stock option six [member] Stock option seven [member] Stock option eight [member] Stock option nine [member] Stock option ten [member] Stock option eleven [member] Directors officers and advisers [member] Executives and directors [member] Employees [member] Officers [member] Products and services [axis] Revenues from services [member] Revenues from leasing [member] Revenues from sales of precision metal parts [member] Revenues from smart carts project [member] External [member] Segments [axis] Precision metal parts [member] Advanced engineering [member] SmartCarts [member] Intersegment [member] Non-adjusting events after reporting period [axis] Nonadjusting event [member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of financial position [abstract] ASSETS Current assets Cash and cash equivalents Restricted cash Inventories Trade receivables, net Other accounts receivable Total current assets Intangible asset - patent, net Goodwill Property, plant and equipment, net Total non-current assets Total Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Short term loan and current portion of long-term loans Lease liability Trade payables Deferred revenues Other accounts payable Total current liabilities Lease liability Long term loans Provisions Warrant Liability (note 3) Severance payment, net Total non-current liabilities Total liabilities Shareholders’ equity (note 4) Share capital and additional paid in capital Warrant Reserve Accumulated other comprehensive income Accumulated deficit Total equity including non-controlling interest Non-controlling interest Total shareholders’ equity Total liabilities and shareholders’ equity Profit or loss [abstract] Revenues (note 7) Cost of revenues Gross profit Expenses: Research and development costs Sales and marketing costs General and administration expenses Operating loss Loss on revaluation of warrant liability (note 4) Loss on sale of property, plant and equipment Financial (income) expense Loss before taxes on income Income tax expense Net loss for the period Less: Net loss attributable to non-controlling interests Net loss attributable to controlling shareholders Other comprehensive income (loss) Item that will not be reclassified to profit or loss: Adjustments arising from translating of financial statements to presentation currency Other comprehensive income (loss) Total comprehensive loss for the period Less: Comprehensive loss attributable to non-controlling interests Comprehensive loss attributable to controlling shareholders Basic loss per share Diluted loss per share Weighted average number of shares outstanding Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance, value Beginning balance, shares Net loss for the period Adjustments arising from translating financial statements of foreign operations Net comprehensive loss for the period Issuance of shares in respect of private placement Issuance of shares in respect of private placement, shares Issuance of shares in respect of registered direct offering Issuance of shares in respect of registered direct offering, shares Exercise of RSU’s Exercise of RSU's, shares Exercise of warrants Exercise of warrants, shares Share based compensation Issuance of shares in respect of crowd funding Issuance of shares in respect of crowd funding, shares Issuance of shares in respect of Isramat deal (note 3) Issuance of shares in respect of Isramat deal (note 3), shares Exercise of options Exercise of options, shares Expiration of warrants Ending balance, value Ending balance, shares Statement of cash flows [abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash provided by operating activities: Amortization and depreciation Share based compensation Loss on revaluation of warrant liability Loss on revaluation of contingent liability Change in severance liability Change in inventory Change in trade receivables Change in other account receivables Accrued interest on loans and leases Loss from sale of property, plant and equipment Change in accounts payable Changes in deferred revenues Change in other accounts payable Cash flow from operating activities Cash flows from investing activities Restricted deposits Newly consolidated subsidiary (see Appendix B) Purchase of property, plant and equipment Cash flow used in investing activities Cash flows from financing activities Issuance of shares and warrants, net Exercise of options Exercise of warrants Lease payments Repayment of loans Proceeds from receipt of loans Cash flows from financing activities Increase (decrease) in cash and cash equivalents Effect of changes in foreign exchange rates Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Interest paid during the period APPENDIX A: NON-CASH ACTIVITIES Issuance of shares in respect of Isramat deal Issuance of the Company’s ordinary shares Working capital other than cash and cash equivalents Liability for severance pay fund, net Provision for vacation leave Property, plant and equipment Goodwill Total cash and cash equivalents paid Disclosure of notes and other explanatory information [text block] NATURE AND CONTINUANCE OF OPERATIONS BASIS OF PREPARATION Warrant Liability WARRANT LIABILITY Disclosure of share capital, reserves and other equity interest [text block] SHAREHOLDERS EQUITY Warrants And Options WARRANTS AND OPTIONS REVENUES OPERATING SEGMENTS FINANCIAL RISK FACTORS SUBSEQUENT EVENTS IfrsStatementTable [Table] SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS SCHEDULE OF WARRANTS TRANSACTIONS SCHEDULE OF OUTSTANDING WARRANTS SCHEDULE OF STOCK OPTION TRANSACTIONS SCHEDULE OF OUTSTANDING STOCK OPTIONS SCHEDULE OF RSU’S TRANSACTIONS SCHEDULE OF REVENUE FROM SERVICES SCHEDULE OF OPERATING SEGMENTS Disclosure of associates [table] Proportion of ownership interest in associate Ownership interest in subsidary Profit (loss) of combined entity as if combination occurred at beginning of period Retained earnings Balance, warrants Issuance, warrants Balance, warrants Revaluation, warrants Reclassification to Warrant Reserve Class of warrant or right outstanding Exercise price of warrant Warrants exercisable term Volatility warrants granted Risk-free interest rate Expected life Share price Gain loss on revaluation of warrant liability Disclosure of detailed information about business combination [table] Number of shares issued Number of warrants exercised Proceeds from exercise of warrants Proceeds from private placements Warrant exercise price per share Issuance of additional common shares Finder fee Private placement of warrant shares issued [custom:ProceedsFromIssuanceOfUnits] Number of warrants outstanding, beginning balance Weighted Average Exercise Price, Beginning Balance Number of warrants outstanding, Expired of warrants Number of warrants outstanding, Exercise of warrants Number of warrants outstanding, warrants issued Number of warrants outstanding, ending balance Weighted Average Exercise Price, Beginning Balance Number of share options outstanding in share-based payment arrangement Number of warrants outstanding Number of warrants outstanding Expiry date Exercise price Schedule Of Stock Option Transactions Number of stock options, beginning balance Weighted Average Exercise Price, beginning balance Number of stock options, options granted Weighted Average Exercise Price, options granted Number of stock options, Exercise of options Weighted Average Exercise Price, Exercise of options Number of stock options, Expiry of options Weighted Average Exercise Price, Expiry of options Number of stock options, ending balance Weighted Average Exercise Price, ending balance Number of stock options, options issued Number of stock options, exercise price Options expire Fair value of options granted Share Price Expected option life Volatility Risk-free interest rate Dividend yield Number of stock options, Outstanding Number of stock options, Exercisable Number of stock options, Expiry date Number of stock options, Exercise price Disclosure of terms and conditions of share-based payment arrangement [table] Number of RSU's, beginning balance Number of RSU's, granted Number of RSU's, Exercise Number of RSU's, Expiry Number of RSU's, ending balance Share based compensation RSU's granted Description of RSU's vesting and conversion RSU's exercisable Disclosure of disaggregation of revenue from contracts with customers [table] Revenues Total Segment loss Loss on revaluation of warrant liability Finance expense, net Tax expenses Loss Loss on sale of fixed asset Number of operating segment Disclosure of non-adjusting events after reporting period [table] Number of share issuance Number of restricted stock units exercised Exercise of option Disclosure of warrant liability explanatory. Class of warrant or right outstanding. Types of Warrants [Axis] November 2022 warrants [member] Disclosure of warrants and option explanatory. Disclosure of warrants transactions explanatory. Exercise price of warrant. Class of warrant or right outstanding warrants expired. Deferred revenues. Provision noncurrent liabilities. Warrants exercisable term. Class of warrant or right outstanding warrants exercised. Non controlling interest. Class of warrant or right outstanding warrants issued. Subsidiary Sale of Stocks [Axis] November 2022 private placement [member] Description of expected volatility warrants granted. Fair value assumptions expected life. Description of risk free interest rate warrants granted. Warrant liability loss. Issuance of warrants. Share price. Class of warrant or right outstanding weighted average exercise price. Adjustments arising from translating financial statements of foreign operations. Revaluation of warrants. Class of warrants or right outstanding. Warrants one [member] Warrants two [member] Warrants three [member] Warrants four [member] Warrants five [member] Warrants and rights outstanding expiry date. Class of warrant or right exercise price. Warrants seven [member] Exercise of warrants. Exercise of restricted stock units. Exercise of stock options. Expiration of warrants. Exercise of stock options, shares. Number of operating segment. Issuance of shares in respect of is ramat deal. Issuance of shares in respect of isramat deal share. Exercise of warrants shares. Issuance of shares in respect of crowd funding. Issuance of shares in respect of crowd funding share. Warrant holders [member] Precision metal parts [member] Advanced engineering [member] SmartCarts [member] Exercise of restricted stock units, shares Issuance of shares in respect of registered direct offering. Issuance of shares in respect of registered direct offering shares. External [member] Intersegment [member] Losses on revaluation of warrant liability. Change in severance liability. Adjustments for increase decrease in deferred revenues. Interest paid during year. Loss on revaluation of warrant liability. Issuance of share in respect of is ramat deal. Adjustments for gain loss on loss on revaluation of contingent liability. Gain loss on sale of fixed asset. Issuance of shares in private placement. Issuance of shares in private placement shares. Working capital other than cash and cash equivalents. Liability for severance pay fund net. Non cash transaction property plant and equipment. Non cash transaction goodwill. Non cash transaction cash and cash equivalents paid. Issuance of companys ordinary shares. Noncash activities [Abstract] Advanced Automotive Innovations Inc. [member] Cust2Mate Ltd [member] Financial income expense. Number of restricted stock units exercised. Provision for vacation leave. Number of warrants exercised. Stock option one [member] Consultant [member] Weighted average remaining contractual life of outstanding share options. Fair value of options granted. Description of option life share option granted. Profit loss attributable to noncontrolling interests. Comprehensive income loss attributable to noncontrolling interests. Stock option two [member] Stock option three [member] Stock option four [member] Stock option five [member] Stock option six [member] Stock option seven [member] Disclosure of number of shares of other equity instruments explanatory. RSU's [member] Stock option eight [member] Stock option nine [member] Stock option ten [member] Stock option eleven [member] Nonadjusting event [member] June 2023 registered direct offerings [member] Trade current payables. Warrant liability non-current. Severance payment net. Disclosure of fair value of warrants explanatory. March 2023 private placement [member] Expenses. March 2023 private placements [member] Number of warrants outstanding. Gain loss on revaluation of warrant liability. November 2022 warrants [member] Warrants six [Member] Directors officers and advisers [member] Executives and directors [member] Employees [member] Officers [member] Warrants [member] Isramat Ltd [member] Warrant exercise price per share. Issuance of additional common shares. March 2023 private placement warrants [member] Finder fee. Private placement warrant share issued. June 2023 registered direct offerings warrants [member] Proceeds from private placements. Proceeds from issuance of units. Revenues from services [member] Revenues from leasing [member] Revenues from sales of precision metal parts [member] Revenues from smart carts project [member] Non-registered Warrants [Member] November 2022 warrants [member] [Default Label] Current assets [Default Label] Non-current assets Assets Current liabilities [Default Label] Non-current lease liabilities Non-current liabilities Liabilities Equity attributable to owners of parent Equity Equity and liabilities Gross profit Profit (loss) from operating activities Gains (losses) on change in fair value of derivatives Adjustments for gain (loss) on disposals, property, plant and equipment FinancialIncomeExpense Profit (loss) before tax Profit (loss), attributable to owners of parent Other comprehensive income Number of shares outstanding Adjustments for share-based payments AdjustmentsForGainLossOnLossOnRevaluationOfContingentLiability Cash flows from (used in) operating activities Other cash payments to acquire interests in joint ventures, classified as investing activities Purchase of property, plant and equipment, classified as investing activities Cash flows from (used in) investing activities Payments of lease liabilities, classified as financing activities Repayments of borrowings, classified as financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents before effect of exchange rate changes NonCashTransactionGoodwill Profit (loss) of combined entity as if combination occurred at beginning of period WarrantLiabilityLoss ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice ClassOfWarrantOrRightOutstandingWarrantsExpired ClassOfWarrantOrRightOutstandingWarrantsExercised ClassOfWarrantsOrRightOutstanding Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options exercised in share-based payment arrangement Number of share options expired in share-based payment arrangement Risk free interest rate, share options granted Number of other equity instruments outstanding in share-based payment arrangement Number of other equity instruments exercised or vested in share-based payment arrangement Number of other equity instruments expired in share-based payment arrangement SharebasedCompensationRecognized LossOnRevaluationOfWarrantLiability EX-101.PRE 7 az-20230630_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
6 Months Ended
Jun. 30, 2023
Cover [Abstract]  
Document Type 6-K/A
Amendment Flag true
Amendment Description Amendment No. 1
Document Period End Date Jun. 30, 2023
Document Fiscal Period Focus Q2
Document Fiscal Year Focus 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-40472
Entity Registrant Name A2Z SMART TECHNOLOGIES CORP
Entity Central Index Key 0001866030
Entity Address, Address Line One 1600-609 Granville Street
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V7Y 1C3
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Interim Consolidated Statements of Financial Position (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 5,671 $ 2,616
Restricted cash 8
Inventories 621 375
Trade receivables, net 1,547 1,373
Other accounts receivable 1,566 2,570
Total current assets 9,405 6,942
Intangible asset - patent, net 2,115 2,207
Goodwill 1,188 1,188
Property, plant and equipment, net 2,059 2,357
Total non-current assets 5,362 5,752
Total Assets 14,767 12,694
Current liabilities    
Short term loan and current portion of long-term loans 1,155 1,403
Lease liability 257 281
Trade payables 2,692 2,224
Deferred revenues 1,373
Other accounts payable 840 956
Total current liabilities 4,944 6,237
Lease liability 447 605
Long term loans 289 341
Provisions 1,466 1,447
Warrant Liability (note 3) 6,249 1,142
Severance payment, net 31 33
Total non-current liabilities 8,482 3,568
Total liabilities 13,426 9,805
Shareholders’ equity (note 4)    
Share capital and additional paid in capital 52,944 43,452
Warrant Reserve 30,863 30,863
Accumulated other comprehensive income (1,409) (1,634)
Accumulated deficit (77,936) (67,395)
Total equity including non-controlling interest 4,462 5,286
Non-controlling interest (3,121) (2,397)
Total shareholders’ equity 1,341 2,889
Total liabilities and shareholders’ equity $ 14,767 $ 12,694
XML 10 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Profit or loss [abstract]        
Revenues (note 7) $ 2,860 $ 1,430 $ 7,468 $ 2,876
Cost of revenues 2,222 1,219 5,809 2,389
Gross profit 638 211 1,659 487
Expenses:        
Research and development costs 1,220 1,106 2,243 2,171
Sales and marketing costs 359 199 482 282
General and administration expenses 3,797 2,276 7,702 4,122
Operating loss (4,738) (3,370) (8,768) (6,088)
Loss on revaluation of warrant liability (note 4) 2,749 2,344
Loss on sale of property, plant and equipment 16
Financial (income) expense (65) (5) 153 (7)
Loss before taxes on income (7,422) (3,365) (11,265) (6,097)
Income tax expense
Net loss for the period (7,422) (3,365) (11,265) (6,097)
Less: Net loss attributable to non-controlling interests (454) (416) (724) (795)
Net loss attributable to controlling shareholders (6,968) (2,949) (10,541) (5,302)
Item that will not be reclassified to profit or loss:        
Adjustments arising from translating of financial statements to presentation currency 574 (425) 225 (997)
Other comprehensive income (loss) 574 (425) 225 (997)
Total comprehensive loss for the period (6,848) (3,790) (11,040) (7,094)
Less: Comprehensive loss attributable to non-controlling interests (454) (410) (724) (795)
Comprehensive loss attributable to controlling shareholders $ (6,394) $ (2,955) $ (10,316) $ (6,298)
Basic loss per share $ (0.19) $ (0.11) $ (0.34) $ (0.23)
Diluted loss per share $ (0.19) $ (0.11) $ (0.34) $ (0.23)
Weighted average number of shares outstanding 33,386,071 27,261,525 32,349,810 27,049,715
XML 11 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Issued capital [member]
Capital reserve [member]
Accumulated other comprehensive income [member]
Retained earnings [member]
Non-controlling interests [member]
Total
Beginning balance, value at Dec. 31, 2021 $ 28,297 $ 34,763 $ (708) $ (50,838) $ (607) $ 10,907
Beginning balance, shares at Dec. 31, 2021 26,326,488          
IfrsStatementLineItems [Line Items]            
Net loss for the period (5,302) (795) (6,097)
Adjustments arising from translating financial statements of foreign operations (997) (12) (997)
Net comprehensive loss for the period (997) (5,302) (795) (7,094)
Exercise of warrants $ 4,072 (2,795) 1,277
Exercise of warrants, shares 584,207          
Share based compensation $ 111 111
Issuance of shares in respect of crowd funding
Issuance of shares in respect of crowd funding, shares 74,895          
Issuance of shares in respect of Isramat deal (note 3) $ 2,089 2,089
Issuance of shares in respect of Isramat deal (note 3), shares 273,774          
Exercise of options $ 20 20
Exercise of options, shares 16,667          
Expiration of warrants $ 51 51
Ending balance, value at Jun. 30, 2022 $ 34,640 31,968 (1,705) (56,140) (1,402) 7,361
Ending balance, shares at Jun. 30, 2022 27,276,031          
Beginning balance, value at Dec. 31, 2022 $ 43,452 30,863 (1,634) (67,395) (2,397) 2,889
Beginning balance, shares at Dec. 31, 2022 30,945,322          
IfrsStatementLineItems [Line Items]            
Net loss for the period (10,541) (724) (11,265)
Adjustments arising from translating financial statements of foreign operations 225 225
Net comprehensive loss for the period 225 (10,541) (724) (11,040)
Issuance of shares in respect of private placement $ 2,233 2,233
Issuance of shares in respect of private placement, shares 1,783,561          
Issuance of shares in respect of registered direct offering $ 4,193 4,193
Issuance of shares in respect of registered direct offering, shares 3,818,275          
Exercise of RSU’s
Exercise of RSU's, shares 30,000          
Exercise of warrants $ 99 99
Exercise of warrants, shares 65,000          
Share based compensation $ 2,967 2,967
Ending balance, value at Jun. 30, 2023 $ 52,944 $ 30,863 $ (1,409) $ (77,936) $ (3,121) $ 1,341
Ending balance, shares at Jun. 30, 2023 36,642,158          
XML 12 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities    
Net loss for the period $ (11,265) $ (6,097)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Amortization and depreciation 547 303
Share based compensation 2,967 111
Loss on revaluation of warrant liability 2,344
Loss on revaluation of contingent liability 19
Change in severance liability (2) (21)
Change in inventory (246) (64)
Change in trade receivables (174) 367
Change in other account receivables 1,005 (2,211)
Accrued interest on loans and leases (10) 1
Loss from sale of property, plant and equipment 16
Change in accounts payable 468 (151)
Changes in deferred revenues (1,373) 1,236
Change in other accounts payable (116) 45
Cash flow from operating activities (5,836) (6,465)
Cash flows from investing activities    
Restricted deposits 8 (14)
Newly consolidated subsidiary (see Appendix B) (879)
Purchase of property, plant and equipment (157) (209)
Cash flow used in investing activities (149) (1,102)
Cash flows from financing activities    
Issuance of shares and warrants, net 9,188
Exercise of options 20
Exercise of warrants 99 1,277
Lease payments (172) (47)
Repayment of loans (394) (282)
Proceeds from receipt of loans 94 429
Cash flows from financing activities 8,815 1,398
Increase (decrease) in cash and cash equivalents 2,830 (6,169)
Effect of changes in foreign exchange rates 225 (639)
Cash and cash equivalents at beginning of period 2,616 8,470
Cash and cash equivalents at end of period 5,671 1,662
Interest paid during the period 57 6
APPENDIX A: NON-CASH ACTIVITIES    
Issuance of shares in respect of Isramat deal 2,089
Issuance of the Company’s ordinary shares 2,089
Working capital other than cash and cash equivalents (878)
Liability for severance pay fund, net 35
Provision for vacation leave 49
Property, plant and equipment (636)
Goodwill (1,538)
Total cash and cash equivalents paid $ (879)
XML 13 R6.htm IDEA: XBRL DOCUMENT v3.23.2
NATURE AND CONTINUANCE OF OPERATIONS
6 Months Ended
Jun. 30, 2023
NATURE AND CONTINUANCE OF OPERATIONS

NOTE 1 – NATURE AND CONTINUANCE OF OPERATIONS

 

A2Z SMART TECHNOLOGIES CORP. (the “Company” or “A2ZST”) was incorporated on January 15, 2018 under the laws of British Columbia. The head office is located at 1600 – 609 Granville Street, Vancouver, British Columbia V7Y 1C3, and the records and registered office is located at 2200 HSBC Building 885 West Georgia Street, British Columbia, V6C 3E8.

 

The Company was listed on the NASDAQ Stock Market LLC (“Nasdaq”) starting January 22, 2022, and trades under the symbol “AZ” and on the TSX Venture Exchange (“TSX Venture”) and trades under the symbol “AZ.V”.

 

The Company owns 76.78% of the common shares of Cust2Mate Ltd (“Cust2Mate”), a technology company focused on providing retail automation solutions, in particular for large grocery stores and supermarkets. The Company’s primary product is the Cust2Mate system which incorporates a “smart cart” which automatically calculates the value of the customers purchases in their smart cart, without having to unload and reload their purchases at a customer checkout point.

 

The Cust2Mate system offers various features for shoppers and retailers such as product information and location, an on-cart scale to weigh items and automatically calculate costs, bar-code scanner and on-board payment system to bypass checkout lines. In addition, the product includes big data smart algorithms and computer vision capabilities, allowing for customer specific targeted advertising. (“The Cust2Mate Platform”).

 

The Cust2Mate Platform is being rolled out in Israel and is being marketed throughout the world, with pilot programs in North and South America, Europe and in the Middle East.

 

The Company’s other activities include the provision of services in the field of services to the military and security markets as well as the development of related products for the civilian markets. Such services include providing maintenance services and container leasing. The Company also provides maintenance services for complex electronic systems and products.

 

On February 3, 2022, the Company announced the closing of acquisition of Isramat Ltd. This strategic acquisition vertically integrates certain manufacturing capabilities for the production of A2Z’s Cust2Mate smart cart while complementing existing contract manufacturing partnerships to support anticipated worldwide growth.

 

The Company, through its 80% owned subsidiary, Advanced Automotive Innovations Inc., (“AAI”) continues the development of a product for the automotive market - the FTICS or Fuel Tank Inertia Capsule System which activates automatically in the event of a vehicle collision. This eliminates the danger of fuel tank combustion thereby saving lives and reducing damage.

 

As of June 30, 2023, the Company had four key subsidiaries, all of which are companies incorporated under the laws of Israel: (1) Cust2mate Ltd. (“Cust2mate”); (2) A2Z Advanced Military Solutions Ltd (“A2Z MS”); (3) A2Z Advanced Solutions Ltd. (“A2Z AS”); and (4) Isramat Ltd., the “Subsidiaries”).

 

The Company had a net loss of approximately $11.3 million for the six months ended June 30, 2023, and $6.1 million for the six months ended June 30, 2022. The Company has an accumulated deficit of $78 million as of June 30, 2023. The Company has incurred negative cash from operations and net losses for the current and recent periods. The Company financed its operation up to date by issuance of shares and warrants. The Company does not have any material financial cash obligations as of the balance date. The company believes that it has sufficient resources to operate in the foreseeable future with the support of its directors and officers.

 

These Condensed Interim Consolidated financial statements were authorized for issue by the Board of Directors on August 14, 2023.

XML 14 R7.htm IDEA: XBRL DOCUMENT v3.23.2
BASIS OF PREPARATION
6 Months Ended
Jun. 30, 2023
BASIS OF PREPARATION

NOTE 2 – BASIS OF PREPARATION

 

1.Significant accounting policy

 

Statement of Compliance

 

These unaudited Condensed Interim Consolidated financial statements of the Company are as of June 30, 2023, and presented in US dollars, which is not the functional currency. The functional currency is the NIS. These unaudited interim condensed consolidated financial statements have been prepared in accordance with the requirements of International Accounting Standard IAS 34 “Interim Financial Reporting” as issued by the IASB. They do not include all the information required in annual financial statements in accordance with IFRS and should be read in conjunction with the financial statements of the Company for the year ended December 31, 2022.

 

The policies applied in these Condensed Interim Consolidated financial statements are based on IFRS effective as of June 30, 2023, and are consistent with those included in the Company’s annual financial statements for the year ended December 31, 2022.

 

Basis of Consolidation

 

The financial results of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Intercompany balances and transactions and any unrealized income and expenses arising from such transactions are eliminated upon consolidation.

 

Basis of measurement

 

These consolidated financial statements have been prepared on a going concern basis, under the historical cost basis, except for financial instruments which have been measured at fair value.

 

2.Critical Estimates and Assumptions

 

The preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these estimates. The Company’s financial statements include estimates which, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the Company’s financial statements and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and also in future periods when the revision affects both current and future periods.

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

The functional currency for each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates; the Company has determined the functional currency of each entity to be the New Israeli Shekel. Such determination involves certain judgements to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions which determine the primary economic environment. During there three and six months ended June 30, 2023, there have been not such changes. The Company’s presentation currency is the U.S. dollar.

 

The critical judgments and significant estimates in applying accounting policies that have the most significant effect on the amounts recognized in the financial statements are the same as at December 31, 2022:

 

  a) The useful life of property and equipment

 

Property and equipment are amortized or depreciated over their useful lives. Useful lives are based on management’s estimates of the period that the assets will generate revenue, which are periodically reviewed for continued appropriateness. Changes to estimates can result in significant variations in the amounts charged to the consolidated statement of comprehensive income in specific periods.

 

  b) Determining the fair value of share-based payment transactions

 

The fair value of share-based payment transactions is determined upon initial recognition by the Binomial model. The Binomial model is based on share price and exercise price and assumptions regarding expected volatility, term of share option, dividend yield and risk-free interest rate.

 

  c) Intangible assets and goodwill

 

Intangible assets and goodwill are tested for impairment annually or more frequently if three is an indication of impairment. The carrying value of intangibles with definite lives is reviewed each reporting period to determine whether there is any indication of impairment. If there are indications of impairment the impairment analysis is completed and if the carrying amount of an asset exceeds its recoverable amount, the asset is impaired and impairment loss is recognized.

 

  d) Derivative liability – Warrants

 

The Company uses the Black-Scholes option-pricing model to estimate fair value at each reporting date. The key assumptions used in the model are the expected future volatility in the price of the Company’s Common Shares and the expected life of the warrants.

 

  e) Going concern

 

In order to assess whether it is appropriate for the Company to continue as going concern, management is required to apply judgements and make estimates with regards to future cash flow projections. In arriving at this judgement there were several assumptions and estimates involved in calculating the future cash flow projections. These includes making estimates regarding the timing and amounts of future expenditures and the ability and timing to raising additional financing.

 

3.New Accounting Standards

 

A number of amended standards became applicable for the current reporting period. The Company and its subsidiaries did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amended standards:

 

1.IFRS 17 Insurance Contracts

2.Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2

3.Definition of Accounting Estimates – Amendments to IAS 8

4.Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

XML 15 R8.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANT LIABILITY
6 Months Ended
Jun. 30, 2023
Warrant Liability  
WARRANT LIABILITY

NOTE 3 – WARRANT LIABILITY

 

  a)

June 2023 Warrants

 

On June 15 and on June 20, 2023, the Company issued an aggregate of 1,909,134 June 2023 Registered Direct Offerings Warrants (as defined below) as part of registered direct offerings (see also note 5(g)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.93) rather than the functional currency of the Company – New Israeli Shekels (NIS). The June 2023 Registered Direct Offerings Warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 99% using the historical prices of the Company, risk-free interest rate of 4.45%, expected life of 2.00 years and share price of CAD2.99.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2023  $- 
Issuance of June 2023 Registered Direct Offerings Warrants   2,333 
      
Balance at June 30, 2023  $2,333 

 

  b)

March 2023 Warrants

 

On March 20, 2023, the Company issued an aggregate of 891,778 March 2023 Warrants (as defined below) as part of a private placement (see also note 5(f)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.35) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 93% using the historical prices of the Company, risk-free interest rate of 3.62%, expected life of 2.00 years and share price of CAD1.74.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2023  $- 
Issuance of March 2023 Warrants   496 
      
Balance at March 31, 2023  $496 
Revaluation at June 30, 2023   1,004 
      
Balance at June 30, 2023  $1,500 

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 3 – WARRANT LIABILITY (CONTINUED)

 

For the three- and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the March 2023 warrant liability in the amount of $1,004 and $1,004, respectively (for the three- and six-month period ended June 30, 2022 - $nil and $nil, respectively).

 

  c)

November 2022 Warrants

 

On November 2, 2022, the Company issued an aggregate of 1,489,166 warrants (November 2022 Warrants) as part of a private placement. The warrants were issued with an exercise price denominated in Canadian Dollars (CAD2.35) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of 2 years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of 110% using the historical prices of the Company, risk-free interest rate of 3.94%, expected life of 2.00 years and share price of CAD1.56.

 

Level 3 for the period ended on June 30, 2023:

 

Balance at January 1, 2022  $- 
Issuance of November 2022 Warrants   894 
Revaluation at December 31,2022   248 
      
Balance at December 31, 2022  $1,142 
Revaluation at March 31, 2023  $(405)
      
Balance at March 31, 2023  $737 
Warrant exercises (note 4(d))  $(66)
Revaluation at June 30, 2023   1,745 
Balance at June 30, 2023  $2,416 

 

For the three-and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the November 2022 warrant liability in the amount of $1,745 and $1,362, respectively (for the three- and six-month period ended June 30, 2022 - $nil and $nil, respectively).

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

XML 16 R9.htm IDEA: XBRL DOCUMENT v3.23.2
SHAREHOLDERS EQUITY
6 Months Ended
Jun. 30, 2023
SHAREHOLDERS EQUITY

NOTE 4 - SHAREHOLDERS EQUITY

 

  a) During the six months ended June 30, 2022, the Company issued 584,207 shares in respect of 584,207 warrants that were exercised for gross proceeds of $1,277 (note 5 (a)).
     
  b) On February 3, 2022, the Company issued the shareholders of Isramat 273,774 common shares in the capital of the Company in respect of the acquisition of Isramat. Total value of the shares issued was $2,089.
     
  c) On February 11, 2022, the Company issued 74,985 shares to a trustee in respect of a crowd funding transaction that was completed in 2019, for which shares were not immediately issued until the completion of an Israeli tax ruling which was only finalized in late 2021.
     
  d)

During the six months ended June 30, 2023, the Company issued 65,000 shares in respect of 65,000 warrants that were exercised for gross proceeds of $99 (note 3 (c) and note 5 (a)).

     

e) During the six months ended June 30, 2023, the Company issued 30,000 shares in respect of 30,000 RSU’s that were exercised (note 5 (c)).
   
  f) On March 20, 2023, the Company closed a private placement for gross proceeds of $2,604 through the issuance of 1,783,561 units (“Units”) at a price per Unit of US$1.46 (CAD$1.95). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of 891,778 Warrants were issued with an exercise price of CAD$2.35 (US$1.75) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional 891,778 common shares (“March 2023 Private Placement Warrants”). A finder’s fee of $208 (CAD$290) was paid and 142,685 March 2023 Private Placement Warrants were issued in connection with the private placement.
     
  g) On June 15 and on June 20, 2023, the Company closed registered direct offerings for gross proceeds of $6,873 through the issuance of 3,818,275 units (“Units”) at a price per Unit of US$1.80 (CAD$2.41). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of 1,909,134 Warrants were issued with an exercise price of CAD$2.93 (US$2.20) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional 1,909,134 common shares (“June 2023 Registered Direct Offerings Warrants”). A finder’s fee of $550 (CAD$733) was paid and 305,462 non-registered warrants were issued in connection with the Registered Direct Offerings.

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

XML 17 R10.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANTS AND OPTIONS
6 Months Ended
Jun. 30, 2023
Warrants And Options  
WARRANTS AND OPTIONS

NOTE 5 - WARRANTS AND OPTIONS

 

a) Warrants

 

  (i) Warrant transactions for the six months ended June 30, 2023 and for the year ended December 31, 2022 are as follows:

   Number   Weighted Average
Exercise Price
 
Balance, January 1, 2022   5,966,204   $3.55 
Expiration of warrants   (5,437)     
Exercise of warrants   (630,161)     
Warrants issued in the November 2022 Private Placement   1,726,366      
Balance, December 31, 2022   7,056,972   $3.07 
Warrants issued in the March 2023 Private Placement   1,034,463      
Exercise of warrants (*)   (65,000)     
Warrants issued in the June 2023 Registered Direct Offerings   2,214,596      
Balance, June 30, 2023   10,241,031   $2.67 

 

(*)During the six months ended June 30, 2023, the Company issued 65,000 shares in respect of 65,000 warrants that were exercised for gross proceeds of $99. All exercised warrants were warrants classified as a liability prior to their exercise.

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)

 

a) Warrants (continued)

 

As at June 30, 2023, the Company had outstanding warrants, enabling the holders to acquire common shares as follows:

June 30, 2023   Expiry date  Exercise price   Exercise price (USD) 
 2,658,313   November 10, 2025    ILS7.1418(1)  $1.93 
 1,366,631   December 24, 2025    ILS7.1418(1)  $1.93 
 221,100   April 22, 2026    ILS29.025(2)  $7.84 
 1,084,562   May 6, 2026    ILS29.025(2)  $7.84 
 1,661,366   November 8, 2024    CAD2.04   $1.60 
 1,034,463   March 13, 2025    CAD2.35   $1.75 
 2,214,596   June 15, 2025    CAD2.93   $2.20 
 10,241,031                

 

  1. On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant.
     
  2. On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026.

 

b) Stock Options

 

Stock option transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number   Weighted
Average
Exercise Price
(CAD)
   Weighted
Average
Exercise Price
(USD)
 
Balance January 1, 2022   820,010   $2.26   $1.78 
Options granted   1,200,000    3.67      
Exercise of options   (116,667)   2.27      
Expiry of options   (20,000)   1.50      
Balance December 31, 2022   1,883,343   $3.17   $2.45 
Options granted (i-iv)   1,585,250    1.78    1.34 
Balance June 30, 2023   3,468,593   $2.53   $1.91 

 

  (i)

On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.

 

  (ii) On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
     
  (iii) On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
     
  (iii) On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)

 

b) Stock Options (continued)

 

As at June 30, 2023, the Company had outstanding stock options, enabling the holders to acquire common shares as follows:

Outstanding as
of June 30,
2023
   Exercisable as
of June 30,
2023
   Expiry date  Exercise price (CAD)   Exercise price (USD) 
 543,333    510,000   August 20, 2025  CAD 1.50   $1.11 
 40,000    40,000   September 1, 2025  CAD 2.25   $1.66 
 33,333    33,333   January 28, 2025  CAD 3.00   $2.21 
 50,000    33,333   June 3, 2026  CAD 8.40   $6.20 
 16,677    11,118   October 28, 2026  CAD 8.00   $5.90 
 900,000    337,500   August 2, 2032  CAD 3.56   $2.63 
 300,000    300,000   August 21, 2032  CAD 4.00   $2.95 
 816,500    802,063   January 4, 2033  CAD 1.65   $1.22 
 100,000    25,000   November 25, 2027  CAD 2.01   $1.48 
 423,750    -   April 18, 2033  CAD 1.60   $1.21 
 245,000    -   June 28, 2028  CAD 2.45   $1.85 
 3,468,593    2,117,347               

 

Share-based compensation expense is recognized over the vesting period of options. During the six months ended June 30, 2022, share-based compensation of $2,547 was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $111).

 

c) RSU’s

 

On August 4, 2022, the Company granted 1,265,000 Restricted Share Units (“RSUs”) to directors, officers and advisers, of which 590,000 RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no-par value in the Company (“Common Shares”).

 

On January 4, 2023, the Company granted 1,027,000 Restricted Share Units (“RSUs”) to directors, officers and advisers, of which 260,000 RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,027,000 common shares of no-par value in the Company (“Common Shares”).

 

On April 18, 2023, the Company granted 116,250 Restricted Share Units (“RSUs”) to employees, pursuant to the Company’s RSU Plan. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 116,250 common shares of no-par value in the Company (“Common Shares”).

 

On June 28, 2023, the Company granted 165,000 Restricted Share Units (“RSUs”) to officers pursuant to the Company’s RSU Plan. The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 165,000 common shares of no-par value in the Company (“Common Shares”).

 

RSU’s transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number 
Balance, January 1, 2022   - 
RSU’s granted   1,265,000 
Exercise of RSU’s   (545,000)
Balance, December 31, 2022   720,000 
RSU’s granted   1,308,250 
Exercise of RSU’s   (30,000)
Expiry of RSU’s   (66,667)
Balance, June 30, 2023   1,931,583 

 

Total exercisable RSU’s as at June 30, 2023, are 585,333 (December 31, 2022 – 225,832). During the six months ended June 30, 2023, share-based compensation of $420 was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $nil).

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

XML 18 R11.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES
6 Months Ended
Jun. 30, 2023
REVENUES

NOTE 6 - REVENUES:

 

Revenue streams:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
                 
Revenues from services:                    
Revenues from services   618    301    1,149    638 
Revenues from leasing   154    75    287    159 
                     
Precision metal parts:                    
Revenues from sales of precision metal parts   795    1,054    1,612    1,872 
Smart Carts:                    
Revenues from smart carts project   1,574    -    4,701    207 
Revenues   3,141    1,430    7,749    2,876 

 

XML 19 R12.htm IDEA: XBRL DOCUMENT v3.23.2
OPERATING SEGMENTS
6 Months Ended
Jun. 30, 2023
OPERATING SEGMENTS

NOTE 7 – OPERATING SEGMENTS:

 

The Company and its subsidiaries are engaged in the following three segments:

 

  a. Services to the military/security markets as well as development of related products for the civilian and retail markets. (“Services”)
     
  b. Retail automation solutions – Smart Carts (“Smart Carts”)
     
  c. Manufacturing and selling of precision metal parts – “Precision Metal Parts”

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,612   $1,436   $4,701   $7,749 
Inter-segment   -    (281)   -    (281)
Total   1,612    1,155    4,701    7,468 
                     
Segment loss (gain)   548    (56)   8,276    8,768 
Loss on revaluation of warrant liability                  2,344 
Finance expense, net                  153 
Tax expenses                  - 
Loss                 $11,265 

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,872   $797   $207   $2,876 
Inter-segment   -    -    -    - 
Total   1,872    797    207    2,876 
                     
Segment loss   199    492    5,397    6,088 
Loss on sale of fixed asset                  16 
Finance expense, net                  (7)
Tax expenses                  - 
Loss                 $6,097 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $795   $772   $1,575   $3,141 
Inter-segment   -    (281)   -    (281)
Total   795    491    1,575    2,860 
                     
Segment loss (gain)   277    122    4,339    4,738 
Loss on revaluation of warrant liability                  2,749 
Finance expense, net                  (65)
Tax expenses                  - 
Loss                 $7,422 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,054   $376   $-   $1,430 
Inter-segment   -    -    -    - 
Total   1,054    376    -    1,430 
                     
Segment loss   137    210    3,023    3,370 
Loss on sale of fixed asset                  - 
Finance expense, net                  (5)
Tax expenses                  - 
Loss                 $3,365 

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

XML 20 R13.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCIAL RISK FACTORS
6 Months Ended
Jun. 30, 2023
FINANCIAL RISK FACTORS

NOTE 8 - FINANCIAL RISK FACTORS:

 

ECL and their measurement

 

ECL are measured as the unbiased probability-weighted present value of all cash shortfalls over the expected life of each financial asset. For receivables from financial services, ECL are mainly calculated with a statistical model using three major risk parameters: probability of default, loss given default and exposure at default. The estimation of these risk parameters incorporates all available relevant information, not only historical and current loss data, but also reasonable and supportable forward-looking information reflected by the future expectation factors. This information includes macroeconomic factors (e.g., gross domestic product growth, unemployment rate, cost performance index) and forecasts of future economic conditions. For receivables from financial services, these forecasts are performed using a scenario analysis (base case, adverse and optimistic scenarios).

 

As of June 30, 2023, and December 31, 2022, ECL for trade and other account receivables are not material, and as such are not disclosed, in accordance IFRS 9.

 

XML 21 R14.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

  a) During July 2023, the Company issued 100,000 shares in respect of 100,000 RSU’s that were exercised.
     
  b) During August 2023, the Company issued 2,000 shares in respect of 2,000 warrants that were exercised for gross proceeds of $3.
XML 22 R15.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANT LIABILITY (Tables)
6 Months Ended
Jun. 30, 2023
June 2023 registered direct offerings [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS

 

Balance at January 1, 2023  $- 
Issuance of June 2023 Registered Direct Offerings Warrants   2,333 
      
Balance at June 30, 2023  $2,333 
March 2023 private placements [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS

 

Balance at January 1, 2023  $- 
Issuance of March 2023 Warrants   496 
      
Balance at March 31, 2023  $496 
Revaluation at June 30, 2023   1,004 
      
Balance at June 30, 2023  $1,500 
November 2022 warrants [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS

 

Balance at January 1, 2022  $- 
Issuance of November 2022 Warrants   894 
Revaluation at December 31,2022   248 
      
Balance at December 31, 2022  $1,142 
Revaluation at March 31, 2023  $(405)
      
Balance at March 31, 2023  $737 
Warrant exercises (note 4(d))  $(66)
Revaluation at June 30, 2023   1,745 
Balance at June 30, 2023  $2,416 
XML 23 R16.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANTS AND OPTIONS (Tables)
6 Months Ended
Jun. 30, 2023
Warrants And Options  
SCHEDULE OF WARRANTS TRANSACTIONS

   Number   Weighted Average
Exercise Price
 
Balance, January 1, 2022   5,966,204   $3.55 
Expiration of warrants   (5,437)     
Exercise of warrants   (630,161)     
Warrants issued in the November 2022 Private Placement   1,726,366      
Balance, December 31, 2022   7,056,972   $3.07 
Warrants issued in the March 2023 Private Placement   1,034,463      
Exercise of warrants (*)   (65,000)     
Warrants issued in the June 2023 Registered Direct Offerings   2,214,596      
Balance, June 30, 2023   10,241,031   $2.67 

 

(*)During the six months ended June 30, 2023, the Company issued 65,000 shares in respect of 65,000 warrants that were exercised for gross proceeds of $99. All exercised warrants were warrants classified as a liability prior to their exercise.
SCHEDULE OF OUTSTANDING WARRANTS

As at June 30, 2023, the Company had outstanding warrants, enabling the holders to acquire common shares as follows:

June 30, 2023   Expiry date  Exercise price   Exercise price (USD) 
 2,658,313   November 10, 2025    ILS7.1418(1)  $1.93 
 1,366,631   December 24, 2025    ILS7.1418(1)  $1.93 
 221,100   April 22, 2026    ILS29.025(2)  $7.84 
 1,084,562   May 6, 2026    ILS29.025(2)  $7.84 
 1,661,366   November 8, 2024    CAD2.04   $1.60 
 1,034,463   March 13, 2025    CAD2.35   $1.75 
 2,214,596   June 15, 2025    CAD2.93   $2.20 
 10,241,031                

 

  1. On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant.
     
  2. On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026.
SCHEDULE OF STOCK OPTION TRANSACTIONS

Stock option transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number   Weighted
Average
Exercise Price
(CAD)
   Weighted
Average
Exercise Price
(USD)
 
Balance January 1, 2022   820,010   $2.26   $1.78 
Options granted   1,200,000    3.67      
Exercise of options   (116,667)   2.27      
Expiry of options   (20,000)   1.50      
Balance December 31, 2022   1,883,343   $3.17   $2.45 
Options granted (i-iv)   1,585,250    1.78    1.34 
Balance June 30, 2023   3,468,593   $2.53   $1.91 

 

  (i)

On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.

 

  (ii) On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
     
  (iii) On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
     
  (iii) On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.
SCHEDULE OF OUTSTANDING STOCK OPTIONS

As at June 30, 2023, the Company had outstanding stock options, enabling the holders to acquire common shares as follows:

Outstanding as
of June 30,
2023
   Exercisable as
of June 30,
2023
   Expiry date  Exercise price (CAD)   Exercise price (USD) 
 543,333    510,000   August 20, 2025  CAD 1.50   $1.11 
 40,000    40,000   September 1, 2025  CAD 2.25   $1.66 
 33,333    33,333   January 28, 2025  CAD 3.00   $2.21 
 50,000    33,333   June 3, 2026  CAD 8.40   $6.20 
 16,677    11,118   October 28, 2026  CAD 8.00   $5.90 
 900,000    337,500   August 2, 2032  CAD 3.56   $2.63 
 300,000    300,000   August 21, 2032  CAD 4.00   $2.95 
 816,500    802,063   January 4, 2033  CAD 1.65   $1.22 
 100,000    25,000   November 25, 2027  CAD 2.01   $1.48 
 423,750    -   April 18, 2033  CAD 1.60   $1.21 
 245,000    -   June 28, 2028  CAD 2.45   $1.85 
 3,468,593    2,117,347               
SCHEDULE OF RSU’S TRANSACTIONS

RSU’s transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:

   Number 
Balance, January 1, 2022   - 
RSU’s granted   1,265,000 
Exercise of RSU’s   (545,000)
Balance, December 31, 2022   720,000 
RSU’s granted   1,308,250 
Exercise of RSU’s   (30,000)
Expiry of RSU’s   (66,667)
Balance, June 30, 2023   1,931,583 
XML 24 R17.htm IDEA: XBRL DOCUMENT v3.23.2
REVENUES (Tables)
6 Months Ended
Jun. 30, 2023
SCHEDULE OF REVENUE FROM SERVICES

Revenue streams:

 

   2023   2022   2023   2022 
   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
                 
Revenues from services:                    
Revenues from services   618    301    1,149    638 
Revenues from leasing   154    75    287    159 
                     
Precision metal parts:                    
Revenues from sales of precision metal parts   795    1,054    1,612    1,872 
Smart Carts:                    
Revenues from smart carts project   1,574    -    4,701    207 
Revenues   3,141    1,430    7,749    2,876 
XML 25 R18.htm IDEA: XBRL DOCUMENT v3.23.2
OPERATING SEGMENTS (Tables)
6 Months Ended
Jun. 30, 2023
SCHEDULE OF OPERATING SEGMENTS

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,612   $1,436   $4,701   $7,749 
Inter-segment   -    (281)   -    (281)
Total   1,612    1,155    4,701    7,468 
                     
Segment loss (gain)   548    (56)   8,276    8,768 
Loss on revaluation of warrant liability                  2,344 
Finance expense, net                  153 
Tax expenses                  - 
Loss                 $11,265 

 

 

A2Z SMART TECHNOLOGIES CORP.

NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(Expressed in thousands of US Dollars)

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Six Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,872   $797   $207   $2,876 
Inter-segment   -    -    -    - 
Total   1,872    797    207    2,876 
                     
Segment loss   199    492    5,397    6,088 
Loss on sale of fixed asset                  16 
Finance expense, net                  (7)
Tax expenses                  - 
Loss                 $6,097 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2023 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $795   $772   $1,575   $3,141 
Inter-segment   -    (281)   -    (281)
Total   795    491    1,575    2,860 
                     
Segment loss (gain)   277    122    4,339    4,738 
Loss on revaluation of warrant liability                  2,749 
Finance expense, net                  (65)
Tax expenses                  - 
Loss                 $7,422 

 

   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
   Three Months Ended June 30, 2022 
   Precision
Metal
Parts
   Advanced Engineering   Smart
Carts
   Total 
Revenues                
External  $1,054   $376   $-   $1,430 
Inter-segment   -    -    -    - 
Total   1,054    376    -    1,430 
                     
Segment loss   137    210    3,023    3,370 
Loss on sale of fixed asset                  - 
Finance expense, net                  (5)
Tax expenses                  - 
Loss                 $3,365 
XML 26 R19.htm IDEA: XBRL DOCUMENT v3.23.2
NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
IfrsStatementLineItems [Line Items]      
Profit (loss) of combined entity as if combination occurred at beginning of period $ 11,300 $ 6,100  
Retained earnings $ 77,936   $ 67,395
Advanced Automotive Innovations Inc. [member]      
IfrsStatementLineItems [Line Items]      
Ownership interest in subsidary 80.00%    
Cust2Mate Ltd [member]      
IfrsStatementLineItems [Line Items]      
Proportion of ownership interest in associate 76.78%    
XML 27 R20.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
IfrsStatementLineItems [Line Items]          
Reclassification to Warrant Reserve     $ (99) $ (1,277)  
June 2023 registered direct offerings [member]          
IfrsStatementLineItems [Line Items]          
Balance, warrants      
Issuance, warrants     2,333    
Balance, warrants $ 2,333   2,333  
March 2023 private placements [member]          
IfrsStatementLineItems [Line Items]          
Balance, warrants 496    
Issuance, warrants   496      
Balance, warrants 1,500 496 1,500  
Revaluation, warrants 1,004        
November 2022 warrants [member]          
IfrsStatementLineItems [Line Items]          
Balance, warrants 737 1,142 1,142
Issuance, warrants         894
Balance, warrants 2,416 737 $ 2,416   1,142
Revaluation, warrants 1,745 $ (405)     $ 248
Reclassification to Warrant Reserve $ (66)        
XML 28 R21.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANT LIABILITY (Details Narrative)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 20, 2023
$ / shares
shares
Jun. 15, 2023
$ / shares
shares
Mar. 20, 2023
$ / shares
shares
Nov. 02, 2022
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
shares
Mar. 20, 2022
$ / shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]                      
Class of warrant or right outstanding | shares         10,241,031   10,241,031   7,056,972   5,966,204
June 2023 registered direct offerings [member]                      
IfrsStatementLineItems [Line Items]                      
Class of warrant or right outstanding | shares 1,909,134 1,909,134                  
Exercise price of warrant $ 2.93 $ 2.93                  
Warrants exercisable term 2 years 2 years                  
Volatility warrants granted 99.00% 99.00%                  
Risk-free interest rate 4.45% 4.45%                  
Expected life 2 years 2 years                  
Share price $ 2.99 $ 2.99                  
March 2023 private placements [member]                      
IfrsStatementLineItems [Line Items]                      
Class of warrant or right outstanding | shares     891,778                
Exercise price of warrant     $ 2.35                
Warrants exercisable term     2 years                
Volatility warrants granted     93.00%                
Risk-free interest rate     3.62%                
Expected life     2 years                
Share price                   $ 1.74  
Gain loss on revaluation of warrant liability | $         $ 1,004 $ 1,004      
November 2022 warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Class of warrant or right outstanding | shares       1,489,166              
Exercise price of warrant       $ 2.35              
Warrants exercisable term       2 years              
Volatility warrants granted       110.00%              
Risk-free interest rate       3.94%              
Expected life       2 years              
Share price       $ 1.56              
Gain loss on revaluation of warrant liability | $         $ 1,745   $ 1,362        
XML 29 R22.htm IDEA: XBRL DOCUMENT v3.23.2
SHAREHOLDERS EQUITY (Details Narrative)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands
6 Months Ended
Jun. 20, 2023
USD ($)
$ / shares
shares
Mar. 20, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
Jun. 20, 2023
CAD ($)
$ / shares
shares
Mar. 20, 2023
CAD ($)
$ / shares
shares
Feb. 11, 2022
shares
Feb. 03, 2022
shares
IfrsStatementLineItems [Line Items]                
Number of shares issued 3,818,275 1,783,561 65,000 584,207 3,818,275 1,783,561 74,985 2,089
Number of warrants exercised     65,000 584,207        
Proceeds from exercise of warrants | $     $ 99 $ 1,277        
Proceeds from private placements | $   $ 2,604            
Warrant exercise price per share | (per share) $ 1.80 $ 1.46     $ 2.41 $ 1.95    
[custom:ProceedsFromIssuanceOfUnits] | $ $ 6,873              
March 2023 private placement warrants [member]                
IfrsStatementLineItems [Line Items]                
Issuance of additional common shares   891,778            
Finder fee   $ 208       $ 290    
Private placement of warrant shares issued   142,685       142,685    
June 2023 registered direct offerings warrants [member]                
IfrsStatementLineItems [Line Items]                
Issuance of additional common shares 1,909,134              
Finder fee $ 550       $ 733      
Non-registered Warrants [Member]                
IfrsStatementLineItems [Line Items]                
Private placement of warrant shares issued 305,462       305,462      
Warrants [member]                
IfrsStatementLineItems [Line Items]                
Number of shares issued 1,909,134 891,778     1,909,134 891,778    
Proceeds from exercise of warrants | $     $ 99          
Warrant exercise price per share | (per share) $ 2.20 $ 1.75     $ 2.93 $ 2.35    
RSU's [member]                
IfrsStatementLineItems [Line Items]                
Number of shares issued     30,000          
Number of warrants exercised     30,000          
Isramat Ltd [member]                
IfrsStatementLineItems [Line Items]                
Number of shares issued               273,774
XML 30 R23.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF WARRANTS TRANSACTIONS (Details) - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Number of warrants outstanding, beginning balance 7,056,972 5,966,204
Weighted Average Exercise Price, Beginning Balance $ 3.07 $ 3.55
Number of warrants outstanding, Expired of warrants   (5,437)
Number of warrants outstanding, Exercise of warrants (65,000) [1] (630,161)
Number of warrants outstanding, ending balance 10,241,031 7,056,972
Weighted Average Exercise Price, Beginning Balance $ 2.67 $ 3.07
November 2022 private placement [member]    
IfrsStatementLineItems [Line Items]    
Number of warrants outstanding, warrants issued   1,726,366
March 2023 private placement [member]    
IfrsStatementLineItems [Line Items]    
Number of warrants outstanding, warrants issued 1,034,463  
June 2023 registered direct offerings [member]    
IfrsStatementLineItems [Line Items]    
Number of warrants outstanding, warrants issued 2,214,596  
[1] During the six months ended June 30, 2023, the Company issued 65,000
XML 31 R24.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]        
Number of share options outstanding in share-based payment arrangement 3,468,593   1,883,343 820,010
Proceeds from exercise of warrants | $ $ 99 $ 1,277    
Warrants [member]        
IfrsStatementLineItems [Line Items]        
Number of share options outstanding in share-based payment arrangement 65,000      
Number of warrants outstanding 65,000      
Proceeds from exercise of warrants | $ $ 99      
XML 32 R25.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OUTSTANDING WARRANTS (Details)
6 Months Ended
Mar. 27, 2023
shares
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2023
$ / shares
shares
Jun. 30, 2023
₪ / shares
shares
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   10,241,031 10,241,031 10,241,031
Warrants one [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding 221,100 2,658,313 2,658,313 2,658,313
Expiry date Apr. 26, 2026 Nov. 10, 2025    
Exercise price | (per share)   $ 1.93   ₪ 7.1418 [1]
Warrants two [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding 1,084,562 1,366,631 1,366,631 1,366,631
Expiry date May 06, 2026 Dec. 24, 2025    
Exercise price | (per share) [1]   $ 1.93   ₪ 7.1418
Warrants three [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   221,100 221,100 221,100
Expiry date   Apr. 22, 2026    
Exercise price | (per share) [2]   $ 7.84   ₪ 29.025
Warrants four [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   1,084,562 1,084,562 1,084,562
Expiry date   May 06, 2026    
Exercise price | (per share) [2]   $ 7.84   ₪ 29.025
Warrants five [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   1,661,366 1,661,366 1,661,366
Expiry date   Nov. 08, 2024    
Exercise price | (per share)   $ 1.60 $ 2.04  
Warrants six [Member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   1,034,463 1,034,463 1,034,463
Expiry date   Mar. 13, 2025    
Exercise price | (per share)   $ 1.75 $ 2.35  
Warrants seven [member]        
IfrsStatementLineItems [Line Items]        
Number of warrants outstanding   2,214,596 2,214,596 2,214,596
Expiry date   Jun. 15, 2025    
Exercise price | (per share)   $ 2.20 $ 2.93  
[1] On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant.
[2] On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026.
XML 33 R26.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)
Jun. 30, 2023
$ / shares
Jun. 30, 2023
₪ / shares
Jun. 30, 2021
$ / shares
Jun. 30, 2021
₪ / shares
Mar. 31, 2021
$ / shares
Mar. 31, 2021
₪ / shares
Warrants two [member]            
IfrsStatementLineItems [Line Items]            
Exercise price | (per share) [1] $ 1.93 ₪ 7.1418        
Warrants two [member] | Warrant holders [member]            
IfrsStatementLineItems [Line Items]            
Exercise price | (per share)         $ 2.70 ₪ 7.1418
Warrants three [member]            
IfrsStatementLineItems [Line Items]            
Exercise price | (per share) [2] $ 7.84 ₪ 29.025        
Warrants three [member] | Warrant holders [member]            
IfrsStatementLineItems [Line Items]            
Exercise price | (per share)     $ 11.04 ₪ 29.025    
[1] On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant.
[2] On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026.
XML 34 R27.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Warrants And Options        
Number of stock options, beginning balance 1,883,343 1,883,343 820,010 820,010
Weighted Average Exercise Price, beginning balance | (per share) $ 2.45 $ 3.17 $ 1.78 $ 2.26
Number of stock options, options granted 1,585,250 [1],[2],[3],[4] 1,585,250 [1],[2],[3],[4] 1,200,000 1,200,000
Weighted Average Exercise Price, options granted | (per share) $ 1.34 [1],[2],[3],[4] $ 1.78 [1],[2],[3],[4]   $ 3.67
Number of stock options, Exercise of options     (116,667) (116,667)
Weighted Average Exercise Price, Exercise of options | $ / shares       $ 2.27
Number of stock options, Expiry of options     (20,000) (20,000)
Weighted Average Exercise Price, Expiry of options | $ / shares       $ 1.50
Number of stock options, ending balance 3,468,593 3,468,593 1,883,343 1,883,343
Weighted Average Exercise Price, ending balance | (per share) $ 1.91 $ 2.53 $ 2.45 $ 3.17
[1] On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.
[2] On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
[3] On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
[4] On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.
XML 35 R28.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 28, 2023
USD ($)
shares
Jun. 28, 2023
$ / shares
Apr. 18, 2023
USD ($)
shares
Apr. 18, 2023
$ / shares
Feb. 08, 2023
USD ($)
shares
Feb. 08, 2023
$ / shares
Jan. 04, 2023
USD ($)
shares
Jan. 04, 2023
$ / shares
Jun. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
Jun. 30, 2023
$ / shares
IfrsStatementLineItems [Line Items]                      
Number of stock options, options issued | shares                 1,585,250 [1],[2],[3],[4] 1,200,000  
Stock option one [member]                      
IfrsStatementLineItems [Line Items]                      
Number of stock options, exercise price | (per share)                 $ 1.11   $ 1.50
Options expire                 Aug. 20, 2025    
Stock option one [member] | Consultant [member]                      
IfrsStatementLineItems [Line Items]                      
Number of stock options, options issued | shares 245,000   423,750   100,000   816,500        
Number of stock options, exercise price | $ / shares   $ 2.45   $ 1.60   $ 1.50   $ 1.65      
Options expire Jun. 28, 2033   Apr. 18, 2033   Nov. 25, 2027   Jan. 04, 2033        
Fair value of options granted | $ $ 443   $ 420   $ 135   $ 1,017        
Share Price | $ / shares   $ 2.92   $ 1.42   $ 2.18   $ 1.80      
Expected option life 5 years   10 years   4 years 9 months 18 days   10 years        
Volatility 111.00%   111.00%   112.00%   112.00%        
Risk-free interest rate 4.14%   3.57%   3.16%   3.28%        
Dividend yield 0.00%   0.00%   0.00%   0.00%        
[1] On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%.
[2] On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%.
[3] On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%.
[4] On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%.
XML 36 R29.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details)
6 Months Ended
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 3,468,593 3,468,593 1,883,343 820,010
Number of stock options, Exercisable 2,117,347 2,117,347    
Stock option one [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 543,333 543,333    
Number of stock options, Exercisable 510,000 510,000    
Number of stock options, Expiry date Aug. 20, 2025      
Number of stock options, Exercise price | (per share) $ 1.11 $ 1.50    
Stock option two [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 40,000 40,000    
Number of stock options, Exercisable 40,000 40,000    
Number of stock options, Expiry date Sep. 01, 2025      
Number of stock options, Exercise price | (per share) $ 1.66 $ 2.25    
Stock option three [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 33,333 33,333    
Number of stock options, Exercisable 33,333 33,333    
Number of stock options, Expiry date Jan. 28, 2025      
Number of stock options, Exercise price | (per share) $ 2.21 $ 3.00    
Stock option four [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 50,000 50,000    
Number of stock options, Exercisable 33,333 33,333    
Number of stock options, Expiry date Jun. 03, 2026      
Number of stock options, Exercise price | (per share) $ 6.20 $ 8.40    
Stock option five [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 16,677 16,677    
Number of stock options, Exercisable 11,118 11,118    
Number of stock options, Expiry date Oct. 28, 2026      
Number of stock options, Exercise price | (per share) $ 5.90 $ 8.00    
Stock option six [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 900,000 900,000    
Number of stock options, Exercisable 337,500 337,500    
Number of stock options, Expiry date Aug. 02, 2032      
Number of stock options, Exercise price | (per share) $ 2.63 $ 3.56    
Stock option seven [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 300,000 300,000    
Number of stock options, Exercisable 300,000 300,000    
Number of stock options, Expiry date Aug. 21, 2032      
Number of stock options, Exercise price | (per share) $ 2.95 $ 4.00    
Stock option eight [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 816,500 816,500    
Number of stock options, Exercisable 802,063 802,063    
Number of stock options, Expiry date Jan. 04, 2033      
Number of stock options, Exercise price | (per share) $ 1.22 $ 1.65    
Stock option nine [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 100,000 100,000    
Number of stock options, Exercisable 25,000 25,000    
Number of stock options, Expiry date Nov. 25, 2027      
Number of stock options, Exercise price | (per share) $ 1.48 $ 2.01    
Stock option ten [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 423,750 423,750    
Number of stock options, Exercisable    
Number of stock options, Expiry date Apr. 18, 2033      
Number of stock options, Exercise price | (per share) $ 1.21 $ 1.60    
Stock option eleven [member]        
IfrsStatementLineItems [Line Items]        
Number of stock options, Outstanding 245,000 245,000    
Number of stock options, Exercisable    
Number of stock options, Expiry date Jun. 28, 2028      
Number of stock options, Exercise price | (per share) $ 1.85 $ 2.45    
XML 37 R30.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF RSU’S TRANSACTIONS (Details) - RSU's [member] - shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Number of RSU's, beginning balance 720,000
Number of RSU's, granted 1,308,250 1,265,000
Number of RSU's, Exercise (30,000) (545,000)
Number of RSU's, Expiry (66,667)  
Number of RSU's, ending balance 1,931,583 720,000
XML 38 R31.htm IDEA: XBRL DOCUMENT v3.23.2
WARRANTS AND OPTIONS (Details Narrative)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 28, 2023
shares
Apr. 18, 2023
shares
Jan. 04, 2023
shares
Aug. 04, 2022
shares
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
shares
IfrsStatementLineItems [Line Items]              
Share based compensation | $           $ 2,547  
Share based compensation | $         $ 2,967 111  
RSU's [member]              
IfrsStatementLineItems [Line Items]              
Share based compensation | $         $ 420  
RSU's granted         1,308,250   1,265,000
Description of RSU's vesting and conversion The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 165,000 common shares of no-par value in the Company (“Common Shares”) The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 116,250 common shares of no-par value in the Company (“Common Shares”) The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,027,000 common shares of no-par value in the Company (“Common Shares”) The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no-par value in the Company (“Common Shares”)      
RSU's exercisable         585,333   225,832
RSU's [member] | Directors officers and advisers [member]              
IfrsStatementLineItems [Line Items]              
RSU's granted     1,027,000 1,265,000      
RSU's [member] | Executives and directors [member]              
IfrsStatementLineItems [Line Items]              
RSU's granted     260,000 590,000      
RSU's [member] | Employees [member]              
IfrsStatementLineItems [Line Items]              
RSU's granted   116,250          
RSU's [member] | Officers [member]              
IfrsStatementLineItems [Line Items]              
RSU's granted 165,000            
XML 39 R32.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF REVENUE FROM SERVICES (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]        
Revenues $ 2,860 $ 1,430 $ 7,468 $ 2,876
Revenues from services [member]        
IfrsStatementLineItems [Line Items]        
Revenues 618 301 1,149 638
Revenues from leasing [member]        
IfrsStatementLineItems [Line Items]        
Revenues 154 75 287 159
Revenues from sales of precision metal parts [member]        
IfrsStatementLineItems [Line Items]        
Revenues 795 1,054 1,612 1,872
Revenues from smart carts project [member]        
IfrsStatementLineItems [Line Items]        
Revenues 1,574 4,701 207
External [member]        
IfrsStatementLineItems [Line Items]        
Revenues $ 3,141 $ 1,430 $ 7,749 $ 2,876
XML 40 R33.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF OPERATING SEGMENTS (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]        
Total $ 2,860 $ 1,430 $ 7,468 $ 2,876
Segment loss 4,738 3,370 8,768 6,088
Loss on revaluation of warrant liability 2,749   2,344  
Finance expense, net (65) (5) 153 (7)
Tax expenses
Loss 7,422 3,365 11,265 6,097
Loss on sale of fixed asset     16
External [member]        
IfrsStatementLineItems [Line Items]        
Total 3,141 1,430 7,749 2,876
Intersegment [member]        
IfrsStatementLineItems [Line Items]        
Total (281) (281)
Precision metal parts [member]        
IfrsStatementLineItems [Line Items]        
Total 795 1,054 1,612 1,872
Segment loss 277 137 548 199
Precision metal parts [member] | External [member]        
IfrsStatementLineItems [Line Items]        
Total 795 1,054 1,612 1,872
Precision metal parts [member] | Intersegment [member]        
IfrsStatementLineItems [Line Items]        
Total
Advanced engineering [member]        
IfrsStatementLineItems [Line Items]        
Total 491 376 1,155 797
Segment loss 122 210 (56) 492
Advanced engineering [member] | External [member]        
IfrsStatementLineItems [Line Items]        
Total 772 376 1,436 797
Advanced engineering [member] | Intersegment [member]        
IfrsStatementLineItems [Line Items]        
Total (281) (281)
SmartCarts [member]        
IfrsStatementLineItems [Line Items]        
Total 1,575 4,701 207
Segment loss 4,339 3,023 8,276 5,397
SmartCarts [member] | External [member]        
IfrsStatementLineItems [Line Items]        
Total 1,575 4,701 207
SmartCarts [member] | Intersegment [member]        
IfrsStatementLineItems [Line Items]        
Total
XML 41 R34.htm IDEA: XBRL DOCUMENT v3.23.2
OPERATING SEGMENTS (Details Narrative)
6 Months Ended
Jun. 30, 2023
Segment
Number of operating segment 3
XML 42 R35.htm IDEA: XBRL DOCUMENT v3.23.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended
Aug. 31, 2023
Jul. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 20, 2023
Mar. 20, 2023
Feb. 11, 2022
Feb. 03, 2022
IfrsStatementLineItems [Line Items]                
Number of share issuance     65,000 584,207 3,818,275 1,783,561 74,985 2,089
Number of warrants exercised     65,000 584,207        
Exercise of option     $ 20        
Nonadjusting event [member]                
IfrsStatementLineItems [Line Items]                
Number of share issuance 2,000 100,000            
Number of restricted stock units exercised   100,000            
Number of warrants exercised 2,000              
Exercise of option $ 3              
XML 43 form6-ka_htm.xml IDEA: XBRL DOCUMENT 0001866030 2023-01-01 2023-06-30 0001866030 2023-06-30 0001866030 2022-12-31 0001866030 2023-04-01 2023-06-30 0001866030 2022-04-01 2022-06-30 0001866030 2022-01-01 2022-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-12-31 0001866030 ifrs-full:CapitalReserveMember 2022-12-31 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001866030 ifrs-full:RetainedEarningsMember 2022-12-31 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001866030 ifrs-full:IssuedCapitalMember 2021-12-31 0001866030 ifrs-full:CapitalReserveMember 2021-12-31 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001866030 ifrs-full:RetainedEarningsMember 2021-12-31 0001866030 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001866030 2021-12-31 0001866030 ifrs-full:IssuedCapitalMember 2023-01-01 2023-06-30 0001866030 ifrs-full:CapitalReserveMember 2023-01-01 2023-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-06-30 0001866030 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-01-01 2022-06-30 0001866030 ifrs-full:CapitalReserveMember 2022-01-01 2022-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001866030 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-06-30 0001866030 ifrs-full:IssuedCapitalMember 2023-06-30 0001866030 ifrs-full:CapitalReserveMember 2023-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001866030 ifrs-full:RetainedEarningsMember 2023-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2023-06-30 0001866030 ifrs-full:IssuedCapitalMember 2022-06-30 0001866030 ifrs-full:CapitalReserveMember 2022-06-30 0001866030 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001866030 ifrs-full:RetainedEarningsMember 2022-06-30 0001866030 ifrs-full:NoncontrollingInterestsMember 2022-06-30 0001866030 2022-06-30 0001866030 AZ:Cust2MateLtdMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedAutomotiveInnovationsIncMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-15 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-15 2023-06-15 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-20 2023-06-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-20 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-04-01 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-01-01 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-04-01 2022-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-01-01 2022-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-11-02 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-11-02 2022-11-02 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-04-01 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-01-01 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoWarrantsMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2022-12-31 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-06-30 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2022-12-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-01-01 2023-03-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-03-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementsMember 2023-06-30 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2021-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-01-01 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-01-01 2023-03-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-03-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementsMember 2023-06-30 0001866030 AZ:IsramatLtdMember 2022-02-03 0001866030 2022-02-03 0001866030 2022-02-11 0001866030 AZ:RestrictedStockUnitsMember 2023-06-30 0001866030 AZ:RestrictedStockUnitsMember 2023-01-01 2023-06-30 0001866030 2023-03-20 2023-03-20 0001866030 2023-03-20 0001866030 AZ:WarrantsMember 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember 2023-03-20 2023-03-20 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember 2023-03-20 0001866030 2023-06-20 2023-06-20 0001866030 2023-06-20 0001866030 AZ:WarrantsMember 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember 2023-06-20 2023-06-20 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember 2023-06-20 0001866030 AZ:NonregisteredWarrantsMember 2023-06-20 0001866030 2022-01-01 2022-12-31 0001866030 AZ:NovemberTwoThousandTwentyTwoPrivatePlacementMember 2022-01-01 2022-12-31 0001866030 AZ:MarchTwoThousandTwentyThreePrivatePlacementMember 2023-01-01 2023-06-30 0001866030 AZ:JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsMember 2023-06-30 0001866030 AZ:WarrantsMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsTwoMember 2023-06-30 0001866030 AZ:WarrantsTwoMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsThreeMember 2023-06-30 0001866030 AZ:WarrantsThreeMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsFourMember 2023-06-30 0001866030 AZ:WarrantsFourMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsFiveMember 2023-06-30 0001866030 AZ:WarrantsFiveMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsSixMember 2023-06-30 0001866030 AZ:WarrantsSixMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsSevenMember 2023-06-30 0001866030 AZ:WarrantsSevenMember 2023-01-01 2023-06-30 0001866030 AZ:WarrantsOneMember 2023-03-27 0001866030 AZ:WarrantsOneMember 2023-03-27 2023-03-27 0001866030 AZ:WarrantsTwoMember 2023-03-27 0001866030 AZ:WarrantsTwoMember 2023-03-27 2023-03-27 0001866030 AZ:WarrantsTwoMember AZ:WarrantHoldersMember 2021-03-31 0001866030 AZ:WarrantsThreeMember AZ:WarrantHoldersMember 2021-06-30 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-01-04 2023-01-04 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-01-04 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-02-08 2023-02-08 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-02-08 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-04-18 2023-04-18 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-04-18 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-06-28 2023-06-28 0001866030 AZ:StockOptionOneMember AZ:ConsultantMember 2023-06-28 0001866030 AZ:StockOptionOneMember 2023-06-30 0001866030 AZ:StockOptionOneMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionTwoMember 2023-06-30 0001866030 AZ:StockOptionTwoMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionThreeMember 2023-06-30 0001866030 AZ:StockOptionThreeMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionFourMember 2023-06-30 0001866030 AZ:StockOptionFourMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionFiveMember 2023-06-30 0001866030 AZ:StockOptionFiveMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionSixMember 2023-06-30 0001866030 AZ:StockOptionSixMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionSevenMember 2023-06-30 0001866030 AZ:StockOptionSevenMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionEightMember 2023-06-30 0001866030 AZ:StockOptionEightMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionNineMember 2023-06-30 0001866030 AZ:StockOptionNineMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionTenMember 2023-06-30 0001866030 AZ:StockOptionTenMember 2023-01-01 2023-06-30 0001866030 AZ:StockOptionElevenMember 2023-06-30 0001866030 AZ:StockOptionElevenMember 2023-01-01 2023-06-30 0001866030 AZ:DirectorsOfficersAndAdvisersMember AZ:RestrictedStockUnitsMember 2022-08-04 2022-08-04 0001866030 AZ:ExecutivesAndDirectorsMember AZ:RestrictedStockUnitsMember 2022-08-04 2022-08-04 0001866030 AZ:RestrictedStockUnitsMember 2022-08-04 2022-08-04 0001866030 AZ:DirectorsOfficersAndAdvisersMember AZ:RestrictedStockUnitsMember 2023-01-04 2023-01-04 0001866030 AZ:ExecutivesAndDirectorsMember AZ:RestrictedStockUnitsMember 2023-01-04 2023-01-04 0001866030 AZ:RestrictedStockUnitsMember 2023-01-04 2023-01-04 0001866030 AZ:EmployeesMember AZ:RestrictedStockUnitsMember 2023-04-18 2023-04-18 0001866030 AZ:RestrictedStockUnitsMember 2023-04-18 2023-04-18 0001866030 AZ:OfficersMember AZ:RestrictedStockUnitsMember 2023-06-28 2023-06-28 0001866030 AZ:RestrictedStockUnitsMember 2023-06-28 2023-06-28 0001866030 AZ:RestrictedStockUnitsMember 2022-12-31 0001866030 AZ:RestrictedStockUnitsMember 2022-01-01 2022-06-30 0001866030 AZ:RestrictedStockUnitsMember 2021-12-31 0001866030 AZ:RestrictedStockUnitsMember 2022-01-01 2022-12-31 0001866030 AZ:RevenuesFromServicesMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromServicesMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromServicesMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromServicesMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromLeasingMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromLeasingMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromLeasingMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromLeasingMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromSalesOfPrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2023-04-01 2023-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2022-04-01 2022-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2023-01-01 2023-06-30 0001866030 AZ:RevenuesFromSmartCartsProjectMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember 2023-04-01 2023-06-30 0001866030 AZ:ExternalMember 2022-04-01 2022-06-30 0001866030 AZ:ExternalMember 2023-01-01 2023-06-30 0001866030 AZ:ExternalMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember AZ:PrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:ExternalMember AZ:AdvancedEngineeringMember 2023-01-01 2023-06-30 0001866030 AZ:ExternalMember AZ:SmartCartsMember 2023-01-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:PrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:AdvancedEngineeringMember 2023-01-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:SmartCartsMember 2023-01-01 2023-06-30 0001866030 AZ:InterSegmentMember 2023-01-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember 2023-01-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember 2023-01-01 2023-06-30 0001866030 AZ:SmartCartsMember 2023-01-01 2023-06-30 0001866030 AZ:ExternalMember AZ:PrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember AZ:AdvancedEngineeringMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember AZ:SmartCartsMember 2022-01-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:PrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:AdvancedEngineeringMember 2022-01-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:SmartCartsMember 2022-01-01 2022-06-30 0001866030 AZ:InterSegmentMember 2022-01-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember 2022-01-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember 2022-01-01 2022-06-30 0001866030 AZ:SmartCartsMember 2022-01-01 2022-06-30 0001866030 AZ:ExternalMember AZ:PrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:ExternalMember AZ:AdvancedEngineeringMember 2023-04-01 2023-06-30 0001866030 AZ:ExternalMember AZ:SmartCartsMember 2023-04-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:PrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:AdvancedEngineeringMember 2023-04-01 2023-06-30 0001866030 AZ:InterSegmentMember AZ:SmartCartsMember 2023-04-01 2023-06-30 0001866030 AZ:InterSegmentMember 2023-04-01 2023-06-30 0001866030 AZ:PrecisionMetalPartsMember 2023-04-01 2023-06-30 0001866030 AZ:AdvancedEngineeringMember 2023-04-01 2023-06-30 0001866030 AZ:SmartCartsMember 2023-04-01 2023-06-30 0001866030 AZ:ExternalMember AZ:PrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:ExternalMember AZ:AdvancedEngineeringMember 2022-04-01 2022-06-30 0001866030 AZ:ExternalMember AZ:SmartCartsMember 2022-04-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:PrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:AdvancedEngineeringMember 2022-04-01 2022-06-30 0001866030 AZ:InterSegmentMember AZ:SmartCartsMember 2022-04-01 2022-06-30 0001866030 AZ:InterSegmentMember 2022-04-01 2022-06-30 0001866030 AZ:PrecisionMetalPartsMember 2022-04-01 2022-06-30 0001866030 AZ:AdvancedEngineeringMember 2022-04-01 2022-06-30 0001866030 AZ:SmartCartsMember 2022-04-01 2022-06-30 0001866030 AZ:NonadjustingEventMember 2023-07-31 0001866030 AZ:NonadjustingEventMember 2023-07-01 2023-07-31 0001866030 AZ:NonadjustingEventMember 2023-08-31 0001866030 AZ:NonadjustingEventMember 2023-08-01 2023-08-31 iso4217:USD shares iso4217:USD shares pure iso4217:CAD iso4217:CAD shares AZ:Segment iso4217:ILS iso4217:ILS shares 6-K/A 001-40472 A2Z SMART TECHNOLOGIES CORP 1600-609 Granville Street Vancouver BC V7Y 1C3 CA 0001866030 true 6-K/A Q2 --12-31 Amendment No. 1 A2Z SMART TECHNOLOGIES CORP 2023-06-30 2023 5671000 2616000 8000 621000 375000 1547000 1373000 1566000 2570000 9405000 6942000 2115000 2207000 1188000 1188000 2059000 2357000 5362000 5752000 14767000 12694000 1155000 1403000 257000 281000 2692000 2224000 1373000 840000 956000 4944000 6237000 447000 605000 289000 341000 1466000 1447000 6249000 1142000 31000 33000 8482000 3568000 13426000 9805000 52944000 43452000 30863000 30863000 -1409000 -1634000 -77936000 -67395000 4462000 5286000 -3121000 -2397000 1341000 2889000 14767000 12694000 2860000 1430000 7468000 2876000 2222000 1219000 5809000 2389000 638000 211000 1659000 487000 1220000 1106000 2243000 2171000 359000 199000 482000 282000 3797000 2276000 7702000 4122000 -4738000 -3370000 -8768000 -6088000 -2749000 -2344000 -16000 65000 5000 -153000 7000 -7422000 -3365000 -11265000 -6097000 -7422000 -3365000 -11265000 -6097000 -454000 -416000 -724000 -795000 -6968000 -2949000 -10541000 -5302000 -7422000 -3365000 -11265000 -6097000 574000 -425000 225000 -997000 574000 -425000 225000 -997000 -6848000 -3790000 -11040000 -7094000 -454000 -410000 -724000 -795000 -6394000 -2955000 -10316000 -6298000 -0.19 -0.19 -0.11 -0.11 -0.34 -0.34 -0.23 -0.23 -0.19 -0.11 -0.34 -0.23 33386071 27261525 32349810 27049715 30945322 43452000 30863000 -1634000 -67395000 -2397000 2889000 -10541000 -724000 -11265000 225000 225000 225000 -10541000 -724000 -11040000 1783561 2233000 2233000 3818275 4193000 4193000 30000 65000 99000 99000 2967000 2967000 36642158 52944000 30863000 -1409000 -77936000 -3121000 1341000 26326488 28297000 34763000 -708000 -50838000 -607000 10907000 28297000 34763000 -708000 -50838000 -607000 10907000 -5302000 -795000 -6097000 -997000 -12000 -997000 -997000 -5302000 -795000 -7094000 74895 584207 4072000 -2795000 1277000 273774 2089000 2089000 16667 20000 20000 51000 51000 111000 111000 27276031 34640000 31968000 -1705000 -56140000 -1402000 7361000 34640000 31968000 -1705000 -56140000 -1402000 7361000 -11265000 -6097000 547000 303000 2967000 111000 2344000 -19000 -2000 -21000 -246000 -64000 -174000 367000 1005000 -2211000 -10000 1000 -16000 468000 -151000 -1373000 1236000 -116000 45000 -5836000 -6465000 8000 -14000 879000 157000 209000 -149000 -1102000 9188000 20000 99000 1277000 172000 47000 394000 282000 94000 429000 8815000 1398000 2830000 -6169000 225000 -639000 2616000 8470000 5671000 1662000 57000 6000 2089000 2089000 -878000 35000 49000 -636000 -1538000 -879000 <p id="xdx_80A_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_ztXr7xhMvaw8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82B_zEnoebX2qLj1">NATURE AND CONTINUANCE OF OPERATIONS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A2Z SMART TECHNOLOGIES CORP. (the “Company” or “A2ZST”) was incorporated on January 15, 2018 under the laws of British Columbia. The head office is located at 1600 – 609 Granville Street, Vancouver, British Columbia V7Y 1C3, and the records and registered office is located at 2200 HSBC Building 885 West Georgia Street, British Columbia, V6C 3E8.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was listed on the NASDAQ Stock Market LLC (“Nasdaq”) starting January 22, 2022, and trades under the symbol “AZ” and on the TSX Venture Exchange (“TSX Venture”) and trades under the symbol “AZ.V”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company owns <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--Cust2MateLtdMember_zBTwI9uGNkdf">76.78</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of the common shares of Cust2Mate Ltd (“Cust2Mate”), a technology company focused on providing retail automation solutions, in particular for large grocery stores and supermarkets. The Company’s primary product is the Cust2Mate system which incorporates a “smart cart” which automatically calculates the value of the customers purchases in their smart cart, without having to unload and reload their purchases at a customer checkout point.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Cust2Mate system offers various features for shoppers and retailers such as product information and location, an on-cart scale to weigh items and automatically calculate costs, bar-code scanner and on-board payment system to bypass checkout lines. In addition, the product includes big data smart algorithms and computer vision capabilities, allowing for customer specific targeted advertising. (“The Cust2Mate Platform”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Cust2Mate Platform is being rolled out in Israel and is being marketed throughout the world, with pilot programs in North and South America, Europe and in the Middle East.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s other activities include the provision of services in the field of services to the military and security markets as well as the development of related products for the civilian markets. Such services include providing maintenance services and container leasing. The Company also provides maintenance services for complex electronic systems and products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company announced the closing of acquisition of Isramat Ltd. This strategic acquisition vertically integrates certain manufacturing capabilities for the production of A2Z’s Cust2Mate smart cart while complementing existing contract manufacturing partnerships to support anticipated worldwide growth.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its <span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AdvancedAutomotiveInnovationsIncMember_zFd506GXTbDl" title="Ownership interest in subsidary">80</span>% owned subsidiary, Advanced Automotive Innovations Inc., (“AAI”) continues the development of a product for the automotive market - the FTICS or Fuel Tank Inertia Capsule System which activates automatically in the event of a vehicle collision. This eliminates the danger of fuel tank combustion thereby saving lives and reducing damage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, the Company had four key subsidiaries, all of which are companies incorporated under the laws of Israel: (1) Cust2mate Ltd. (“Cust2mate”); (2) A2Z Advanced Military Solutions Ltd (“A2Z MS”); (3) A2Z Advanced Solutions Ltd. (“A2Z AS”); and (4) Isramat Ltd., the “Subsidiaries”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had a net loss of approximately $<span id="xdx_900_eifrs-full--ProfitLossOfCombinedEntity_iN_pn5n6_di_c20230101__20230630_zVwilDIz1vd6">11.3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for the six months ended June 30, 2023, and $<span id="xdx_904_eifrs-full--ProfitLossOfCombinedEntity_iN_pn5n6_di_c20220101__20220630_zqpWGhdzvC5d">6.1</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for the six months ended June 30, 2022. The Company has an accumulated deficit of $<span id="xdx_90A_eifrs-full--RetainedEarnings_iNI_pn6n6_di_c20230630_zJZVV9oJB1Cl">78</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million as of June 30, 2023. The Company has incurred negative cash from operations and net losses for the current and recent periods. The Company financed its operation up to date by issuance of shares and warrants. The Company does not have any material financial cash obligations as of the balance date. The company believes that it has sufficient resources to operate in the foreseeable future with the support of its directors and officers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These Condensed Interim Consolidated financial statements were authorized for issue by the Board of Directors on August 14, 2023.</span></p> 0.7678 0.80 -11300000 -6100000 -78000000 <p id="xdx_80C_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zSgMKIgAJdAe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_826_zNN0vyosJ3Ac">BASIS OF PREPARATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant accounting policy</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Statement of Compliance</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These unaudited Condensed Interim Consolidated financial statements of the Company are as of June 30, 2023, and presented in US dollars, which is not the functional currency. The functional currency is the NIS. These unaudited interim condensed consolidated financial statements have been prepared in accordance with the requirements of International Accounting Standard IAS 34 “Interim Financial Reporting” as issued by the IASB. They do not include all the information required in annual financial statements in accordance with IFRS and should be read in conjunction with the financial statements of the Company for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The policies applied in these Condensed Interim Consolidated financial statements are based on IFRS effective as of June 30, 2023, and are consistent with those included in the Company’s annual financial statements for the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of Consolidation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial results of subsidiaries are included in the consolidated financial statements from the date that control commences until the date that control ceases. Intercompany balances and transactions and any unrealized income and expenses arising from such transactions are eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Basis of measurement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These consolidated financial statements have been prepared on a going concern basis, under the historical cost basis, except for financial instruments which have been measured at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical Estimates and Assumptions</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these estimates. The Company’s financial statements include estimates which, by their nature, are uncertain. The impacts of such estimates are pervasive throughout the Company’s financial statements and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and also in future periods when the revision affects both current and future periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency for each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates; the Company has determined the functional currency of each entity to be the New Israeli Shekel. Such determination involves certain judgements to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions which determine the primary economic environment. During there three and six months ended June 30, 2023, there have been not such changes. The Company’s presentation currency is the U.S. dollar.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The critical judgments and significant estimates in applying accounting policies that have the most significant effect on the amounts recognized in the financial statements are the same as at December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 96px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>a)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The useful life of property and equipment</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are amortized or depreciated over their useful lives. Useful lives are based on management’s estimates of the period that the assets will generate revenue, which are periodically reviewed for continued appropriateness. Changes to estimates can result in significant variations in the amounts charged to the consolidated statement of comprehensive income in specific periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 96px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>b)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determining the fair value of share-based payment transactions</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of share-based payment transactions is determined upon initial recognition by the Binomial model. The Binomial model is based on share price and exercise price and assumptions regarding expected volatility, term of share option, dividend yield and risk-free interest rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 96px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Intangible assets and goodwill</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets and goodwill are tested for impairment annually or more frequently if three is an indication of impairment. The carrying value of intangibles with definite lives is reviewed each reporting period to determine whether there is any indication of impairment. If there are indications of impairment the impairment analysis is completed and if the carrying amount of an asset exceeds its recoverable amount, the asset is impaired and impairment loss is recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 96px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>d)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Derivative liability – Warrants</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the Black-Scholes option-pricing model to estimate fair value at each reporting date. The key assumptions used in the model are the expected future volatility in the price of the Company’s Common Shares and the expected life of the warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 96px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>e)</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going concern</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to assess whether it is appropriate for the Company to continue as going concern, management is required to apply judgements and make estimates with regards to future cash flow projections. In arriving at this judgement there were several assumptions and estimates involved in calculating the future cash flow projections. These includes making estimates regarding the timing and amounts of future expenditures and the ability and timing to raising additional financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New Accounting Standards</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A number of amended standards became applicable for the current reporting period. The Company and its subsidiaries did not have to change its accounting policies or make retrospective adjustments as a result of adopting these amended standards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.IFRS 17 Insurance Contracts</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.Disclosure of Accounting Policies – Amendments to IAS 1 and IFRS Practice Statement 2</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.Definition of Accounting Estimates – Amendments to IAS 8</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.Deferred Tax related to Assets and Liabilities arising from a Single Transaction – Amendments to IAS 12</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_808_ecustom--DisclosureOfWarrantLiabilityExplanatory_ztPXxs7w0Tv3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_825_zSvISd4OCMIc">WARRANT LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">June 2023 Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 15 and on June 20, 2023, the Company issued an aggregate of <span id="xdx_906_ecustom--ClassOfWarrantOrRightOutstanding1_iI_pid_c20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zVAEAfGdwpY8"><span id="xdx_904_ecustom--ClassOfWarrantOrRightOutstanding1_iI_pid_c20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zsUpLEPckxn6" title="Class of warrant or right outstanding">1,909,134</span></span> June 2023 Registered Direct Offerings Warrants (as defined below) as part of registered direct offerings (see also note 5(g)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD<span id="xdx_90E_ecustom--ExercisePriceOfWarrant_iI_pid_uCADPShares_c20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zfhpn1PIWZNg"><span id="xdx_901_ecustom--ExercisePriceOfWarrant_iI_pid_uCADPShares_c20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zstnR18dcFI8">2.93</span></span>) rather than the functional currency of the Company – New Israeli Shekels (NIS). The June 2023 Registered Direct Offerings Warrants are exercisable for a period of <span id="xdx_901_ecustom--WarrantsExercisableTerm_dtY_c20230615__20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zwvZWTSQtKe2"><span id="xdx_909_ecustom--WarrantsExercisableTerm_dtY_c20230620__20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_ztZDpOaXvdod">2</span></span> years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of <span id="xdx_90F_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_pid_dp_uPure_c20230615__20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zvOdYMGaawUc"><span id="xdx_904_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_pid_dp_uPure_c20230620__20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zGjZ3ZRWle92">99</span></span>% using the historical prices of the Company, risk-free interest rate of <span id="xdx_902_ecustom--DescriptionOfRiskFreeInterestRateWarrantsGranted_pid_dp_uPure_c20230615__20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_ztLlhmnXus7g"><span id="xdx_905_ecustom--DescriptionOfRiskFreeInterestRateWarrantsGranted_pid_dp_uPure_c20230620__20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zJckqVu4h7q7">4.45</span></span>%, expected life of <span id="xdx_90E_ecustom--FairValueAssumptionsExpectedLife_dtY_c20230615__20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zudfDaEFmZdg"><span id="xdx_907_ecustom--FairValueAssumptionsExpectedLife_dtY_c20230620__20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zroXA0qD5U78">2.00</span></span> years and share price of CAD<span id="xdx_903_ecustom--FairValueSharePrice_iI_pid_uCADPShares_c20230615__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zlpZWdwu0gkb"><span id="xdx_906_ecustom--FairValueSharePrice_iI_pid_uCADPShares_c20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zzF223yWcbc4">2.99</span></span>.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 for the period ended on June 30, 2023:</span></p> <p id="xdx_89D_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_z58xzXZHgNC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zy90zMXQfJ08" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at January 1, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_ziLvuuBNrl9c" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left; padding-bottom: 1.5pt">Issuance of June 2023 Registered Direct Offerings Warrants</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--IssuanceOfWarrants_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zAClwa0TJkma" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Issuance, warrants">2,333</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_z0QCYdhC0T69" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">2,333</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z9lp8NsmZ16k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">March 2023 Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 20, 2023, the Company issued an aggregate of <span id="xdx_903_ecustom--ClassOfWarrantOrRightOutstanding1_iI_pid_c20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zjUmhwwd0yPh">891,778</span> March 2023 Warrants (as defined below) as part of a private placement (see also note 5(f)). The warrants were issued with an exercise price denominated in Canadian Dollars (CAD<span id="xdx_90B_ecustom--ExercisePriceOfWarrant_iI_pid_uCADPShares_c20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z1Nlz2ju5OUb">2.35</span>) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of <span id="xdx_900_ecustom--WarrantsExercisableTerm_dtY_c20230320__20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zpDwKMFUxrn4">2</span> years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of <span id="xdx_905_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_pid_dp_uPure_c20230320__20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zRAdCLMoouA1">93</span>% using the historical prices of the Company, risk-free interest rate of <span id="xdx_90E_ecustom--DescriptionOfRiskFreeInterestRateWarrantsGranted_pid_dp_uPure_c20230320__20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zLzvRZnQHaKb">3.62</span>%, expected life of <span id="xdx_901_ecustom--FairValueAssumptionsExpectedLife_dtY_c20230320__20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zaH4G3Ijj6oc">2.00</span> years and share price of CAD<span id="xdx_906_ecustom--FairValueSharePrice_iI_pid_uCADPShares_c20220320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zM6paEvh9pvd">1.74</span>.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 for the period ended on June 30, 2023:</span></p> <p id="xdx_892_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z0b8qTjdfmr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zgDZU3PFRWu1" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at January 1, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zJKisnp4xU09" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; padding-bottom: 1.5pt">Issuance of March 2023 Warrants</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--IssuanceOfWarrants_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_ziotFhM374ql" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Issuance, warrants">496</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z95nLSE0SrE" style="text-align: right" title="Balance, warrants">496</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Revaluation at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--RevaluationOfWarrants_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zfpkvWWo8ODc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revaluation, warrants">1,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zpzig9VoBqA9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">1,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zcCVs0CyWaWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – WARRANT LIABILITY (CONTINUED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three- and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the March 2023 warrant liability in the amount of $<span id="xdx_900_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zUJUDHUOFBDf" title="Revaluation of warrant liability">1,004</span> and $<span id="xdx_90E_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zIyNgLyp5L9h" title="Revaluation of warrant liability">1,004</span>, respectively (for the three- and six-month period ended June 30, 2022 - $<span id="xdx_901_ecustom--GainLossOnRevaluationOfWarrantLiability_dxL_c20220401__20220630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z2zTX9nFq6Y8" title="Revaluation of warrant liability::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0661">nil</span></span> and $<span id="xdx_90F_ecustom--GainLossOnRevaluationOfWarrantLiability_dxL_c20220101__20220630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zAtaY8EkGlY5" title="Revaluation of warrant liability::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0663">nil</span></span>, respectively).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">November 2022 Warrants</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 2, 2022, the Company issued an aggregate of <span id="xdx_907_ecustom--ClassOfWarrantOrRightOutstanding1_iI_pid_c20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zPjwqhIWbVO4">1,489,166</span> warrants (November 2022 Warrants) as part of a private placement. The warrants were issued with an exercise price denominated in Canadian Dollars (CAD<span id="xdx_90D_ecustom--ExercisePriceOfWarrant_iI_pid_uCADPShares_c20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zcNCSojHyTL" title="Exercise price of warrant">2.35</span>) rather than the functional currency of the Company – New Israeli Shekels (NIS). The warrants are exercisable for a period of <span id="xdx_900_ecustom--WarrantsExercisableTerm_dtY_c20221102__20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_z9dsLh1kekMa" title="Warrants exercisable term">2</span> years from the issue date. The Black-Scholes option pricing model was used to measure the warrant liability with the following assumptions: volatility of <span id="xdx_90C_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_pid_dp_uPure_c20221102__20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zQuHXj0ZeX88" title="Volatility warrants granted">110</span>% using the historical prices of the Company, risk-free interest rate of <span id="xdx_909_ecustom--DescriptionOfRiskFreeInterestRateWarrantsGranted_pid_dp_uPure_c20221102__20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zQpkL0zph2Qg" title="Risk-free interest rate">3.94</span>%, expected life of <span id="xdx_903_ecustom--FairValueAssumptionsExpectedLife_dtY_c20221102__20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zVkdcOl7Q3x6" title="Expected life">2.00</span> years and share price of CAD<span id="xdx_903_ecustom--FairValueSharePrice_iI_pid_uCADPShares_c20221102__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zBfXIsHK9u48" title="Share price">1.56</span>.</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 for the period ended on June 30, 2023:</span></p> <p id="xdx_890_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoWarrantsMember_zLZYKFlJnuq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_z07Zzn5xr4Y" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at January 1, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zIWeNcpfE2pf" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify">Issuance of November 2022 Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--IssuanceOfWarrants_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zm4KESyRLNf6" style="width: 16%; text-align: right" title="Issuance, warrants">894</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Revaluation at December 31,2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--RevaluationOfWarrants_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zMqpNPlBbTqc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revaluation, warrants">248</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zPytj3Uf6EN2" style="text-align: right" title="Balance, warrants">1,142</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Revaluation at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--RevaluationOfWarrants_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zRd0AjYCpgHf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revaluation, warrants">(405</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Balance at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zn4Fzs0Kqy16" style="text-align: right" title="Balance, warrants">737</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrant exercises (note 4(d))</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eifrs-full--ProceedsFromExerciseOfWarrants_iN_pn3n3_di_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_z4E99OYcVL14" style="text-align: right" title="Reclassification to Warrant Reserve">(66</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Revaluation at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--RevaluationOfWarrants_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zbVet0fEhtRf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revaluation, warrants">1,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zsvcJOGYzkrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">2,416</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zvfuQvvFU9bi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the three-and six-month period ended June 30, 2023, the Company recorded a loss on the revaluation of the November 2022 warrant liability in the amount of $<span id="xdx_904_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zEKRWZOwvJV" title="Gain loss on revaluation of warrant liability">1,745 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90B_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zD7atR9tmqmg" title="Gain loss on revaluation of warrant liability">1,362</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively (for the three- and six-month period ended June 30, 2022 - $<span id="xdx_901_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_d0_c20220401__20220630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zd5aMJd8VPcf" title="Gain loss on revaluation of warrant liability">nil</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_ecustom--GainLossOnRevaluationOfWarrantLiability_pn3n3_d0_c20220101__20220630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zDYjvJUsEETd" title="Gain loss on revaluation of warrant liability">nil</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1909134 1909134 2.93 2.93 P2Y P2Y 0.99 0.99 0.0445 0.0445 P2Y P2Y 2.99 2.99 <p id="xdx_89D_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_z58xzXZHgNC7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zy90zMXQfJ08" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at January 1, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_ziLvuuBNrl9c" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left; padding-bottom: 1.5pt">Issuance of June 2023 Registered Direct Offerings Warrants</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98D_ecustom--IssuanceOfWarrants_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zAClwa0TJkma" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Issuance, warrants">2,333</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230101__20230630__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_z0QCYdhC0T69" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">2,333</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 2333000 2333000 891778 2.35 P2Y 0.93 0.0362 P2Y 1.74 <p id="xdx_892_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z0b8qTjdfmr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BF_zgDZU3PFRWu1" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Balance at January 1, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zJKisnp4xU09" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0647">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; padding-bottom: 1.5pt">Issuance of March 2023 Warrants</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--IssuanceOfWarrants_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_ziotFhM374ql" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Issuance, warrants">496</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Balance at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_z95nLSE0SrE" style="text-align: right" title="Balance, warrants">496</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Revaluation at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_ecustom--RevaluationOfWarrants_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zfpkvWWo8ODc" style="border-bottom: Black 2.5pt double; text-align: right" title="Revaluation, warrants">1,004</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementsMember_zpzig9VoBqA9" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">1,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 496000 496000 1004000 1500000 1004000 1004000 1489166 2.35 P2Y 1.10 0.0394 P2Y 1.56 <p id="xdx_890_ecustom--DisclosureOfFairValueOfWarrantsExplanatory_hcustom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoWarrantsMember_zLZYKFlJnuq2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B2_z07Zzn5xr4Y" style="display: none">SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at January 1, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zIWeNcpfE2pf" style="text-align: right" title="Balance, warrants"><span style="-sec-ix-hidden: xdx2ixbrl0680">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify">Issuance of November 2022 Warrants</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--IssuanceOfWarrants_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zm4KESyRLNf6" style="width: 16%; text-align: right" title="Issuance, warrants">894</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Revaluation at December 31,2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_ecustom--RevaluationOfWarrants_pn3n3_c20220101__20221231__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zMqpNPlBbTqc" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revaluation, warrants">248</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Balance at December 31, 2022</td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zPytj3Uf6EN2" style="text-align: right" title="Balance, warrants">1,142</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Revaluation at March 31, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_989_ecustom--RevaluationOfWarrants_pn3n3_c20230101__20230331__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zRd0AjYCpgHf" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revaluation, warrants">(405</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Balance at March 31, 2023</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WarrantLiabilityLoss_iS_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zn4Fzs0Kqy16" style="text-align: right" title="Balance, warrants">737</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Warrant exercises (note 4(d))</td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eifrs-full--ProceedsFromExerciseOfWarrants_iN_pn3n3_di_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_z4E99OYcVL14" style="text-align: right" title="Reclassification to Warrant Reserve">(66</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Revaluation at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--RevaluationOfWarrants_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zbVet0fEhtRf" style="border-bottom: Black 2.5pt double; text-align: right" title="Revaluation, warrants">1,745</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt">Balance at June 30, 2023</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--WarrantLiabilityLoss_iE_pn3n3_c20230401__20230630__custom--TypesOfWarrantsAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementsMember_zsvcJOGYzkrc" style="border-bottom: Black 2.5pt double; text-align: right" title="Balance, warrants">2,416</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 894000 248000 1142000 -405000 737000 66000 1745000 2416000 1745000 1362000 <p id="xdx_80D_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zUmV1HoLnK9h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 - <span id="xdx_823_zUVVQ118Fgk7">SHAREHOLDERS EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2022, the Company issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20220630_zhzX8WBIflDf" title="Number of share issuance in escrow">584,207</span> shares in respect of <span id="xdx_90B_ecustom--NumberOfWarrantsExercised_pid_c20220101__20220630_zl8fA2b8VPva" title="Number of warrants exercised">584,207</span> warrants that were exercised for gross proceeds of $<span id="xdx_903_eifrs-full--ProceedsFromExerciseOfWarrants_pn3n3_c20220101__20220630_zDLTe42I2jN9" title="Proceeds from exercise of warrants">1,277</span> (note 5 (a)).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company issued the shareholders of Isramat <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20220203__ifrs-full--BusinessCombinationsAxis__custom--IsramatLtdMember_z1W8N4YryAH1" title="Number of share issuance in escrow">273,774</span> common shares in the capital of the Company in respect of the acquisition of Isramat. Total value of the shares issued was $<span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20220203_zkWGtzAbVwc1" title="Number of share issuance in escrow">2,089</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 11, 2022, the Company issued <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20220211_zrTfSmk6Fsq3" title="Shares issued">74,985</span> shares to a trustee in respect of a crowd funding transaction that was completed in 2019, for which shares were not immediately issued until the completion of an Israeli tax ruling which was only finalized in late 2021. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company issued <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20230630_zZGNQSEpgok1" title="Shares issued">65,000</span> shares in respect of <span id="xdx_901_ecustom--NumberOfWarrantsExercised_pid_uShares_c20230101__20230630_zPettCo0ADMc" title="Number of warrants exercised">65,000</span> warrants that were exercised for gross proceeds of $<span id="xdx_90C_eifrs-full--ProceedsFromExerciseOfWarrants_c20230101__20230630_zDfYU5eithy5" title="Proceeds from exercise of warrants">99</span> (note 3 (c) and note 5 (a)).</span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company issued <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zZPDa1Ywv0Zd" title="Shares issued">30,000</span> shares in respect of <span id="xdx_906_ecustom--NumberOfWarrantsExercised_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zw7DsoYQtcz6" title="Number of warrants exercised">30,000</span> RSU’s that were exercised (note 5 (c)).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 20, 2023, the Company closed a private placement for gross proceeds of $<span id="xdx_909_ecustom--ProceedsFromPrivatePlacements_pn3n3_c20230320__20230320_zEbK6vDIsRz8" title="Proceeds from private placements">2,604</span> through the issuance of <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20230320_zzf6DjT81Ged" title="Number of shares issued">1,783,561</span> units (“Units”) at a price per Unit of US$<span id="xdx_90E_ecustom--WarrantExercisePricePerShare_iI_pid_c20230320_ztluvAv35Gjk" title="Warrant exercise price per share">1.46</span> (CAD$<span id="xdx_90C_ecustom--WarrantExercisePricePerShare_iI_pid_uCADPShares_c20230320_zOR4UxAIJcB5" title="Warrant exercise price per share">1.95</span>). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20230320__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zL7b5BpcNXqe" title="Number of shares issued">891,778</span> Warrants were issued with an exercise price of CAD$<span id="xdx_907_ecustom--WarrantExercisePricePerShare_iI_pid_uCADPShares_c20230320__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_z5AnyDHVKCYc" title="Warrant exercise price per share">2.35</span> (US$<span id="xdx_90A_ecustom--WarrantExercisePricePerShare_iI_pid_c20230320__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_z9HKzfOfp4ek" title="Warrant exercise price per share">1.75</span>) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional <span id="xdx_903_ecustom--IssuanceOfAdditionalCommonShares_pid_c20230320__20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember_zIk2YAWfLMU7" title="Issuance of additional common shares">891,778</span> common shares (“March 2023 Private Placement Warrants”). A finder’s fee of $<span id="xdx_902_ecustom--FinderFee_iI_pn3n3_c20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember_zw8lDBYioxS3" title="Finder fee">208</span> (CAD$<span id="xdx_90C_ecustom--FinderFee_iI_pn3n3_uCAD_c20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember_zdJTGofcuI1j" title="Finder fee">290</span>) was paid and <span id="xdx_90E_ecustom--PrivatePlacementWarrantShareIssued_iI_pid_c20230320__custom--TypesOfWarrantsAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember_zVTp63m4M6ib" title="Private placement of warrant shares issued">142,685</span> March 2023 Private Placement Warrants were issued in connection with the private placement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 15 and on June 20, 2023, the Company closed registered direct offerings for gross proceeds of $<span id="xdx_904_ecustom--ProceedsFromIssuanceOfUnits_pn3n3_c20230620__20230620_zMBCBnD1gp83">6,873 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">through the issuance of <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20230620_zK3oudYG7oB1">3,818,275 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">units (“Units”) at a price per Unit of US$<span id="xdx_909_ecustom--WarrantExercisePricePerShare_iI_pid_c20230620_zpNkvsR971gg">1.80</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(CAD$<span id="xdx_906_ecustom--WarrantExercisePricePerShare_iI_pid_uCADPShares_c20230620_zbZtoKR6P1f1">2.41</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). Each Unit consists of one common share and one half of one common share purchase warrant (each whole such warrant a “Warrant”). An aggregate of <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230620__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zeMubwjPiWI3">1,909,134 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants were issued with an exercise price of CAD$<span id="xdx_908_ecustom--WarrantExercisePricePerShare_iI_pid_uCADPShares_c20230620__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zzqj0Ply0rtf">2.93 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(US$<span id="xdx_90F_ecustom--WarrantExercisePricePerShare_iI_pid_c20230620__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zNDmhE3LVfYj">2.20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) The Warrants have a term of two years and if fully exercised, will result in the issuance of an additional <span id="xdx_905_ecustom--IssuanceOfAdditionalCommonShares_pid_c20230620__20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember_zJiJKNARVDvk">1,909,134 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common shares (“June 2023 Registered Direct Offerings Warrants”). A finder’s fee of $<span id="xdx_90B_ecustom--FinderFee_iI_pn3n3_c20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember_zQXdf5JhPojd">550 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(CAD$<span id="xdx_909_ecustom--FinderFee_iI_pn3n3_uCAD_c20230620__custom--TypesOfWarrantsAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember_zMMdRkPllipf">733</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) was paid and <span id="xdx_90A_ecustom--PrivatePlacementWarrantShareIssued_iI_pid_c20230620__custom--TypesOfWarrantsAxis__custom--NonregisteredWarrantsMember_z6x4qs1DG0B4">305,462 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-registered warrants</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> were issued in connection with the Registered Direct Offerings.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 584207 584207 1277000 273774 2089 74985 65000 65000 99000 30000 30000 2604000 1783561 1.46 1.95 891778 2.35 1.75 891778 208000 290000 142685 6873000 3818275 1.80 2.41 1909134 2.93 2.20 1909134 550000 733000 305462 <p id="xdx_809_ecustom--DisclosureOfWarrantsAndOptionExplanatory_zh7fGostFb5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 - <span id="xdx_828_zFtsEVG3lhAb">WARRANTS AND OPTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a) Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant transactions for the six months ended June 30, 2023 and for the year ended December 31, 2022 are as follows:</span></td></tr> </table> <p id="xdx_893_ecustom--DisclosureOfWarrantsTransactionsExplanatory_z6UYTBHEt3cb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zq8DwZS0GO11" style="display: none">SCHEDULE OF WARRANTS TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold; padding-bottom: 1.5pt">Balance, January 1, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstanding1_iS_pid_c20220101__20221231_zh1sT57aqVA7" style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right" title="Number of warrants outstanding, beginning balance">5,966,204</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zyBAR3GYm8u7" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">3.55</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Expiration of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExpired_iN_pid_di_c20220101__20221231_zneJmQtW72W6" style="text-align: right" title="Number of warrants outstanding, Expired of warrants">(5,437</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExercised_iN_pid_di_c20220101__20221231_zh2puVZn07v7" style="text-align: right" title="Number of warrants outstanding, Exercise of warrants">(630,161</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants issued in the November 2022 Private Placement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20220101__20221231__custom--SubsidiarySaleOfStocksAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementMember_zubwctN5XYN8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, warrants issued">1,726,366</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance, December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightOutstanding1_iS_pid_c20230101__20230630_zKv2YjtC4qkb" style="font-weight: bold; text-align: right" title="Number of warrants outstanding, beginning balance">7,056,972</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zy0S0o506tl9" style="text-align: right" title="Weighted Average Exercise Price, Beginning Balance">3.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued in the March 2023 Private Placement</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20230101__20230630__custom--SubsidiarySaleOfStocksAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementMember_zbt9twcKbjtc" style="text-align: right" title="Number of warrants outstanding, warrants issued">1,034,463</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4B_zyjzQZEfZnzi">Exercise of warrants (*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExercised_iN_pid_di_c20230101__20230630_fKCop_zqTB4SA1d3H3" style="text-align: right" title="Number of warrants outstanding, Exercise of warrants">(65,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants issued in the June 2023 Registered Direct Offerings</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20230101__20230630__custom--SubsidiarySaleOfStocksAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zfTC8aEvprs6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, warrants issued">2,214,596</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightOutstanding1_iE_pid_c20230101__20230630_z5cKMKMb1Gc6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding, ending balance">10,241,031</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zDviwtWkAMLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">2.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0F_zhDngWdjkMn" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zqDPjEcl4I85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zmWKtDEDHAbb">65,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in respect of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_ecustom--NumberOfWarrantsOutstanding_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_znfN5PNWjKof" title="Number of warrants outstanding">65,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants that were exercised for gross proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eifrs-full--ProceedsFromExerciseOfWarrants_uUSD_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_z33X7zftOj2b">99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. All exercised warrants were warrants classified as a liability prior to their exercise.</span></td> </tr></table> <p id="xdx_8A0_zeVDXR1J7ds3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a) Warrants (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zmxpLcVqbxKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at June 30, 2023, the Company had outstanding warrants, enabling the holders to acquire common shares as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zaZTJgBrcmZ7" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (USD)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zBGkRMehE724" style="width: 21%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,658,313</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zU0qfH4nIEle" title="Expiry date">November 10, 2025</span></span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_fKDEp_zkYu0GmTOy96" style="width: 20%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1418</span></td><td style="width: 1%; text-align: left"><span id="xdx_F25_zukGhZDZVEWi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_z3ziAaELoWWg" style="width: 20%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.93</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zLh8qgkI5Teh" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zvi0LoWneuzi" title="Expiry date">December 24, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_fKDEp_zKKxkG9gRhBd" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1418</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F2A_zyErru9d9Clg">(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_fKDEp_z6lXDXqkFGn8" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_zGPYSEs5GhWj" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_z7TdPAq0UgPg" title="Expiry date">April 22, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_fKDIp_zpZwRYPRvy39" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F28_zAuuFNx5ACK4">(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_fKDIp_zQNi4YRxZBq2" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_zjjUD0jOR4S5" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,084,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_zar3CfDA2mfh" title="Expiry date">May 6, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_fKDIp_zoNSFYVX3nnc" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F29_zo4rMbssJ4B3">(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_fKDIp_zwL3aozbOyV6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zsOJkJK85WRa" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,661,366</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zLMoli5D2Rmk" title="Expiry date">November 8, 2024</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zwPFIjFNKZk9" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_fKDMp_zZ6sSrZ2D1L1" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_ztbwAxPaFMr5" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,034,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_zuN8DsAMW8Ai" title="Expiry date">March 13, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_zWsgMiXIxNfb" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_fKDMp_zydmTjHBZ8R9" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zrG8Gw01Y67j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,214,596</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zvbMwCQNU9jk" title="Expiry date">June 15, 2025</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zmT5JLHxdKYb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.93</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_fKDMp_zrOTRILqwSHh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630_zhietvqjlNWh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,241,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F03_ziTPCAsbHJg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zP7LZK34HDcj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20210331__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_z9OL4e6dTLf" title="Exercise price">2.70</span> would be payable in New Israeli Shekels. The exercise price is NIS <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20210331__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zt2PVz6IPk9a" title="Exercise price">7.1418</span> per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zsYYXCAUUH0k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zo7XiZJoa6U4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20210630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zkByyL30sZgk" title="Exercise price">11.04</span> would be payable in New Israeli Shekels. The exercise price is NIS <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20210630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zDsvwwc1horg" title="Exercise price">29.025</span> per warrant. On March 27, 2023, the expiry dates of a total of <span id="xdx_90C_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_uShares_c20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zU58xgIjnBJ4" title="Number of warrants outstanding">221,100</span> share purchase warrants were extended by three years to <span id="xdx_907_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230327__20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zD6KRqZ9kVV2" title="Expiry date">April 26, 2026</span>, and the expiry dates of a total of <span id="xdx_90A_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_uShares_c20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zpksQIjLAtog" title="Number of warrants outstanding">1,084,562</span> share purchase warrants were extended by three years to <span id="xdx_90C_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230327__20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zTq49qI38vQf" title="Expiry date">May 6, 2026</span>.</span></td></tr> </table> <p id="xdx_8A4_zfej7bnvZ5m4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -13.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b) Stock Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89D_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_zKolMs1YuEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zT6ZlM61ukM7" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise Price<br/> (CAD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise Price<br/> (USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance January 1, 2022</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20220101__20221231_z2vosPyWdtu7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of stock options, beginning balance">820,010</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uCADPShares_c20220101__20221231_z4ho5OI432lj" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance">2.26</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20220101__20221231_zNGq8SRDIjnb" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance">1.78</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20220101__20221231_zWW7l6E9BMR1" style="text-align: right" title="Number of stock options, options granted">1,200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_zSR5JLs1QQXk" style="text-align: right" title="Weighted Average Exercise Price, options granted">3.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231_zaMZdG9ED29h" style="text-align: right" title="Number of stock options, Exercise of options">(116,667</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_z9KcSIhn8cA5" style="text-align: right" title="Weighted Average Exercise Price, Exercise of options">2.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Expiry of options</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231_zCPi5rmQSjB6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Expiry of options">(20,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_zTdd69JrCXM5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expiry of options">1.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20230101__20230630_zbfGouuf9Utd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, beginning balance">1,883,343</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uCADPShares_c20230101__20230630_zNz6FtlsDoLe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance">3.17</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20230101__20230630_zr9NpnJ9Md8g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance">2.45</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F41_zYMPwO1ZXe5g" style="text-align: justify; padding-bottom: 1.5pt">Options granted (i-iv)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zEqRnGyzAHZ3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, options granted">1,585,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zyttGK2uhQ56" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, options granted">1.78</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zea1lz2AMVEh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, options granted">1.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20230101__20230630_zMUZMNFXWW92" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, ending balance">3,468,593</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uCADPShares_c20230101__20230630_zTxbuxZHRYO1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance">2.53</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zAnzmh1dYK71" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance">1.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F08_zsdXK8JUs99h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_F1C_zRx3WiMffRmf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z3zaev7xXvN3" title="Number of stock options, options issued">816,500</span> stock options were issued to directors and consultants with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zmUrMYHwVOWe" title="Number of stock options, exercise price">1.65</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_ztWDwXuNgiO7" title="Options expire">January 4, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zfgZCar5ZKIh" title="Fair value of options granted">1,017</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zVkqJdMhp46j" title="Share Price">1.80</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zBaEOyD8TSv6" title="Expected option life">10</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zSVWOFMHN50h" title="Volatility">112</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z6VqODBcKmdi" title="Risk-free interest rate">3.28</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zltp1j7bIhpd" title="Dividend yield">0</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0B_zci6nnuJPAPl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjiEgOi1bIHj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zXgr9QfF4ena" title="Number of stock options, options issued">100,000</span> stock options were issued to a consultant with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z5kKrUWGsbke" title="Number of stock options, exercise price">1.50</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zTntMhkOfVp2" title="Options expire">November 25, 2027</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z5Rl2kcUMP81" title="Fair value of options granted">135</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zhXXyDBTrDzf" title="Share Price">2.18</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zlgsfrecgf6" title="Expected option life">4.8</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zpxiB19ABhYc" title="Volatility">112</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z2j88GEEHn31" title="Risk-free interest rate">3.16</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zPA85Ttn2aq4" title="Dividend yield">0</span>%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F00_zIMog7CLWC1k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zuOh4JIDyBA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 18, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zDmzs6kxtH4a" title="Number of stock options, options issued">423,750</span> stock options were issued to employees with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z44biUrJ63r1" title="Number of stock options, exercise price">1.60</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zGaBzoa7QfK2" title="Options expire">April 18, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zJIgjlhLf0ki" title="Fair value of options granted">420</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zCd8RTtURm29" title="Share Price">1.42</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zTnIKkp2fmb6" title="Expected option life">10</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zcQC1YbATnr7" title="Volatility">111</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zch6S5G2JN5a" title="Risk-free interest rate">3.57</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z6I7gxMHGDve" title="Dividend yield">0</span>%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0E_zEzpSRIi6OVl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z2t6BUrk5Z4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zHo5H8G5D94b" title="Number of stock options, options issued">245,000</span> stock options were issued to officers with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zgdhWYRrNi95" title="Number of stock options, exercise price">2.45</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zf4BaaestsJg" title="Options expire">June 28, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zmVu5Za0gCol" title="Fair value of options granted">443</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_znV1RyutnMPh" title="Share Price">2.92</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zVTBkODxJTh" title="Expected option life">5</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zB6GFOoF40jc" title="Volatility">111</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zCkvlxWRdYZ1" title="Risk-free interest rate">4.14</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zigGEVoSPNHf" title="Dividend yield">0</span>%.</span></td></tr> </table> <p id="xdx_8AF_zlhxtZCXrq3e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 - WARRANTS AND OPTIONS (CONTINUED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b) Stock Options (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 40.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zydLEMB7nMC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at June 30, 2023, the Company had outstanding stock options, enabling the holders to acquire common shares as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zLLwysc0NQvc" style="display: none">SCHEDULE OF OUTSTANDING STOCK OPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Outstanding as<br/> of June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercisable as<br/> of June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price (CAD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price (USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zGH07TmHT3d2" style="width: 15%; text-align: right" title="Number of stock options, ending balance">543,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zczaVVHCoSPf" style="width: 15%; text-align: right" title="Number of stock options, Exercisable">510,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 24%"><span id="xdx_90F_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zTo0p8lWFsG" title="Number of stock options, Expiry date">August 20, 2025</span></td><td style="width: 2%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zK6VIDRBAWib" style="width: 15%; text-align: right" title="Number of stock options, Exercise price">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zPq0C5b1fNYb" style="width: 15%; text-align: right" title="Number of stock options, Exercise price">1.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zqMxoxVsNW1g" style="text-align: right" title="Number of stock options, Outstanding">40,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zL6fKPE63idh" style="text-align: right" title="Number of stock options, Exercisable">40,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_900_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zgcjFUWOyeSe" title="Number of stock options, Expiry date">September 1, 2025</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_z4xuCcdNJy74" style="text-align: right" title="Number of stock options, Exercise price">2.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zx832ChJD6l" style="text-align: right" title="Number of stock options, Exercise price">1.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zvbAvIQz48Q6" style="text-align: right" title="Number of stock options, Outstanding">33,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zsIxoa0PO4wa" style="text-align: right" title="Number of stock options, Exercisable">33,333</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90B_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zhgJnOSuoKDa" title="Number of stock options, Expiry date">January 28, 2025</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zsfczaKzRD1f" style="text-align: right" title="Number of stock options, Exercise price">3.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_z1j0LTwWeZWd" style="text-align: right" title="Number of stock options, Exercise price">2.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zSci4vdwSfr8" style="text-align: right" title="Number of stock options, Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zIEUxdIFi4K5" style="text-align: right" title="Number of stock options, Exercisable">33,333</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zWbpzwDUv8Lg" title="Number of stock options, Expiry date">June 3, 2026</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zi0zRJ6vJMy3" style="text-align: right" title="Number of stock options, Exercise price">8.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zhb0WUE6MwG1" style="text-align: right" title="Number of stock options, Exercise price">6.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zvs2CIn9RFjk" style="text-align: right" title="Number of stock options, Outstanding">16,677</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zFoAJXlmQOVg" style="text-align: right" title="Number of stock options, Exercisable">11,118</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zh3uK1vFtmI7" title="Number of stock options, Expiry date">October 28, 2026</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zOe2Oi4848i1" style="text-align: right" title="Number of stock options, Exercise price">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zpIPd3RcqwU9" style="text-align: right" title="Number of stock options, Exercise price">5.90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zrOfnGMD2dci" style="text-align: right" title="Number of stock options, Outstanding">900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zN0cnRONFkpg" style="text-align: right" title="Number of stock options, Exercisable">337,500</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_z80iGS3No6n6" title="Number of stock options, Expiry date">August 2, 2032</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_981_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zewD3L4IxBvh" style="text-align: right" title="Number of stock options, Exercise price">3.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zvesMMEWE6O4" style="text-align: right" title="Number of stock options, Exercise price">2.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zzwkFZfGOQPa" style="text-align: right" title="Number of stock options, Outstanding">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zGZWKrZQ3Vj8" style="text-align: right" title="Number of stock options, Exercisable">300,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zXw3SvF7iKh8" title="Number of stock options, Expiry date">August 21, 2032</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zGXVsukdoiha" style="text-align: right" title="Number of stock options, Exercise price">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zfTTXxl1qnef" style="text-align: right" title="Number of stock options, Exercise price">2.95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zEsha0ZzWEY9" style="text-align: right" title="Number of stock options, Outstanding">816,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zWyrHXERWfUg" style="text-align: right" title="Number of stock options, Exercisable">802,063</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_903_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zbpZEspyflEl" title="Number of stock options, Expiry date">January 4, 2033</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zCsw917tr5Ll" style="text-align: right" title="Number of stock options, Exercise price">1.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zZLwOHpyuADa" style="text-align: right" title="Number of stock options, Exercise price">1.22</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zkfxIzfL7ND" style="text-align: right" title="Number of stock options, Outstanding">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zFUNmI7Grgpc" style="text-align: right" title="Number of stock options, Exercisable">25,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_904_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zUJjH0pqKHk9" title="Number of stock options, Expiry date">November 25, 2027</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zOkZNFtPfnVa" style="text-align: right" title="Number of stock options, Exercise price">2.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zU4smiBLIjUk" style="text-align: right" title="Number of stock options, Exercise price">1.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zR6iyeSbN0Fj" style="text-align: right" title="Number of stock options, Outstanding">423,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_z2HkPPcDS2yk" style="text-align: right" title="Number of stock options, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_904_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zJbhnvCzEPY3" title="Number of stock options, Expiry date">April 18, 2033</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zVW50E0Ll1Tg" style="text-align: right" title="Number of stock options, Exercise price">1.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zu4GYNZLiwhc" style="text-align: right" title="Number of stock options, Exercise price">1.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zQ8W7VNdgUTd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Outstanding">245,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_z1tYAxFVelt1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"><span id="xdx_908_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zaB1t0Kzb2qh" title="Number of stock options, Expiry date">June 28, 2028</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zGfszEGs7E13" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercise price">2.45</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_z3I2XfEbFBLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercise price">1.85</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630_zBdKgUng3Vp9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Outstanding">3,468,593</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630_zpnzn4xEXUI8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercisable">2,117,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zdEEb87Hy2ee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share-based compensation expense is recognized over the vesting period of options. During the six months ended June 30, 2022, share-based compensation of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFdBUlJBTlRTIEFORCBPUFRJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_902_ecustom--SharebasedCompensationRecognized_pn3n3_c20220101__20220630_zsVAieeGtak2" title="Share based compensation">2,547</span> was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFdBUlJBTlRTIEFORCBPUFRJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_900_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_pn3n3_c20220101__20220630_zDKvsYuUEe88" title="Share based compensation">111</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c) RSU’s</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 4, 2022, the Company granted <span id="xdx_902_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20220804__20220804__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--DirectorsOfficersAndAdvisersMember_zRTJm1ElSth4" title="RSU's granted">1,265,000</span> Restricted Share Units (“RSUs”) to directors, officers and advisers, of which <span id="xdx_909_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20220804__20220804__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--ExecutivesAndDirectorsMember_zTKzz0zvOK0a" title="RSU's granted">590,000</span> RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. <span id="xdx_901_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20220804__20220804__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zS22OpEwBqYb" title="Description of RSU's vesting and conversion">The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no-par value in the Company (“Common Shares”)</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2023, the Company granted <span id="xdx_90B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230104__20230104__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--DirectorsOfficersAndAdvisersMember_z4uoCeoCZja6" title="RSU's granted">1,027,000</span> Restricted Share Units (“RSUs”) to directors, officers and advisers, of which <span id="xdx_902_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230104__20230104__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--ExecutivesAndDirectorsMember_ztXnGyHP4NDa" title="RSU's granted">260,000</span> RSU’s are to executives and directors, pursuant to the Company’s RSU Plan and in acknowledgment of the Company’s management recent success and increased future workload. <span id="xdx_900_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20230104__20230104__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z1zrUpm5gBsk" title="Description of RSU's vesting and conversion">The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,027,000 common shares of no-par value in the Company (“Common Shares”)</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 18, 2023, the Company granted <span id="xdx_902_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230418__20230418__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--EmployeesMember_zxvoDLn4U8Bg" title="RSU's granted">116,250</span> Restricted Share Units (“RSUs”) to employees, pursuant to the Company’s RSU Plan. <span id="xdx_90A_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20230418__20230418__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zIeWKjK5zZq2" title="Description of RSU's vesting and conversion">The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 116,250 common shares of no-par value in the Company (“Common Shares”)</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2023, the Company granted <span id="xdx_90C_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230628__20230628__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember__ifrs-full--CounterpartiesAxis__custom--OfficersMember_zQsmZlKmu348" title="RSU's granted">165,000</span> Restricted Share Units (“RSUs”) to officers pursuant to the Company’s RSU Plan. <span id="xdx_90E_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20230628__20230628__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zSpcxeU9H6eh" title="Description of RSU's vesting and conversion">The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 165,000 common shares of no-par value in the Company (“Common Shares”)</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory_z4Zo514Q2IN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU’s transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z4a7iPu3y0Gg" style="display: none">SCHEDULE OF RSU’S TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Balance, January 1, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zM8jjZQFMrOa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1130">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify">RSU’s granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zITPmQbZerOh" style="width: 16%; text-align: right" title="Number of RSU's, granted">1,265,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Exercise of RSU’s</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zVC2kY0TkEd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, Exercise">(545,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Balance, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zH1HQoAhU8k5" style="text-align: right" title="Number of RSU's, beginning balance">720,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">RSU’s granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zJv9MhQmMc2g" style="text-align: right" title="Number of RSU's, granted">1,308,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise of RSU’s</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z85fvexlZMj7" style="text-align: right" title="Number of RSU's, Exercise">(30,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Expiry of RSU’s</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z5d7CSfYGNia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, Expiry">(66,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Balance, June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_znIXirhXfP5f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, ending balance">1,931,583</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_ztABjuYhcQn" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total exercisable RSU’s as at June 30, 2023, are <span id="xdx_90A_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zwLbEULr1J17" title="RSU's exercisable">585,333</span> (December 31, 2022 – <span id="xdx_904_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zDE2IoAc4IRd" title="RSU's exercisable">225,832</span>). During the six months ended June 30, 2023, share-based compensation of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFdBUlJBTlRTIEFORCBPUFRJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_90C_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_pn3n3_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zXvVLlshngIl" title="Share based compensation">420</span> was recognized and charged to the Consolidated Statement of Comprehensive Loss (June 30, 2022 – $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFdBUlJBTlRTIEFORCBPUFRJT05TIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_909_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_dxL_c20220101__20220630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zjLuy1mUsUl" title="Share based compensation::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1152">nil</span></span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 38pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--DisclosureOfWarrantsTransactionsExplanatory_z6UYTBHEt3cb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zq8DwZS0GO11" style="display: none">SCHEDULE OF WARRANTS TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted Average <br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; font-weight: bold; padding-bottom: 1.5pt">Balance, January 1, 2022</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstanding1_iS_pid_c20220101__20221231_zh1sT57aqVA7" style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right" title="Number of warrants outstanding, beginning balance">5,966,204</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zyBAR3GYm8u7" style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">3.55</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Expiration of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExpired_iN_pid_di_c20220101__20221231_zneJmQtW72W6" style="text-align: right" title="Number of warrants outstanding, Expired of warrants">(5,437</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExercised_iN_pid_di_c20220101__20221231_zh2puVZn07v7" style="text-align: right" title="Number of warrants outstanding, Exercise of warrants">(630,161</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants issued in the November 2022 Private Placement</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20220101__20221231__custom--SubsidiarySaleOfStocksAxis__custom--NovemberTwoThousandTwentyTwoPrivatePlacementMember_zubwctN5XYN8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, warrants issued">1,726,366</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance, December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td id="xdx_985_ecustom--ClassOfWarrantOrRightOutstanding1_iS_pid_c20230101__20230630_zKv2YjtC4qkb" style="font-weight: bold; text-align: right" title="Number of warrants outstanding, beginning balance">7,056,972</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iS_pid_c20230101__20230630_zy0S0o506tl9" style="text-align: right" title="Weighted Average Exercise Price, Beginning Balance">3.07</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Warrants issued in the March 2023 Private Placement</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20230101__20230630__custom--SubsidiarySaleOfStocksAxis__custom--MarchTwoThousandTwentyThreePrivatePlacementMember_zbt9twcKbjtc" style="text-align: right" title="Number of warrants outstanding, warrants issued">1,034,463</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F4B_zyjzQZEfZnzi">Exercise of warrants (*)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ClassOfWarrantOrRightOutstandingWarrantsExercised_iN_pid_di_c20230101__20230630_fKCop_zqTB4SA1d3H3" style="text-align: right" title="Number of warrants outstanding, Exercise of warrants">(65,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Warrants issued in the June 2023 Registered Direct Offerings</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--ClassOfWarrantOrRightOutstandingWarrantsIssued_pid_c20230101__20230630__custom--SubsidiarySaleOfStocksAxis__custom--JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember_zfTC8aEvprs6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding, warrants issued">2,214,596</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance, June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightOutstanding1_iE_pid_c20230101__20230630_z5cKMKMb1Gc6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right" title="Number of warrants outstanding, ending balance">10,241,031</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice_iE_pid_c20230101__20230630_zDviwtWkAMLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Beginning Balance">2.67</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0F_zhDngWdjkMn" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(*)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zqDPjEcl4I85" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90E_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zmWKtDEDHAbb">65,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in respect of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_ecustom--NumberOfWarrantsOutstanding_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_znfN5PNWjKof" title="Number of warrants outstanding">65,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants that were exercised for gross proceeds of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdBUlJBTlRTIFRSQU5TQUNUSU9OUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eifrs-full--ProceedsFromExerciseOfWarrants_uUSD_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_z33X7zftOj2b">99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. All exercised warrants were warrants classified as a liability prior to their exercise.</span></td> </tr></table> 5966204 3.55 5437 630161 1726366 7056972 3.07 1034463 65000 2214596 10241031 2.67 65000 65000 99000 <p id="xdx_896_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zmxpLcVqbxKg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at June 30, 2023, the Company had outstanding warrants, enabling the holders to acquire common shares as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zaZTJgBrcmZ7" style="display: none">SCHEDULE OF OUTSTANDING WARRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expiry date</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (USD)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zBGkRMehE724" style="width: 21%; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,658,313</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 26%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zU0qfH4nIEle" title="Expiry date">November 10, 2025</span></span></td><td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_980_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_fKDEp_zkYu0GmTOy96" style="width: 20%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1418</span></td><td style="width: 1%; text-align: left"><span id="xdx_F25_zukGhZDZVEWi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup>(1)</sup></span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_z3ziAaELoWWg" style="width: 20%; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.93</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zLh8qgkI5Teh" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366,631</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zvi0LoWneuzi" title="Expiry date">December 24, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_fKDEp_zKKxkG9gRhBd" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1418</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F2A_zyErru9d9Clg">(1)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_fKDEp_z6lXDXqkFGn8" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.93</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_zGPYSEs5GhWj" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221,100</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_z7TdPAq0UgPg" title="Expiry date">April 22, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_fKDIp_zpZwRYPRvy39" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F28_zAuuFNx5ACK4">(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember_fKDIp_zQNi4YRxZBq2" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_zjjUD0jOR4S5" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,084,562</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_zar3CfDA2mfh" title="Expiry date">May 6, 2026</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ILS</span></td><td id="xdx_98C_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_fKDIp_zoNSFYVX3nnc" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.025</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F29_zo4rMbssJ4B3">(2)</sup></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFourMember_fKDIp_zwL3aozbOyV6" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.84</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zsOJkJK85WRa" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,661,366</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zLMoli5D2Rmk" title="Expiry date">November 8, 2024</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_982_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_zwPFIjFNKZk9" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.04</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsFiveMember_fKDMp_zZ6sSrZ2D1L1" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.60</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_ztbwAxPaFMr5" style="text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,034,463</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_zuN8DsAMW8Ai" title="Expiry date">March 13, 2025</span></span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_987_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_zWsgMiXIxNfb" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.35</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSixMember_fKDMp_zydmTjHBZ8R9" style="text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.75</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zrG8Gw01Y67j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,214,596</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zvbMwCQNU9jk" title="Expiry date">June 15, 2025</span></span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td><td id="xdx_989_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_zmT5JLHxdKYb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.93</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uUSDPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsSevenMember_fKDMp_zrOTRILqwSHh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Exercise price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.20</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_c20230630_zhietvqjlNWh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of warrants outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,241,031</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 81pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F03_ziTPCAsbHJg6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F14_zP7LZK34HDcj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_906_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20210331__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_z9OL4e6dTLf" title="Exercise price">2.70</span> would be payable in New Israeli Shekels. The exercise price is NIS <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20210331__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zt2PVz6IPk9a" title="Exercise price">7.1418</span> per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F09_zsYYXCAUUH0k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zo7XiZJoa6U4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90F_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uCADPShares_c20210630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zkByyL30sZgk" title="Exercise price">11.04</span> would be payable in New Israeli Shekels. The exercise price is NIS <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9VVFNUQU5ESU5HIFdBUlJBTlRTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_902_ecustom--ClassOfWarrantOrRightExercisePrice_iI_pid_uILSPShares_c20210630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsThreeMember__ifrs-full--CounterpartiesAxis__custom--WarrantHoldersMember_zDsvwwc1horg" title="Exercise price">29.025</span> per warrant. On March 27, 2023, the expiry dates of a total of <span id="xdx_90C_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_uShares_c20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zU58xgIjnBJ4" title="Number of warrants outstanding">221,100</span> share purchase warrants were extended by three years to <span id="xdx_907_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230327__20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsOneMember_zD6KRqZ9kVV2" title="Expiry date">April 26, 2026</span>, and the expiry dates of a total of <span id="xdx_90A_ecustom--ClassOfWarrantsOrRightOutstanding_iI_pid_uShares_c20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zpksQIjLAtog" title="Number of warrants outstanding">1,084,562</span> share purchase warrants were extended by three years to <span id="xdx_90C_ecustom--WarrantsAndRightsOutstandingExpiryDate_dd_c20230327__20230327__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsTwoMember_zTq49qI38vQf" title="Expiry date">May 6, 2026</span>.</span></td></tr> </table> 2658313 2025-11-10 7.1418 1.93 1366631 2025-12-24 7.1418 1.93 221100 2026-04-22 29.025 7.84 1084562 2026-05-06 29.025 7.84 1661366 2024-11-08 2.04 1.60 1034463 2025-03-13 2.35 1.75 2214596 2025-06-15 2.93 2.20 10241031 2.70 7.1418 11.04 29.025 221100 2026-04-26 1084562 2026-05-06 <p id="xdx_89D_eifrs-full--DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory_zKolMs1YuEHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock option transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zT6ZlM61ukM7" style="display: none">SCHEDULE OF STOCK OPTION TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 0.75in"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise Price<br/> (CAD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise Price<br/> (USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance January 1, 2022</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20220101__20221231_z2vosPyWdtu7" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Number of stock options, beginning balance">820,010</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uCADPShares_c20220101__20221231_z4ho5OI432lj" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance">2.26</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20220101__20221231_zNGq8SRDIjnb" style="border-bottom: Black 1.5pt solid; width: 14%; text-align: right" title="Weighted Average Exercise Price, beginning balance">1.78</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Options granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20220101__20221231_zWW7l6E9BMR1" style="text-align: right" title="Number of stock options, options granted">1,200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_zSR5JLs1QQXk" style="text-align: right" title="Weighted Average Exercise Price, options granted">3.67</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Exercise of options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231_zaMZdG9ED29h" style="text-align: right" title="Number of stock options, Exercise of options">(116,667</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_z9KcSIhn8cA5" style="text-align: right" title="Weighted Average Exercise Price, Exercise of options">2.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Expiry of options</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231_zCPi5rmQSjB6" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Expiry of options">(20,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uCADPShares_c20220101__20221231_zTdd69JrCXM5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, Expiry of options">1.50</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance December 31, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pid_uShares_c20230101__20230630_zbfGouuf9Utd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, beginning balance">1,883,343</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uCADPShares_c20230101__20230630_zNz6FtlsDoLe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance">3.17</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20230101__20230630_zr9NpnJ9Md8g" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, beginning balance">2.45</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td id="xdx_F41_zYMPwO1ZXe5g" style="text-align: justify; padding-bottom: 1.5pt">Options granted (i-iv)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zEqRnGyzAHZ3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, options granted">1,585,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uCADPShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zyttGK2uhQ56" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, options granted">1.78</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_fKGkpIChpaSkgKGlpaSkgKGl2KQ_____zea1lz2AMVEh" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, options granted">1.34</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 1.5pt">Balance June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pid_uShares_c20230101__20230630_zMUZMNFXWW92" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, ending balance">3,468,593</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uCADPShares_c20230101__20230630_zTxbuxZHRYO1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance">2.53</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zAnzmh1dYK71" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Exercise Price, ending balance">1.91</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span id="xdx_F08_zsdXK8JUs99h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_F1C_zRx3WiMffRmf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z3zaev7xXvN3" title="Number of stock options, options issued">816,500</span> stock options were issued to directors and consultants with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zmUrMYHwVOWe" title="Number of stock options, exercise price">1.65</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_909_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_ztWDwXuNgiO7" title="Options expire">January 4, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zfgZCar5ZKIh" title="Fair value of options granted">1,017</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zVkqJdMhp46j" title="Share Price">1.80</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zBaEOyD8TSv6" title="Expected option life">10</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zSVWOFMHN50h" title="Volatility">112</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z6VqODBcKmdi" title="Risk-free interest rate">3.28</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230104__20230104__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zltp1j7bIhpd" title="Dividend yield">0</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0B_zci6nnuJPAPl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F15_zjiEgOi1bIHj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zXgr9QfF4ena" title="Number of stock options, options issued">100,000</span> stock options were issued to a consultant with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z5kKrUWGsbke" title="Number of stock options, exercise price">1.50</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zTntMhkOfVp2" title="Options expire">November 25, 2027</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z5Rl2kcUMP81" title="Fair value of options granted">135</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zhXXyDBTrDzf" title="Share Price">2.18</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zlgsfrecgf6" title="Expected option life">4.8</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zpxiB19ABhYc" title="Volatility">112</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z2j88GEEHn31" title="Risk-free interest rate">3.16</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230208__20230208__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zPA85Ttn2aq4" title="Dividend yield">0</span>%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F00_zIMog7CLWC1k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zuOh4JIDyBA1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 18, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zDmzs6kxtH4a" title="Number of stock options, options issued">423,750</span> stock options were issued to employees with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z44biUrJ63r1" title="Number of stock options, exercise price">1.60</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_905_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zGaBzoa7QfK2" title="Options expire">April 18, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zJIgjlhLf0ki" title="Fair value of options granted">420</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zCd8RTtURm29" title="Share Price">1.42</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zTnIKkp2fmb6" title="Expected option life">10</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zcQC1YbATnr7" title="Volatility">111</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zch6S5G2JN5a" title="Risk-free interest rate">3.57</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230418__20230418__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_z6I7gxMHGDve" title="Dividend yield">0</span>%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F0E_zEzpSRIi6OVl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z2t6BUrk5Z4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 28, 2023, <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zHo5H8G5D94b" title="Number of stock options, options issued">245,000</span> stock options were issued to officers with an exercise price of CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zgdhWYRrNi95" title="Number of stock options, exercise price">2.45</span>. The options expire on <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zf4BaaestsJg" title="Options expire">June 28, 2033</span>. The fair value of the options granted was estimated at $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90A_ecustom--FairValueOfOptionsGranted_pn3n3_uUSD_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zmVu5Za0gCol" title="Fair value of options granted">443</span> using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_903_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_uCADPShares_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_znV1RyutnMPh" title="Share Price">2.92</span>; Expected option life <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_ecustom--DescriptionOfOptionLifeShareOptionGranted_dtY_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zVTBkODxJTh" title="Expected option life">5</span> years; Volatility <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zB6GFOoF40jc" title="Volatility">111</span>%; Risk-free interest rate <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zCkvlxWRdYZ1" title="Risk-free interest rate">4.14</span>%; Dividend yield <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBUUkFOU0FDVElPTlMgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230628__20230628__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember__ifrs-full--CounterpartiesAxis__custom--ConsultantMember_zigGEVoSPNHf" title="Dividend yield">0</span>%.</span></td></tr> </table> 820010 2.26 1.78 1200000 3.67 116667 2.27 20000 1.50 1883343 3.17 2.45 1585250 1.78 1.34 3468593 2.53 1.91 816500 1.65 2033-01-04 1017000 1.80 P10Y 1.12 0.0328 0 100000 1.50 2027-11-25 135000 2.18 P4Y9M18D 1.12 0.0316 0 423750 1.60 2033-04-18 420000 1.42 P10Y 1.11 0.0357 0 245000 2.45 2033-06-28 443000 2.92 P5Y 1.11 0.0414 0 <p id="xdx_890_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zydLEMB7nMC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at June 30, 2023, the Company had outstanding stock options, enabling the holders to acquire common shares as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-align: justify; text-indent: -27pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zLLwysc0NQvc" style="display: none">SCHEDULE OF OUTSTANDING STOCK OPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Outstanding as<br/> of June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercisable as<br/> of June 30,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price (CAD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Exercise price (USD)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zGH07TmHT3d2" style="width: 15%; text-align: right" title="Number of stock options, ending balance">543,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zczaVVHCoSPf" style="width: 15%; text-align: right" title="Number of stock options, Exercisable">510,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 24%"><span id="xdx_90F_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zTo0p8lWFsG" title="Number of stock options, Expiry date">August 20, 2025</span></td><td style="width: 2%"> </td> <td style="white-space: nowrap; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zK6VIDRBAWib" style="width: 15%; text-align: right" title="Number of stock options, Exercise price">1.50</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionOneMember_zPq0C5b1fNYb" style="width: 15%; text-align: right" title="Number of stock options, Exercise price">1.11</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zqMxoxVsNW1g" style="text-align: right" title="Number of stock options, Outstanding">40,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zL6fKPE63idh" style="text-align: right" title="Number of stock options, Exercisable">40,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_900_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zgcjFUWOyeSe" title="Number of stock options, Expiry date">September 1, 2025</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_z4xuCcdNJy74" style="text-align: right" title="Number of stock options, Exercise price">2.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTwoMember_zx832ChJD6l" style="text-align: right" title="Number of stock options, Exercise price">1.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zvbAvIQz48Q6" style="text-align: right" title="Number of stock options, Outstanding">33,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zsIxoa0PO4wa" style="text-align: right" title="Number of stock options, Exercisable">33,333</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90B_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zhgJnOSuoKDa" title="Number of stock options, Expiry date">January 28, 2025</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_zsfczaKzRD1f" style="text-align: right" title="Number of stock options, Exercise price">3.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionThreeMember_z1j0LTwWeZWd" style="text-align: right" title="Number of stock options, Exercise price">2.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zSci4vdwSfr8" style="text-align: right" title="Number of stock options, Outstanding">50,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zIEUxdIFi4K5" style="text-align: right" title="Number of stock options, Exercisable">33,333</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zWbpzwDUv8Lg" title="Number of stock options, Expiry date">June 3, 2026</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zi0zRJ6vJMy3" style="text-align: right" title="Number of stock options, Exercise price">8.40</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFourMember_zhb0WUE6MwG1" style="text-align: right" title="Number of stock options, Exercise price">6.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zvs2CIn9RFjk" style="text-align: right" title="Number of stock options, Outstanding">16,677</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zFoAJXlmQOVg" style="text-align: right" title="Number of stock options, Exercisable">11,118</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_907_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zh3uK1vFtmI7" title="Number of stock options, Expiry date">October 28, 2026</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zOe2Oi4848i1" style="text-align: right" title="Number of stock options, Exercise price">8.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionFiveMember_zpIPd3RcqwU9" style="text-align: right" title="Number of stock options, Exercise price">5.90</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zrOfnGMD2dci" style="text-align: right" title="Number of stock options, Outstanding">900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zN0cnRONFkpg" style="text-align: right" title="Number of stock options, Exercisable">337,500</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_z80iGS3No6n6" title="Number of stock options, Expiry date">August 2, 2032</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_981_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zewD3L4IxBvh" style="text-align: right" title="Number of stock options, Exercise price">3.56</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSixMember_zvesMMEWE6O4" style="text-align: right" title="Number of stock options, Exercise price">2.63</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zzwkFZfGOQPa" style="text-align: right" title="Number of stock options, Outstanding">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zGZWKrZQ3Vj8" style="text-align: right" title="Number of stock options, Exercisable">300,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_90D_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zXw3SvF7iKh8" title="Number of stock options, Expiry date">August 21, 2032</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zGXVsukdoiha" style="text-align: right" title="Number of stock options, Exercise price">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionSevenMember_zfTTXxl1qnef" style="text-align: right" title="Number of stock options, Exercise price">2.95</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zEsha0ZzWEY9" style="text-align: right" title="Number of stock options, Outstanding">816,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zWyrHXERWfUg" style="text-align: right" title="Number of stock options, Exercisable">802,063</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_903_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zbpZEspyflEl" title="Number of stock options, Expiry date">January 4, 2033</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_989_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zCsw917tr5Ll" style="text-align: right" title="Number of stock options, Exercise price">1.65</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionEightMember_zZLwOHpyuADa" style="text-align: right" title="Number of stock options, Exercise price">1.22</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zkfxIzfL7ND" style="text-align: right" title="Number of stock options, Outstanding">100,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zFUNmI7Grgpc" style="text-align: right" title="Number of stock options, Exercisable">25,000</td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_904_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zUJjH0pqKHk9" title="Number of stock options, Expiry date">November 25, 2027</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_980_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zOkZNFtPfnVa" style="text-align: right" title="Number of stock options, Exercise price">2.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionNineMember_zU4smiBLIjUk" style="text-align: right" title="Number of stock options, Exercise price">1.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zR6iyeSbN0Fj" style="text-align: right" title="Number of stock options, Outstanding">423,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_z2HkPPcDS2yk" style="text-align: right" title="Number of stock options, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1082">-</span></td><td style="text-align: left"> </td><td> </td> <td><span id="xdx_904_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zJbhnvCzEPY3" title="Number of stock options, Expiry date">April 18, 2033</span></td><td> </td> <td style="white-space: nowrap; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_98C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zVW50E0Ll1Tg" style="text-align: right" title="Number of stock options, Exercise price">1.60</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionTenMember_zu4GYNZLiwhc" style="text-align: right" title="Number of stock options, Exercise price">1.21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zQ8W7VNdgUTd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Outstanding">245,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_z1tYAxFVelt1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl1092">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"><span id="xdx_908_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_dd_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zaB1t0Kzb2qh" title="Number of stock options, Expiry date">June 28, 2028</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAD</span></td> <td id="xdx_983_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uCADPShares_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_zGfszEGs7E13" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercise price">2.45</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--StockOptionElevenMember_z3I2XfEbFBLb" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercise price">1.85</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pid_uShares_c20230630_zBdKgUng3Vp9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Outstanding">3,468,593</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pid_uShares_c20230630_zpnzn4xEXUI8" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of stock options, Exercisable">2,117,347</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 543333 510000 2025-08-20 1.50 1.11 40000 40000 2025-09-01 2.25 1.66 33333 33333 2025-01-28 3.00 2.21 50000 33333 2026-06-03 8.40 6.20 16677 11118 2026-10-28 8.00 5.90 900000 337500 2032-08-02 3.56 2.63 300000 300000 2032-08-21 4.00 2.95 816500 802063 2033-01-04 1.65 1.22 100000 25000 2027-11-25 2.01 1.48 423750 2033-04-18 1.60 1.21 245000 2028-06-28 2.45 1.85 3468593 2117347 2547000 111000 1265000 590000 The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,265,000 common shares of no-par value in the Company (“Common Shares”) 1027000 260000 The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 1,027,000 common shares of no-par value in the Company (“Common Shares”) 116250 The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 116,250 common shares of no-par value in the Company (“Common Shares”) 165000 The RSUs will vest at each recipient’s discretion and taking into account personal tax implications and convert into 165,000 common shares of no-par value in the Company (“Common Shares”) <p id="xdx_899_ecustom--DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory_z4Zo514Q2IN1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU’s transactions for the six months ended June 30, 2023, and for the year ending December 31, 2022, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_z4a7iPu3y0Gg" style="display: none">SCHEDULE OF RSU’S TRANSACTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; vertical-align: bottom; text-align: center">Number</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Balance, January 1, 2022</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zM8jjZQFMrOa" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1130">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: justify">RSU’s granted</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zITPmQbZerOh" style="width: 16%; text-align: right" title="Number of RSU's, granted">1,265,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Exercise of RSU’s</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zVC2kY0TkEd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, Exercise">(545,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Balance, December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zH1HQoAhU8k5" style="text-align: right" title="Number of RSU's, beginning balance">720,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">RSU’s granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_zJv9MhQmMc2g" style="text-align: right" title="Number of RSU's, granted">1,308,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Exercise of RSU’s</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pid_di_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z85fvexlZMj7" style="text-align: right" title="Number of RSU's, Exercise">(30,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1.5pt">Expiry of RSU’s</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pid_di_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_z5d7CSfYGNia" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, Expiry">(66,667</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1.5pt">Balance, June 30, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pid_uShares_c20230101__20230630__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedStockUnitsMember_znIXirhXfP5f" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of RSU's, ending balance">1,931,583</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1265000 545000 720000 1308250 30000 66667 1931583 585333 225832 420000 <p id="xdx_807_eifrs-full--DisclosureOfRevenueExplanatory_zMNSBEKEfxLd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - <span id="xdx_826_zBr1Wcc7g2N8">REVENUES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zjtybBBvHL7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue streams:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zGtr4LRYHJpg" style="display: none">SCHEDULE OF REVENUE FROM SERVICES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230401__20230630_z6IYaw2Aa3xd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220401__20220630_zK6IdLyV5Shb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230101__20230630_zztgkS0U2Fp7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220630_zU8s4uspIDc5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenues from services:</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromServicesMember_zq8XETd02a5f" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Revenues from services</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 11%; font-weight: bold; text-align: right">618</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">301</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 11%; font-weight: bold; text-align: right">1,149</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">638</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromLeasingMember_z1fzMuN5g4Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenues from leasing</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">154</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">287</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">159</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Precision metal parts:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromSalesOfPrecisionMetalPartsMember_znobZM6B3YDc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues from sales of precision metal parts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">795</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,054</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,612</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,872</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Smart Carts:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromSmartCartsProjectMember_zldwAXROqvL2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues from smart carts project</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,574</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,701</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zIwNmJ7lrhg4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,141</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,430</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,749</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,876</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A9_zwghtMyZQYdh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfProductsAndServicesExplanatory_zjtybBBvHL7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Revenue streams:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zGtr4LRYHJpg" style="display: none">SCHEDULE OF REVENUE FROM SERVICES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 93%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230401__20230630_z6IYaw2Aa3xd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20220401__20220630_zK6IdLyV5Shb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20230101__20230630_zztgkS0U2Fp7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220630_zU8s4uspIDc5" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Revenues from services:</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromServicesMember_zq8XETd02a5f" style="vertical-align: bottom; background-color: White"> <td style="width: 40%; text-align: left">Revenues from services</td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 11%; font-weight: bold; text-align: right">618</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">301</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 11%; font-weight: bold; text-align: right">1,149</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">638</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromLeasingMember_z1fzMuN5g4Ad" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Revenues from leasing</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">154</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">75</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">287</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">159</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Precision metal parts:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromSalesOfPrecisionMetalPartsMember_znobZM6B3YDc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues from sales of precision metal parts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">795</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,054</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,612</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,872</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Smart Carts:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--RevenuesFromSmartCartsProjectMember_zldwAXROqvL2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Revenues from smart carts project</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,574</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1174">-</span></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,701</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zIwNmJ7lrhg4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,141</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,430</td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,749</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,876</td><td style="text-align: left"> </td></tr> </table> 618000 301000 1149000 638000 154000 75000 287000 159000 795000 1054000 1612000 1872000 1574000 4701000 207000 3141000 1430000 7749000 2876000 <p id="xdx_800_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zwU5lCnsuah6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span><span id="xdx_82D_zAWLCGT4kSJd">OPERATING SEGMENTS</span>:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its subsidiaries are engaged in the following <span id="xdx_901_ecustom--NumberOfOperatingSegment_dc_uSegment_c20230101__20230630_zHAHn9GLUso9" title="Number of operating segment">three</span> segments:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services to the military/security markets as well as development of related products for the civilian and retail markets. (“Services”)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retail automation solutions – Smart Carts (“Smart Carts”)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manufacturing and selling of precision metal parts – “Precision Metal Parts”</span></td></tr> </table> <p id="xdx_899_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z2FtXVyL7Iaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zhvF1YZHHTV9" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zKn2EJ6oCVC1" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zIHUwQToj09a" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zEcoXCqIbLol" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230630_z21fOspkvtQh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zMh12ShyETfe" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,612</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,436</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,701</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,749</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zD8LHBjAHlnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eifrs-full--Revenue_z8kIQ0UbjBN2" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,612</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,155</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,701</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,468</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zaoXDpCaCoSk" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss (gain)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(56</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,276</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,768</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LossOnRevaluationOfWarrantLiability_zwQD7OZblrnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on revaluation of warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,344</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zD26BSCp1gjj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_z8LVbucqgqx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--ProfitLoss_iN_di_zJFLRvxEtume" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zIZVf3OOS6U5" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zfvrQ8UoNM65" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zjQMRCwLG1Y5" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zWdBrL2AT31a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zKBtXKWeXupc" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,872</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">207</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,876</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zpqbwnDxcCS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1235">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1236">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_zH7Feqs84cS7" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,872</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">797</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,876</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zxFFEm3uEQGb" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">199</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">492</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,397</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,088</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--GainLossOnSaleOfFixedAsset_z4aOyDAPCzp4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on sale of fixed asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_z4YQrPIOsPg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zZG0YetaHHsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--ProfitLoss_iN_di_zYPYmOnmr684" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,097</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230401__20230630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zS5rCsj3OyA6" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230401__20230630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zZT70VENjdd4" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230401__20230630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zYJVNZlePyqj" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230401__20230630_z6oRkXrgf9i3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zBbslxvST4jg" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">795</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,575</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,141</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_z9DLe1rZvp1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eifrs-full--Revenue_zhl3CeOU4df6" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">795</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">491</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,575</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zB1v0tavTqnh" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss (gain)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">277</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">122</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,339</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,738</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--LossOnRevaluationOfWarrantLiability_zsJet4nwtoog" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on revaluation of warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,749</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zfyGoQCLWDO2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zjqMy97doRu3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eifrs-full--ProfitLoss_iN_di_zrnFXCGGTsNf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,422</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20220630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zYgK4xXo7GC8" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220401__20220630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zkQAIsAneVg4" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220401__20220630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zLJYDkYg7KF8" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220401__20220630_zBOJ0sF6MNic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zGiDbIs3FxIb" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,054</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">376</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,430</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zwkJwO67Xsw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1314">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1315">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1317">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_zEmDRB56vpl4" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,054</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,430</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zVBd6L4cY6Ug" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">210</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,370</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--GainLossOnSaleOfFixedAsset_zQ4sIW9vLX82" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on sale of fixed asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1332">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zOvGzDO4XKIg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eifrs-full--IncomeTaxExpenseContinuingOperations_z3uZ2YdT6j99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eifrs-full--ProfitLoss_iN_di_z5UMiY5MzR8j" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,365</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zts39ujwwuFg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3 <p id="xdx_899_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_z2FtXVyL7Iaa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8B6_zhvF1YZHHTV9" style="display: none">SCHEDULE OF OPERATING SEGMENTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zKn2EJ6oCVC1" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20230101__20230630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zIHUwQToj09a" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230101__20230630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zEcoXCqIbLol" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20230101__20230630_z21fOspkvtQh" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zMh12ShyETfe" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,612</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,436</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">4,701</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">7,749</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zD8LHBjAHlnb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1194">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1196">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eifrs-full--Revenue_z8kIQ0UbjBN2" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,612</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,155</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,701</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,468</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_408_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zaoXDpCaCoSk" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss (gain)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">548</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(56</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,276</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,768</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--LossOnRevaluationOfWarrantLiability_zwQD7OZblrnl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on revaluation of warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,344</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zD26BSCp1gjj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_z8LVbucqgqx6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eifrs-full--ProfitLoss_iN_di_zJFLRvxEtume" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,265</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A2Z SMART TECHNOLOGIES CORP.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Unaudited)</span></p> <p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Expressed in thousands of US Dollars)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20220630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zIZVf3OOS6U5" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20220101__20220630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zfvrQ8UoNM65" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20220630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zjQMRCwLG1Y5" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20220101__20220630_zWdBrL2AT31a" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zKBtXKWeXupc" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,872</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">797</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">207</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">2,876</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zpqbwnDxcCS2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1234">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1235">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1236">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1237">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_zH7Feqs84cS7" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,872</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">797</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,876</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zxFFEm3uEQGb" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">199</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">492</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,397</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,088</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--GainLossOnSaleOfFixedAsset_z4aOyDAPCzp4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on sale of fixed asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_z4YQrPIOsPg8" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zZG0YetaHHsk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1262">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--ProfitLoss_iN_di_zYPYmOnmr684" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,097</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20230401__20230630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zS5rCsj3OyA6" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20230401__20230630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zZT70VENjdd4" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20230401__20230630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zYJVNZlePyqj" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20230401__20230630_z6oRkXrgf9i3" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zBbslxvST4jg" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">795</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,575</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,141</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_z9DLe1rZvp1a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1276">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_400_eifrs-full--Revenue_zhl3CeOU4df6" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">795</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">491</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,575</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,860</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zB1v0tavTqnh" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss (gain)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">277</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">122</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,339</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,738</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--LossOnRevaluationOfWarrantLiability_zsJet4nwtoog" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on revaluation of warrant liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,749</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zfyGoQCLWDO2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(65</td><td style="text-align: left">)</td></tr> <tr id="xdx_40A_eifrs-full--IncomeTaxExpenseContinuingOperations_zjqMy97doRu3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1302">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eifrs-full--ProfitLoss_iN_di_zrnFXCGGTsNf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,422</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-right: auto; border-collapse: collapse; width: 82%; margin-left: auto"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20220401__20220630__ifrs-full--SegmentsAxis__custom--PrecisionMetalPartsMember_zYgK4xXo7GC8" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220401__20220630__ifrs-full--SegmentsAxis__custom--AdvancedEngineeringMember_zkQAIsAneVg4" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220401__20220630__ifrs-full--SegmentsAxis__custom--SmartCartsMember_zLJYDkYg7KF8" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220401__20220630_zBOJ0sF6MNic" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Precision<br/> Metal<br/> Parts</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Advanced Engineering</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Smart<br/> Carts</td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic">Revenues</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_404_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--ExternalMember_zGiDbIs3FxIb" style="vertical-align: bottom; background-color: White"> <td style="width: 40%">External</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,054</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">376</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1311">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,430</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_hifrs-full--ProductsAndServicesAxis__custom--InterSegmentMember_zwkJwO67Xsw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Inter-segment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1314">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1315">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1316">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1317">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eifrs-full--Revenue_zEmDRB56vpl4" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; padding-bottom: 1.5pt">Total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,054</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">376</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1321">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,430</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eifrs-full--ProfitLossFromOperatingActivities_iN_di_zVBd6L4cY6Ug" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Segment loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">210</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,023</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,370</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--GainLossOnSaleOfFixedAsset_zQ4sIW9vLX82" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on sale of fixed asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1332">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eifrs-full--FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss_zOvGzDO4XKIg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Finance expense, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_eifrs-full--IncomeTaxExpenseContinuingOperations_z3uZ2YdT6j99" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Tax expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1342">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eifrs-full--ProfitLoss_iN_di_z5UMiY5MzR8j" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Loss</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,365</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1612000 1436000 4701000 7749000 -281000 -281000 1612000 1155000 4701000 7468000 -548000 56000 -8276000 -8768000 2344000 153000 -11265000 1872000 797000 207000 2876000 1872000 797000 207000 2876000 -199000 -492000 -5397000 -6088000 16000 -7000 -6097000 795000 772000 1575000 3141000 -281000 -281000 795000 491000 1575000 2860000 -277000 -122000 -4339000 -4738000 2749000 -65000 -7422000 1054000 376000 1430000 1054000 376000 1430000 -137000 -210000 -3023000 -3370000 -5000 -3365000 <p id="xdx_80B_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zWnXmeUi80rb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_823_zExQM0fWuYD6">FINANCIAL RISK FACTORS</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>ECL and their measurement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ECL are measured as the unbiased probability-weighted present value of all cash shortfalls over the expected life of each financial asset. For receivables from financial services, ECL are mainly calculated with a statistical model using three major risk parameters: probability of default, loss given default and exposure at default. The estimation of these risk parameters incorporates all available relevant information, not only historical and current loss data, but also reasonable and supportable forward-looking information reflected by the future expectation factors. This information includes macroeconomic factors (e.g., gross domestic product growth, unemployment rate, cost performance index) and forecasts of future economic conditions. For receivables from financial services, these forecasts are performed using a scenario analysis (base case, adverse and optimistic scenarios).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, and December 31, 2022, ECL for trade and other account receivables are not material, and as such are not disclosed, in accordance IFRS 9.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_808_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zWb42bG8BR5h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82D_z8ReMD25VoN3">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During July 2023, the Company issued <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20230731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zK8YjRbwM5Se">100,000 </span>shares in respect of <span id="xdx_901_ecustom--NumberOfRestrictedStockUnitsExercised_pid_c20230701__20230731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z4kcnRZIBli3" title="Number of restricted stock units exercised">100,000</span> RSU’s that were exercised.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During August 2023, the Company issued <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20230831__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zCrKlI2Vrad8" title="Number of share issuance">2,000</span> shares in respect of <span id="xdx_90A_ecustom--NumberOfWarrantsExercised_pid_c20230801__20230831__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zPiuOqL7UYOh" title="Number of warrants exercised">2,000</span> warrants that were exercised for gross proceeds of $<span id="xdx_901_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20230801__20230831__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zYSiujQtZxLg" title="Exercise of option">3</span>. </span></td></tr> </table> 100000 100000 2000 2000 3000 During the six months ended June 30, 2023, the Company issued 65,000 On March 31, 2021, warrant holders and the Company, agreed that the exercise price of CAD$2.70 would be payable in New Israeli Shekels. The exercise price is NIS 7.1418 per warrant. On June 30, 2021, warrant holders and the Company, agreed that the exercise price of CAD$11.04 would be payable in New Israeli Shekels. The exercise price is NIS 29.025 per warrant. On March 27, 2023, the expiry dates of a total of 221,100 share purchase warrants were extended by three years to April 26, 2026, and the expiry dates of a total of 1,084,562 share purchase warrants were extended by three years to May 6, 2026. On January 4, 2023, 816,500 stock options were issued to directors and consultants with an exercise price of CAD$1.65. The options expire on January 4, 2033. The fair value of the options granted was estimated at $1,017 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.80; Expected option life 10 years; Volatility 112%; Risk-free interest rate 3.28%; Dividend yield 0%. On February 8, 2023, 100,000 stock options were issued to a consultant with an exercise price of CAD$1.50. The options expire on November 25, 2027. The fair value of the options granted was estimated at $135 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.18; Expected option life 4.8 years; Volatility 112%; Risk-free interest rate 3.16%; Dividend yield 0%. On April 18, 2023, 423,750 stock options were issued to employees with an exercise price of CAD$1.60. The options expire on April 18, 2033. The fair value of the options granted was estimated at $420 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$1.42; Expected option life 10 years; Volatility 111%; Risk-free interest rate 3.57%; Dividend yield 0%. On June 28, 2023, 245,000 stock options were issued to officers with an exercise price of CAD$2.45. The options expire on June 28, 2033. The fair value of the options granted was estimated at $443 using the Black-Scholes option pricing model, using the following assumptions: Share Price: CAD$2.92; Expected option life 5 years; Volatility 111%; Risk-free interest rate 4.14%; Dividend yield 0%. EXCEL 44 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 45 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 46 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 219 199 1 true 54 0 false 9 false false R1.htm 00000001 - Document - Cover Sheet http://a2zas.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited) Sheet http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition Condensed Interim Consolidated Statements of Financial Position (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited) Sheet http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited) Statements 3 false false R4.htm 00000004 - Statement - Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) Sheet http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited) Sheet http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows Condensed Interim Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS Sheet http://a2zas.com/role/NatureAndContinuanceOfOperations NATURE AND CONTINUANCE OF OPERATIONS Notes 6 false false R7.htm 00000007 - Disclosure - BASIS OF PREPARATION Sheet http://a2zas.com/role/BasisOfPreparation BASIS OF PREPARATION Notes 7 false false R8.htm 00000008 - Disclosure - WARRANT LIABILITY Sheet http://a2zas.com/role/WarrantLiability WARRANT LIABILITY Notes 8 false false R9.htm 00000009 - Disclosure - SHAREHOLDERS EQUITY Sheet http://a2zas.com/role/ShareholdersEquity SHAREHOLDERS EQUITY Notes 9 false false R10.htm 00000010 - Disclosure - WARRANTS AND OPTIONS Sheet http://a2zas.com/role/WarrantsAndOptions WARRANTS AND OPTIONS Notes 10 false false R11.htm 00000011 - Disclosure - REVENUES Sheet http://a2zas.com/role/Revenues REVENUES Notes 11 false false R12.htm 00000012 - Disclosure - OPERATING SEGMENTS Sheet http://a2zas.com/role/OperatingSegments OPERATING SEGMENTS Notes 12 false false R13.htm 00000013 - Disclosure - FINANCIAL RISK FACTORS Sheet http://a2zas.com/role/FinancialRiskFactors FINANCIAL RISK FACTORS Notes 13 false false R14.htm 00000014 - Disclosure - SUBSEQUENT EVENTS Sheet http://a2zas.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 00000015 - Disclosure - WARRANT LIABILITY (Tables) Sheet http://a2zas.com/role/WarrantLiabilityTables WARRANT LIABILITY (Tables) Tables http://a2zas.com/role/WarrantLiability 15 false false R16.htm 00000016 - Disclosure - WARRANTS AND OPTIONS (Tables) Sheet http://a2zas.com/role/WarrantsAndOptionsTables WARRANTS AND OPTIONS (Tables) Tables http://a2zas.com/role/WarrantsAndOptions 16 false false R17.htm 00000017 - Disclosure - REVENUES (Tables) Sheet http://a2zas.com/role/RevenuesTables REVENUES (Tables) Tables http://a2zas.com/role/Revenues 17 false false R18.htm 00000018 - Disclosure - OPERATING SEGMENTS (Tables) Sheet http://a2zas.com/role/OperatingSegmentsTables OPERATING SEGMENTS (Tables) Tables http://a2zas.com/role/OperatingSegments 18 false false R19.htm 00000019 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) Sheet http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative) Details http://a2zas.com/role/NatureAndContinuanceOfOperations 19 false false R20.htm 00000020 - Disclosure - SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details) Sheet http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details) Details 20 false false R21.htm 00000021 - Disclosure - WARRANT LIABILITY (Details Narrative) Sheet http://a2zas.com/role/WarrantLiabilityDetailsNarrative WARRANT LIABILITY (Details Narrative) Details http://a2zas.com/role/WarrantLiabilityTables 21 false false R22.htm 00000022 - Disclosure - SHAREHOLDERS EQUITY (Details Narrative) Sheet http://a2zas.com/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS EQUITY (Details Narrative) Details http://a2zas.com/role/ShareholdersEquity 22 false false R23.htm 00000023 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details) Sheet http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails SCHEDULE OF WARRANTS TRANSACTIONS (Details) Details 23 false false R24.htm 00000024 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical) Sheet http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical) Details 24 false false R25.htm 00000025 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) Sheet http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails SCHEDULE OF OUTSTANDING WARRANTS (Details) Details 25 false false R26.htm 00000026 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) Sheet http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical) Details 26 false false R27.htm 00000027 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Sheet http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) Details 27 false false R28.htm 00000028 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical) Sheet http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical) Details 28 false false R29.htm 00000029 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) Sheet http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details) Details 29 false false R30.htm 00000030 - Disclosure - SCHEDULE OF RSU???S TRANSACTIONS (Details) Sheet http://a2zas.com/role/ScheduleOfRsusTransactionsDetails SCHEDULE OF RSU???S TRANSACTIONS (Details) Details 30 false false R31.htm 00000031 - Disclosure - WARRANTS AND OPTIONS (Details Narrative) Sheet http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative WARRANTS AND OPTIONS (Details Narrative) Details http://a2zas.com/role/WarrantsAndOptionsTables 31 false false R32.htm 00000032 - Disclosure - SCHEDULE OF REVENUE FROM SERVICES (Details) Sheet http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails SCHEDULE OF REVENUE FROM SERVICES (Details) Details 32 false false R33.htm 00000033 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details) Sheet http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails SCHEDULE OF OPERATING SEGMENTS (Details) Details 33 false false R34.htm 00000034 - Disclosure - OPERATING SEGMENTS (Details Narrative) Sheet http://a2zas.com/role/OperatingSegmentsDetailsNarrative OPERATING SEGMENTS (Details Narrative) Details http://a2zas.com/role/OperatingSegmentsTables 34 false false R35.htm 00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://a2zas.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://a2zas.com/role/SubsequentEvents 35 false false All Reports Book All Reports ex99-1.htm form6-ka.htm az-20230630.xsd az-20230630_cal.xml az-20230630_def.xml az-20230630_lab.xml az-20230630_pre.xml http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true JSON 49 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ex99-1.htm form6-ka.htm": { "axisCustom": 2, "axisStandard": 9, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 17, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 518 }, "contextCount": 219, "dts": { "calculationLink": { "local": [ "az-20230630_cal.xml" ] }, "definitionLink": { "local": [ "az-20230630_def.xml" ] }, "inline": { "local": [ "ex99-1.htm", "form6-ka.htm" ] }, "labelLink": { "local": [ "az-20230630_lab.xml" ] }, "presentationLink": { "local": [ "az-20230630_pre.xml" ] }, "schema": { "local": [ "az-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 347, "entityCount": 1, "hidden": { "http://a2zas.com/20230630": 56, "http://xbrl.sec.gov/dei/2022": 7, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 62, "total": 125 }, "keyCustom": 77, "keyStandard": 122, "memberCustom": 48, "memberStandard": 5, "nsprefix": "AZ", "nsuri": "http://a2zas.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://a2zas.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantsAndOptionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - WARRANTS AND OPTIONS", "menuCat": "Notes", "order": "10", "role": "http://a2zas.com/role/WarrantsAndOptions", "shortName": "WARRANTS AND OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantsAndOptionExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - REVENUES", "menuCat": "Notes", "order": "11", "role": "http://a2zas.com/role/Revenues", "shortName": "REVENUES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRevenueExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - OPERATING SEGMENTS", "menuCat": "Notes", "order": "12", "role": "http://a2zas.com/role/OperatingSegments", "shortName": "OPERATING SEGMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - FINANCIAL RISK FACTORS", "menuCat": "Notes", "order": "13", "role": "http://a2zas.com/role/FinancialRiskFactors", "shortName": "FINANCIAL RISK FACTORS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "14", "role": "http://a2zas.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "AZ:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-012023-06-30_custom_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfFairValueOfWarrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - WARRANT LIABILITY (Tables)", "menuCat": "Tables", "order": "15", "role": "http://a2zas.com/role/WarrantLiabilityTables", "shortName": "WARRANT LIABILITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AZ:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-012023-06-30_custom_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfFairValueOfWarrantsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantsTransactionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - WARRANTS AND OPTIONS (Tables)", "menuCat": "Tables", "order": "16", "role": "http://a2zas.com/role/WarrantsAndOptionsTables", "shortName": "WARRANTS AND OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantsTransactionsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - REVENUES (Tables)", "menuCat": "Tables", "order": "17", "role": "http://a2zas.com/role/RevenuesTables", "shortName": "REVENUES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - OPERATING SEGMENTS (Tables)", "menuCat": "Tables", "order": "18", "role": "http://a2zas.com/role/OperatingSegmentsTables", "shortName": "OPERATING SEGMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-5", "first": true, "lang": null, "name": "ifrs-full:ProfitLossOfCombinedEntity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative", "shortName": "NATURE AND CONTINUANCE OF OPERATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-5", "first": true, "lang": null, "name": "ifrs-full:ProfitLossOfCombinedEntity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:CashAndCashEquivalents", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Interim Consolidated Statements of Financial Position (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition", "shortName": "Condensed Interim Consolidated Statements of Financial Position (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "lang": null, "name": "ifrs-full:RestrictedCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProceedsFromExerciseOfWarrants", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details)", "menuCat": "Details", "order": "20", "role": "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "shortName": "SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfFairValueOfWarrantsExplanatory", "AZ:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-012023-06-30_custom_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember", "decimals": "-3", "lang": null, "name": "AZ:IssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfWarrantsTransactionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AZ:ClassOfWarrantOrRightOutstanding1", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - WARRANT LIABILITY (Details Narrative)", "menuCat": "Details", "order": "21", "role": "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "shortName": "WARRANT LIABILITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "AZ:ClassOfWarrantOrRightOutstanding1", "span", "span", "span", "p", "td", "tr", "table", "AZ:DisclosureOfWarrantLiabilityExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-20_custom_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember", "decimals": "INF", "lang": null, "name": "AZ:ClassOfWarrantOrRightOutstanding1", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-20", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SHAREHOLDERS EQUITY (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "shortName": "SHAREHOLDERS EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-03-202023-03-20", "decimals": "-3", "lang": null, "name": "AZ:ProceedsFromPrivatePlacements", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfWarrantsTransactionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "AZ:ClassOfWarrantOrRightOutstanding1", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details)", "menuCat": "Details", "order": "23", "role": "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails", "shortName": "SCHEDULE OF WARRANTS TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfWarrantsTransactionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "AZ:ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical)", "menuCat": "Details", "order": "24", "role": "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "shortName": "SCHEDULE OF WARRANTS TRANSACTIONS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "AZ:DisclosureOfWarrantsTransactionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30_custom_WarrantsMember", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AZ:ClassOfWarrantsOrRightOutstanding", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details)", "menuCat": "Details", "order": "25", "role": "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-03-27_custom_WarrantsOneMember", "decimals": "INF", "lang": null, "name": "AZ:ClassOfWarrantsOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30_custom_WarrantsTwoMember", "decimals": "INF", "first": true, "lang": null, "name": "AZ:ClassOfWarrantOrRightExercisePrice", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)", "menuCat": "Details", "order": "26", "role": "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "shortName": "SCHEDULE OF OUTSTANDING WARRANTS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2021-03-31_custom_WarrantsTwoMember_custom_WarrantHoldersMember", "decimals": "INF", "lang": null, "name": "AZ:ClassOfWarrantOrRightExercisePrice", "reportCount": 1, "unique": true, "unitRef": "CADPShares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "menuCat": "Details", "order": "27", "role": "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails", "shortName": "SCHEDULE OF STOCK OPTION TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical)", "menuCat": "Details", "order": "28", "role": "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "shortName": "SCHEDULE OF STOCK OPTION TRANSACTIONS (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-06-282023-06-28_custom_StockOptionOneMember_custom_ConsultantMember", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOutstandingShareOptions", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details)", "menuCat": "Details", "order": "29", "role": "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "shortName": "SCHEDULE OF OUTSTANDING STOCK OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-012023-06-30_custom_StockOptionTwoMember", "decimals": null, "lang": "en-US", "name": "AZ:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited)", "menuCat": "Statements", "order": "3", "role": "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss", "shortName": "Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:CostOfSales", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2022-12-31_custom_RestrictedStockUnitsMember", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - SCHEDULE OF RSU\u2019S TRANSACTIONS (Details)", "menuCat": "Details", "order": "30", "role": "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "shortName": "SCHEDULE OF RSU\u2019S TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AZ:DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-012023-06-30_custom_RestrictedStockUnitsMember", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "p", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2022-01-012022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "AZ:SharebasedCompensationRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - WARRANTS AND OPTIONS (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative", "shortName": "WARRANTS AND OPTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AZ:DisclosureOfWarrantsAndOptionExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2022-01-012022-06-30", "decimals": "-3", "first": true, "lang": null, "name": "AZ:SharebasedCompensationRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - SCHEDULE OF REVENUE FROM SERVICES (Details)", "menuCat": "Details", "order": "32", "role": "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails", "shortName": "SCHEDULE OF REVENUE FROM SERVICES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfProductsAndServicesExplanatory", "ifrs-full:DisclosureOfRevenueExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30_custom_RevenuesFromServicesMember", "decimals": "-3", "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - SCHEDULE OF OPERATING SEGMENTS (Details)", "menuCat": "Details", "order": "33", "role": "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "shortName": "SCHEDULE OF OPERATING SEGMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-04-012023-06-30", "decimals": "-3", "lang": null, "name": "AZ:LossOnRevaluationOfWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AZ:NumberOfOperatingSegment", "reportCount": 1, "unique": true, "unitRef": "Segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - OPERATING SEGMENTS (Details Narrative)", "menuCat": "Details", "order": "34", "role": "http://a2zas.com/role/OperatingSegmentsDetailsNarrative", "shortName": "OPERATING SEGMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AZ:NumberOfOperatingSegment", "reportCount": 1, "unique": true, "unitRef": "Segment", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "p", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-06-30", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://a2zas.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2023-08-31_custom_NonadjustingEventMember", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2021-12-31_ifrs-full_IssuedCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "shortName": "Condensed Interim Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "AsOf2021-12-31_ifrs-full_IssuedCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Interim Consolidated Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "5", "role": "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "shortName": "Condensed Interim Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": "-3", "lang": null, "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000006 - Disclosure - NATURE AND CONTINUANCE OF OPERATIONS", "menuCat": "Notes", "order": "6", "role": "http://a2zas.com/role/NatureAndContinuanceOfOperations", "shortName": "NATURE AND CONTINUANCE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - BASIS OF PREPARATION", "menuCat": "Notes", "order": "7", "role": "http://a2zas.com/role/BasisOfPreparation", "shortName": "BASIS OF PREPARATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - WARRANT LIABILITY", "menuCat": "Notes", "order": "8", "role": "http://a2zas.com/role/WarrantLiability", "shortName": "WARRANT LIABILITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AZ:DisclosureOfWarrantLiabilityExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SHAREHOLDERS EQUITY", "menuCat": "Notes", "order": "9", "role": "http://a2zas.com/role/ShareholdersEquity", "shortName": "SHAREHOLDERS EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ex99-1.htm", "contextRef": "From2023-01-01to2023-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 54, "tag": { "AZ_AdjustmentsForGainLossOnLossOnRevaluationOfContingentLiability": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for gain loss on loss on revaluation of contingent liability.", "label": "AdjustmentsForGainLossOnLossOnRevaluationOfContingentLiability", "negatedLabel": "Loss on revaluation of contingent liability" } } }, "localname": "AdjustmentsForGainLossOnLossOnRevaluationOfContingentLiability", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_AdjustmentsForIncreaseDecreaseInDeferredRevenues": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments for increase decrease in deferred revenues.", "label": "Changes in deferred revenues" } } }, "localname": "AdjustmentsForIncreaseDecreaseInDeferredRevenues", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_AdvancedAutomotiveInnovationsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advanced Automotive Innovations Inc. [member]", "label": "Advanced Automotive Innovations Inc. [member]" } } }, "localname": "AdvancedAutomotiveInnovationsIncMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_AdvancedEngineeringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advanced engineering [member]", "label": "Advanced engineering [member]" } } }, "localname": "AdvancedEngineeringMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "AZ_ChangeInSeveranceLiability": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in severance liability.", "label": "Change in severance liability" } } }, "localname": "ChangeInSeveranceLiability", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_ClassOfWarrantOrRightExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right exercise price.", "label": "Exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePrice", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "AZ_ClassOfWarrantOrRightOutstanding1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right outstanding.", "label": "Class of warrant or right outstanding", "periodEndLabel": "Number of warrants outstanding, ending balance", "periodStartLabel": "Number of warrants outstanding, beginning balance" } } }, "localname": "ClassOfWarrantOrRightOutstanding1", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AZ_ClassOfWarrantOrRightOutstandingWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right outstanding warrants exercised.", "label": "ClassOfWarrantOrRightOutstandingWarrantsExercised", "negatedLabel": "Number of warrants outstanding, Exercise of warrants" } } }, "localname": "ClassOfWarrantOrRightOutstandingWarrantsExercised", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "AZ_ClassOfWarrantOrRightOutstandingWarrantsExpired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right outstanding warrants expired.", "label": "ClassOfWarrantOrRightOutstandingWarrantsExpired", "negatedLabel": "Number of warrants outstanding, Expired of warrants" } } }, "localname": "ClassOfWarrantOrRightOutstandingWarrantsExpired", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "AZ_ClassOfWarrantOrRightOutstandingWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right outstanding warrants issued.", "label": "Number of warrants outstanding, warrants issued" } } }, "localname": "ClassOfWarrantOrRightOutstandingWarrantsIssued", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "sharesItemType" }, "AZ_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right outstanding weighted average exercise price.", "label": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Exercise Price, Beginning Balance", "periodStartLabel": "Weighted Average Exercise Price, Beginning Balance" } } }, "localname": "ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "perShareItemType" }, "AZ_ClassOfWarrantsOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or right outstanding.", "label": "ClassOfWarrantsOrRightOutstanding", "verboseLabel": "Number of warrants outstanding" } } }, "localname": "ClassOfWarrantsOrRightOutstanding", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "sharesItemType" }, "AZ_ComprehensiveIncomeLossAttributableToNoncontrollingInterests": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Comprehensive income loss attributable to noncontrolling interests.", "label": "Less: Comprehensive loss attributable to non-controlling interests" } } }, "localname": "ComprehensiveIncomeLossAttributableToNoncontrollingInterests", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AZ_ConsultantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consultant [member]", "label": "Consultant [member]" } } }, "localname": "ConsultantMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AZ_Cust2MateLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cust2Mate Ltd [member]", "label": "Cust2Mate Ltd [member]" } } }, "localname": "Cust2MateLtdMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_DeferredRevenues": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred revenues.", "label": "Deferred revenues" } } }, "localname": "DeferredRevenues", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_DescriptionOfExpectedVolatilityWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of expected volatility warrants granted.", "label": "Volatility warrants granted" } } }, "localname": "DescriptionOfExpectedVolatilityWarrantsGranted", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "percentItemType" }, "AZ_DescriptionOfOptionLifeShareOptionGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of option life share option granted.", "label": "Expected option life" } } }, "localname": "DescriptionOfOptionLifeShareOptionGranted", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "durationItemType" }, "AZ_DescriptionOfRiskFreeInterestRateWarrantsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of risk free interest rate warrants granted.", "label": "Risk-free interest rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateWarrantsGranted", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "percentItemType" }, "AZ_DirectorsOfficersAndAdvisersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Directors officers and advisers [member]", "label": "Directors officers and advisers [member]" } } }, "localname": "DirectorsOfficersAndAdvisersMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_DisclosureOfFairValueOfWarrantsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of fair value of warrants explanatory.", "label": "SCHEDULE OF FAIR VALUE HIERARCHY OF WARRANTS" } } }, "localname": "DisclosureOfFairValueOfWarrantsExplanatory", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "textBlockItemType" }, "AZ_DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of number of shares of other equity instruments explanatory.", "label": "SCHEDULE OF RSU\u2019S TRANSACTIONS" } } }, "localname": "DisclosureOfNumberOfSharesOfOtherEquityInstrumentsExplanatory", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "AZ_DisclosureOfWarrantLiabilityExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrant liability explanatory.", "label": "WARRANT LIABILITY" } } }, "localname": "DisclosureOfWarrantLiabilityExplanatory", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "AZ_DisclosureOfWarrantsAndOptionExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrants and option explanatory.", "label": "WARRANTS AND OPTIONS" } } }, "localname": "DisclosureOfWarrantsAndOptionExplanatory", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptions" ], "xbrltype": "textBlockItemType" }, "AZ_DisclosureOfWarrantsTransactionsExplanatory": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of warrants transactions explanatory.", "label": "SCHEDULE OF WARRANTS TRANSACTIONS" } } }, "localname": "DisclosureOfWarrantsTransactionsExplanatory", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "AZ_DisclosureWarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability" } } }, "localname": "DisclosureWarrantLiabilityAbstract", "nsuri": "http://a2zas.com/20230630", "xbrltype": "stringItemType" }, "AZ_DisclosureWarrantsAndOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants And Options", "verboseLabel": "Schedule Of Stock Option Transactions" } } }, "localname": "DisclosureWarrantsAndOptionsAbstract", "nsuri": "http://a2zas.com/20230630", "xbrltype": "stringItemType" }, "AZ_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees [member]", "label": "Employees [member]" } } }, "localname": "EmployeesMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_ExecutivesAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executives and directors [member]", "label": "Executives and directors [member]" } } }, "localname": "ExecutivesAndDirectorsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_ExerciseOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of restricted stock units.", "label": "Exercise of RSU\u2019s" } } }, "localname": "ExerciseOfRestrictedStockUnits", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_ExerciseOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of restricted stock units, shares", "label": "Exercise of RSU's, shares" } } }, "localname": "ExerciseOfRestrictedStockUnitsShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_ExerciseOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of stock options.", "label": "Exercise of options" } } }, "localname": "ExerciseOfStockOptions", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_ExerciseOfStockOptionsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of stock options, shares.", "label": "Exercise of options, shares" } } }, "localname": "ExerciseOfStockOptionsShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_ExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of warrants.", "label": "Exercise of warrants" } } }, "localname": "ExerciseOfWarrants", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_ExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of warrants shares.", "label": "Exercise of warrants, shares" } } }, "localname": "ExerciseOfWarrantsShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_ExercisePriceOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise price of warrant.", "label": "Exercise price of warrant" } } }, "localname": "ExercisePriceOfWarrant", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AZ_Expenses": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expenses.", "label": "Expenses:" } } }, "localname": "Expenses", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "AZ_ExpirationOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Expiration of warrants.", "label": "Expiration of warrants" } } }, "localname": "ExpirationOfWarrants", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_ExternalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "External [member]", "label": "External [member]" } } }, "localname": "ExternalMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "AZ_FairValueAssumptionsExpectedLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value assumptions expected life.", "label": "Expected life" } } }, "localname": "FairValueAssumptionsExpectedLife", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "durationItemType" }, "AZ_FairValueOfOptionsGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of options granted.", "label": "Fair value of options granted" } } }, "localname": "FairValueOfOptionsGranted", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "AZ_FairValueSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share price.", "label": "Share price" } } }, "localname": "FairValueSharePrice", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AZ_FinancialIncomeExpense": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 4.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financial income expense.", "label": "FinancialIncomeExpense", "negatedLabel": "Financial (income) expense" } } }, "localname": "FinancialIncomeExpense", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AZ_FinderFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finder fee.", "label": "Finder fee" } } }, "localname": "FinderFee", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AZ_GainLossOnRevaluationOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on revaluation of warrant liability.", "label": "Gain loss on revaluation of warrant liability" } } }, "localname": "GainLossOnRevaluationOfWarrantLiability", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AZ_GainLossOnSaleOfFixedAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on sale of fixed asset.", "label": "Loss on sale of fixed asset" } } }, "localname": "GainLossOnSaleOfFixedAsset", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "AZ_IfrsStatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "localname": "IfrsStatementLineItems", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative", "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails", "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/SubsequentEventsDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "AZ_IfrsStatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "IfrsStatementTable [Table]" } } }, "localname": "IfrsStatementTable", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "stringItemType" }, "AZ_InterSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intersegment [member]", "label": "Intersegment [member]" } } }, "localname": "InterSegmentMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "AZ_InterestPaidDuringYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest paid during year.", "label": "Interest paid during the period" } } }, "localname": "InterestPaidDuringYear", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_IsramatLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Isramat Ltd [member]", "label": "Isramat Ltd [member]" } } }, "localname": "IsramatLtdMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_IssuanceOfAdditionalCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of additional common shares.", "label": "Issuance of additional common shares" } } }, "localname": "IssuanceOfAdditionalCommonShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AZ_IssuanceOfCompanysOrdinaryShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of companys ordinary shares.", "label": "Issuance of the Company\u2019s ordinary shares" } } }, "localname": "IssuanceOfCompanysOrdinaryShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfShareInRespectOfIsramatDeal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of share in respect of is ramat deal.", "label": "Issuance of shares in respect of Isramat deal" } } }, "localname": "IssuanceOfShareInRespectOfIsramatDeal", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfSharesInPrivatePlacement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares in private placement.", "label": "Issuance of shares in respect of private placement" } } }, "localname": "IssuanceOfSharesInPrivatePlacement", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfSharesInPrivatePlacementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of shares in private placement shares.", "label": "Issuance of shares in respect of private placement, shares" } } }, "localname": "IssuanceOfSharesInPrivatePlacementShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_IssuanceOfSharesInRespectOfCrowdFunding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of crowd funding.", "label": "Issuance of shares in respect of crowd funding" } } }, "localname": "IssuanceOfSharesInRespectOfCrowdFunding", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfSharesInRespectOfCrowdFundingShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of crowd funding share.", "label": "Issuance of shares in respect of crowd funding, shares" } } }, "localname": "IssuanceOfSharesInRespectOfCrowdFundingShare", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_IssuanceOfSharesInRespectOfIsramatDeal": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of is ramat deal.", "label": "Issuance of shares in respect of Isramat deal (note 3)" } } }, "localname": "IssuanceOfSharesInRespectOfIsramatDeal", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfSharesInRespectOfIsramatDealShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of isramat deal share.", "label": "Issuance of shares in respect of Isramat deal (note 3), shares" } } }, "localname": "IssuanceOfSharesInRespectOfIsramatDealShare", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_IssuanceOfSharesInRespectOfRegisteredDirectOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of registered direct offering.", "label": "Issuance of shares in respect of registered direct offering" } } }, "localname": "IssuanceOfSharesInRespectOfRegisteredDirectOffering", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "AZ_IssuanceOfSharesInRespectOfRegisteredDirectOfferingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of shares in respect of registered direct offering shares.", "label": "Issuance of shares in respect of registered direct offering, shares" } } }, "localname": "IssuanceOfSharesInRespectOfRegisteredDirectOfferingShares", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "AZ_IssuanceOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of warrants.", "label": "Issuance, warrants" } } }, "localname": "IssuanceOfWarrants", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "AZ_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 2023 registered direct offerings [member]", "label": "June 2023 registered direct offerings [member]" } } }, "localname": "JuneTwoThousandTwentyThreeRegisteredDirectOfferingsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "domainItemType" }, "AZ_JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "June 2023 registered direct offerings warrants [member]", "label": "June 2023 registered direct offerings warrants [member]" } } }, "localname": "JuneTwoThousandTwentyThreeRegisteredDirectOfferingsWarrantsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_LiabilityForSeverancePayFundNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability for severance pay fund net.", "label": "Liability for severance pay fund, net" } } }, "localname": "LiabilityForSeverancePayFundNet", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_LossOnRevaluationOfWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Loss on revaluation of warrant liability.", "label": "LossOnRevaluationOfWarrantLiability", "verboseLabel": "Loss on revaluation of warrant liability" } } }, "localname": "LossOnRevaluationOfWarrantLiability", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "AZ_LossesOnRevaluationOfWarrantLiability": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Losses on revaluation of warrant liability.", "label": "Loss on revaluation of warrant liability" } } }, "localname": "LossesOnRevaluationOfWarrantLiability", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_MarchTwoThousandTwentyThreePrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2023 private placement [member]", "label": "March 2023 private placement [member]" } } }, "localname": "MarchTwoThousandTwentyThreePrivatePlacementMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "domainItemType" }, "AZ_MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2023 private placement warrants [member]", "label": "March 2023 private placement warrants [member]" } } }, "localname": "MarchTwoThousandTwentyThreePrivatePlacementWarrantsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_MarchTwoThousandTwentyThreePrivatePlacementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "March 2023 private placements [member]", "label": "March 2023 private placements [member]" } } }, "localname": "MarchTwoThousandTwentyThreePrivatePlacementsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "domainItemType" }, "AZ_NonCashTransactionCashAndCashEquivalentsPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non cash transaction cash and cash equivalents paid.", "label": "Total cash and cash equivalents paid" } } }, "localname": "NonCashTransactionCashAndCashEquivalentsPaid", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_NonCashTransactionGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash transaction goodwill.", "label": "NonCashTransactionGoodwill", "verboseLabel": "Goodwill" } } }, "localname": "NonCashTransactionGoodwill", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_NonCashTransactionPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash transaction property plant and equipment.", "label": "Property, plant and equipment" } } }, "localname": "NonCashTransactionPropertyPlantAndEquipment", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_NonadjustingEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nonadjusting event [member]", "label": "Nonadjusting event [member]" } } }, "localname": "NonadjustingEventMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_NoncashActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash activities [Abstract]", "label": "APPENDIX A: NON-CASH ACTIVITIES" } } }, "localname": "NoncashActivitiesAbstract", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "AZ_NoncontrollingInterest": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest.", "label": "Non-controlling interest" } } }, "localname": "NoncontrollingInterest", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_NonregisteredWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-registered Warrants [Member]", "label": "Non-registered Warrants [Member]" } } }, "localname": "NonregisteredWarrantsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_NovemberTwoThousandTwentyTwoPrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 2022 private placement [member]", "label": "November 2022 private placement [member]" } } }, "localname": "NovemberTwoThousandTwentyTwoPrivatePlacementMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "domainItemType" }, "AZ_NovemberTwoThousandTwentyTwoPrivatePlacementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 2022 warrants [member]", "label": "November 2022 warrants [member]" } } }, "localname": "NovemberTwoThousandTwentyTwoPrivatePlacementsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_NovemberTwoThousandTwentyTwoWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "November 2022 warrants [member]", "label": "November 2022 warrants [member] [Default Label]", "verboseLabel": "November 2022 warrants [member]" } } }, "localname": "NovemberTwoThousandTwentyTwoWarrantsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "domainItemType" }, "AZ_NumberOfOperatingSegment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operating segment.", "label": "Number of operating segment" } } }, "localname": "NumberOfOperatingSegment", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/OperatingSegmentsDetailsNarrative" ], "xbrltype": "integerItemType" }, "AZ_NumberOfRestrictedStockUnitsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of restricted stock units exercised.", "label": "Number of restricted stock units exercised" } } }, "localname": "NumberOfRestrictedStockUnitsExercised", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AZ_NumberOfWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercised.", "label": "Number of warrants exercised" } } }, "localname": "NumberOfWarrantsExercised", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AZ_NumberOfWarrantsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants outstanding.", "label": "Number of warrants outstanding" } } }, "localname": "NumberOfWarrantsOutstanding", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical" ], "xbrltype": "decimalItemType" }, "AZ_OfficersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Officers [member]", "label": "Officers [member]" } } }, "localname": "OfficersMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslations": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments arising from translating financial statements of foreign operations.", "label": "Adjustments arising from translating of financial statements to presentation currency" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslations", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AZ_PrecisionMetalPartsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Precision metal parts [member]", "label": "Precision metal parts [member]" } } }, "localname": "PrecisionMetalPartsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "AZ_PrivatePlacementWarrantShareIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement warrant share issued.", "label": "Private placement of warrant shares issued" } } }, "localname": "PrivatePlacementWarrantShareIssued", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "AZ_ProceedsFromIssuanceOfUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from issuance of units.", "label": "[custom:ProceedsFromIssuanceOfUnits]" } } }, "localname": "ProceedsFromIssuanceOfUnits", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AZ_ProceedsFromPrivatePlacements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from private placements.", "label": "Proceeds from private placements" } } }, "localname": "ProceedsFromPrivatePlacements", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AZ_ProfitLossAttributableToNoncontrollingInterest": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossAttributableToOwnersOfParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Profit loss attributable to noncontrolling interests.", "label": "Less: Net loss attributable to non-controlling interests" } } }, "localname": "ProfitLossAttributableToNoncontrollingInterest", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "AZ_ProvisionForVacationLeave": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Provision for vacation leave.", "label": "Provision for vacation leave" } } }, "localname": "ProvisionForVacationLeave", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AZ_ProvisionNonCurrentLiabilities": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Provision noncurrent liabilities.", "label": "Provisions" } } }, "localname": "ProvisionNonCurrentLiabilities", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_RestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSU's [member]", "label": "RSU's [member]" } } }, "localname": "RestrictedStockUnitsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_RevaluationOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revaluation of warrants.", "label": "Revaluation, warrants" } } }, "localname": "RevaluationOfWarrants", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "AZ_RevenuesFromLeasingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues from leasing [member]", "label": "Revenues from leasing [member]" } } }, "localname": "RevenuesFromLeasingMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "AZ_RevenuesFromSalesOfPrecisionMetalPartsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues from sales of precision metal parts [member]", "label": "Revenues from sales of precision metal parts [member]" } } }, "localname": "RevenuesFromSalesOfPrecisionMetalPartsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "AZ_RevenuesFromServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues from services [member]", "label": "Revenues from services [member]" } } }, "localname": "RevenuesFromServicesMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "AZ_RevenuesFromSmartCartsProjectMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenues from smart carts project [member]", "label": "Revenues from smart carts project [member]" } } }, "localname": "RevenuesFromSmartCartsProjectMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "AZ_SeverancePaymentNet": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Severance payment net.", "label": "Severance payment, net" } } }, "localname": "SeverancePaymentNet", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_SharebasedCompensationRecognized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "SharebasedCompensationRecognized", "verboseLabel": "Share based compensation" } } }, "localname": "SharebasedCompensationRecognized", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AZ_SmartCartsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SmartCarts [member]", "label": "SmartCarts [member]" } } }, "localname": "SmartCartsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option eight [member]", "label": "Stock option eight [member]" } } }, "localname": "StockOptionEightMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionElevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option eleven [member]", "label": "Stock option eleven [member]" } } }, "localname": "StockOptionElevenMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option five [member]", "label": "Stock option five [member]" } } }, "localname": "StockOptionFiveMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option four [member]", "label": "Stock option four [member]" } } }, "localname": "StockOptionFourMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option nine [member]", "label": "Stock option nine [member]" } } }, "localname": "StockOptionNineMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option one [member]", "label": "Stock option one [member]" } } }, "localname": "StockOptionOneMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AZ_StockOptionSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option seven [member]", "label": "Stock option seven [member]" } } }, "localname": "StockOptionSevenMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option six [member]", "label": "Stock option six [member]" } } }, "localname": "StockOptionSixMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionTenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option ten [member]", "label": "Stock option ten [member]" } } }, "localname": "StockOptionTenMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option three [member]", "label": "Stock option three [member]" } } }, "localname": "StockOptionThreeMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_StockOptionTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option two [member]", "label": "Stock option two [member]" } } }, "localname": "StockOptionTwoMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "domainItemType" }, "AZ_SubsidiarySaleOfStocksAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subsidiary Sale of Stocks [Axis]", "label": "Subsidiary Sale of Stocks [Axis]" } } }, "localname": "SubsidiarySaleOfStocksAxis", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "stringItemType" }, "AZ_SubsidiarySaleOfStocksDomain": { "auth_ref": [], "localname": "SubsidiarySaleOfStocksDomain", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetails" ], "xbrltype": "domainItemType" }, "AZ_TradeCurrentPayables": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Trade current payables.", "label": "Trade payables" } } }, "localname": "TradeCurrentPayables", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_TypesOfWarrantsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Types of Warrants [Axis]", "label": "Types of Warrants [Axis]" } } }, "localname": "TypesOfWarrantsAxis", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "stringItemType" }, "AZ_TypesOfWarrantsDomain": { "auth_ref": [], "localname": "TypesOfWarrantsDomain", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityDetailsNarrative", "http://a2zas.com/role/WarrantLiabilityTables" ], "xbrltype": "domainItemType" }, "AZ_WarrantExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercise price per share.", "label": "Warrant exercise price per share" } } }, "localname": "WarrantExercisePricePerShare", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "AZ_WarrantHoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant holders [member]", "label": "Warrant holders [member]" } } }, "localname": "WarrantHoldersMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AZ_WarrantLiabilityLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability loss.", "label": "WarrantLiabilityLoss", "periodEndLabel": "Balance, warrants", "periodStartLabel": "Balance, warrants" } } }, "localname": "WarrantLiabilityLoss", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails" ], "xbrltype": "monetaryItemType" }, "AZ_WarrantLiabilityNonCurrent": { "auth_ref": [], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liability non-current.", "label": "Warrant Liability (note 3)" } } }, "localname": "WarrantLiabilityNonCurrent", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "AZ_WarrantsAndRightsOutstandingExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants and rights outstanding expiry date.", "label": "Expiry date" } } }, "localname": "WarrantsAndRightsOutstandingExpiryDate", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "dateItemType" }, "AZ_WarrantsExercisableTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercisable term.", "label": "Warrants exercisable term" } } }, "localname": "WarrantsExercisableTerm", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/WarrantLiabilityDetailsNarrative" ], "xbrltype": "durationItemType" }, "AZ_WarrantsFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants five [member]", "label": "Warrants five [member]" } } }, "localname": "WarrantsFiveMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AZ_WarrantsFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants four [member]", "label": "Warrants four [member]" } } }, "localname": "WarrantsFourMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AZ_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [member]", "label": "Warrants [member]" } } }, "localname": "WarrantsMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AZ_WarrantsOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants one [member]", "label": "Warrants one [member]" } } }, "localname": "WarrantsOneMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AZ_WarrantsSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants seven [member]", "label": "Warrants seven [member]" } } }, "localname": "WarrantsSevenMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AZ_WarrantsSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants six [Member]", "label": "Warrants six [Member]" } } }, "localname": "WarrantsSixMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails" ], "xbrltype": "domainItemType" }, "AZ_WarrantsThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants three [member]", "label": "Warrants three [member]" } } }, "localname": "WarrantsThreeMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AZ_WarrantsTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants two [member]", "label": "Warrants two [member]" } } }, "localname": "WarrantsTwoMember", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical" ], "xbrltype": "domainItemType" }, "AZ_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual life of outstanding share options.", "label": "Options expire", "verboseLabel": "Number of stock options, Expiry date" } } }, "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "dateItemType" }, "AZ_WorkingCapitalOtherThanCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Working capital other than cash and cash equivalents.", "label": "Working capital other than cash and cash equivalents" } } }, "localname": "WorkingCapitalOtherThanCashAndCashEquivalents", "nsuri": "http://a2zas.com/20230630", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r146", "r148", "r149" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r135" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r142" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r143" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r136" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r153" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://a2zas.com/role/Cover" ], "xbrltype": "booleanItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r157" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income [member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "ifrs-full_AdditionalPaidinCapital": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } }, "en-us": { "role": { "label": "Share capital and additional paid in capital" } } }, "localname": "AdditionalPaidinCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets": { "auth_ref": [ "r164" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for the decrease (increase) in accrued income including contract assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Accrued income including contract assets; Profit (loss)]" } }, "en-us": { "role": { "label": "Accrued interest on loans and leases" } } }, "localname": "AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "auth_ref": [ "r164" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } }, "en-us": { "role": { "label": "Change in inventory" } } }, "localname": "AdjustmentsForDecreaseIncreaseInInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "auth_ref": [ "r164" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Change in other account receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "auth_ref": [ "r166" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } }, "en-us": { "role": { "label": "Change in trade receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "auth_ref": [ "r165" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Amortization and depreciation" } } }, "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "auth_ref": [ "r166" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 }, "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 3.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } }, "en-us": { "role": { "label": "Adjustments for gain (loss) on disposals, property, plant and equipment", "negatedLabel": "Loss on sale of property, plant and equipment", "negatedTerseLabel": "Loss from sale of property, plant and equipment" } } }, "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "auth_ref": [ "r164" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in other operating payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Change in other accounts payable" } } }, "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r164" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Change in accounts payable" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash provided by operating activities:" } } }, "localname": "AdjustmentsForReconcileProfitLossAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r165" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "verboseLabel": "Share based compensation" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r14", "r74", "r75", "r76", "r100", "r103" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r44", "r45" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Basic loss per share" } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_BusinessCombinationsAxis": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Business combinations [axis]" } } }, "localname": "BusinessCombinationsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CapitalReserveMember": { "auth_ref": [ "r157" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } }, "en-us": { "role": { "label": "Capital reserve [member]" } } }, "localname": "CapitalReserveMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r11", "r55", "r70" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": { "auth_ref": [ "r162" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments." } }, "en-us": { "role": { "label": "Restricted deposits" } } }, "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r51", "r56" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "totalLabel": "Cash flows from financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r51", "r56" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "totalLabel": "Cash flow used in investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r51", "r56" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0 } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "totalLabel": "Cash flow from operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Item that will not be reclassified to profit or loss:" } } }, "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r2", "r25", "r58", "r60", "r67", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Net comprehensive loss for the period", "totalLabel": "Total comprehensive loss for the period" } } }, "localname": "ComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "auth_ref": [ "r2", "r27" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } }, "en-us": { "role": { "label": "Comprehensive loss attributable to controlling shareholders" } } }, "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r1", "r31" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of revenues" } } }, "localname": "CostOfSales", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CounterpartiesAxis": { "auth_ref": [ "r96" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Counterparties [axis]" } } }, "localname": "CounterpartiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_CounterpartiesMember": { "auth_ref": [ "r96" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "localname": "CounterpartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r15", "r63", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets [Default Label]", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r79" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Lease liability" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r16", "r65", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities [Default Label]", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r117", "r118" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Trade receivables, net" } } }, "localname": "CurrentTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Volatility" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "verboseLabel": "Risk-free interest rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": { "auth_ref": [ "r80" ], "lang": { "en": { "role": { "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]" } }, "en-us": { "role": { "label": "Description of RSU's vesting and conversion" } } }, "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r44", "r45" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted loss per share" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "auth_ref": [ "r155" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } }, "en-us": { "role": { "label": "NATURE AND CONTINUANCE OF OPERATIONS" } } }, "localname": "DisclosureOfBasisOfConsolidationExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperations" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r155" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "BASIS OF PREPARATION" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/BasisOfPreparation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } }, "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } } }, "localname": "DisclosureOfBusinessCombinationsTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r21" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "SHAREHOLDERS EQUITY" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "auth_ref": [ "r77" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } }, "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } } }, "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "auth_ref": [ "r109" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for operating segments." } }, "en-us": { "role": { "label": "OPERATING SEGMENTS" } } }, "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/OperatingSegments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r33" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } }, "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "auth_ref": [ "r97" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for financial instruments." } }, "en-us": { "role": { "label": "FINANCIAL RISK FACTORS" } } }, "localname": "DisclosureOfFinancialInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/FinancialRiskFactors" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } } }, "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory": { "auth_ref": [ "r0" ], "lang": { "en": { "role": { "documentation": "The disclosure of notes and other explanatory information as part of a complete set of financial statements." } }, "en-us": { "role": { "label": "Disclosure of notes and other explanatory information [text block]" } } }, "localname": "DisclosureOfNotesAndOtherExplanatoryInformationExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } }, "en-us": { "role": { "label": "SCHEDULE OF OUTSTANDING WARRANTS" } } }, "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF OUTSTANDING STOCK OPTIONS" } } }, "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "auth_ref": [ "r100" ], "lang": { "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF OPERATING SEGMENTS" } } }, "localname": "DisclosureOfOperatingSegmentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/OperatingSegmentsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfProductsAndServicesExplanatory": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The disclosure of the entity's products and services. [Refer: Products and services [member]]" } }, "en-us": { "role": { "label": "SCHEDULE OF REVENUE FROM SERVICES" } } }, "localname": "DisclosureOfProductsAndServicesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "The disclosure of the range of exercise prices for outstanding share options." } }, "en-us": { "role": { "label": "SCHEDULE OF STOCK OPTION TRANSACTIONS" } } }, "localname": "DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRevenueExplanatory": { "auth_ref": [ "r155" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for revenue." } }, "en-us": { "role": { "label": "REVENUES" } } }, "localname": "DisclosureOfRevenueExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/Revenues" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "auth_ref": [ "r22" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } }, "en-us": { "role": { "label": "Disclosure of share capital, reserves and other equity interest [text block]" } } }, "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": { "auth_ref": [ "r41", "r43", "r73" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to associates." } }, "en-us": { "role": { "label": "Disclosure of associates [table]" } } }, "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "auth_ref": [ "r88" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } }, "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } } }, "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r53", "r54" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of changes in foreign exchange rates" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForAssociatesMember": { "auth_ref": [ "r41", "r43", "r73", "r112", "r113" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "localname": "EntitysTotalForAssociatesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "auth_ref": [ "r92", "r94" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "localname": "EntitysTotalForBusinessCombinationsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "auth_ref": [ "r41", "r43", "r72" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "localname": "EntitysTotalForSubsidiariesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r14", "r19", "r57", "r59", "r74", "r75", "r76" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "Equity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity (note 4)" } } }, "localname": "EquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r14" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "EquityAndLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAttributableToOwnersOfParent": { "auth_ref": [ "r13" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } }, "en-us": { "role": { "label": "Equity attributable to owners of parent", "totalLabel": "Total equity including non-controlling interest" } } }, "localname": "EquityAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "localname": "EquityMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r87" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "Number of stock options, exercise price", "verboseLabel": "Number of stock options, Exercise price" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Dividend yield" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "percentItemType" }, "ifrs-full_FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss": { "auth_ref": [ "r110", "r111" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of finance income (expenses) from reinsurance contracts held that is recognised in profit or loss. [Refer: Insurance finance income (expenses); Reinsurance contracts held [member]]" } }, "en-us": { "role": { "label": "Finance expense, net" } } }, "localname": "FinanceIncomeExpensesFromReinsuranceContractsHeldRecognisedInProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r161" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Gains (losses) on change in fair value of derivatives", "negatedLabel": "Loss on revaluation of warrant liability (note 4)" } } }, "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeneralAndAdministrativeExpense": { "auth_ref": [ "r158" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 4.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administration expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Goodwill": { "auth_ref": [ "r8", "r48", "r49", "r93" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r115" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "auth_ref": [ "r29", "r34", "r35", "r36", "r39", "r71", "r99" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } }, "en-us": { "role": { "label": "Tax expenses", "negatedLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseContinuingOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss", "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "auth_ref": [ "r55" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes", "totalLabel": "Increase (decrease) in cash and cash equivalents" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Share based compensation" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IntangibleAssetsAndGoodwill": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Intangible asset - patent, net" } } }, "localname": "IntangibleAssetsAndGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r9", "r38", "r117" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Inventories" } } }, "localname": "Inventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } }, "en-us": { "role": { "label": "Issued capital [member]" } } }, "localname": "IssuedCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r14", "r74", "r75", "r76", "r100", "r104" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "stringItemType" }, "ifrs-full_LongtermBorrowings": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Long term loans" } } }, "localname": "LongtermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsMember": { "auth_ref": [ "r32" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "localname": "NonadjustingEventsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncontrollingInterestsMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } }, "en-us": { "role": { "label": "Non-controlling interests [member]" } } }, "localname": "NoncontrollingInterestsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentAssets": { "auth_ref": [ "r15", "r64", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } }, "en-us": { "role": { "label": "Non-current assets", "totalLabel": "Total non-current assets" } } }, "localname": "NoncurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r79" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "verboseLabel": "Lease liability" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentLiabilities": { "auth_ref": [ "r16", "r66", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } }, "en-us": { "role": { "label": "Non-current liabilities", "totalLabel": "Total non-current liabilities" } } }, "localname": "NoncurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "auth_ref": [ "r90", "r167" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of RSU's, granted", "verboseLabel": "RSU's granted" } } }, "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "RSU's exercisable" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments exercised or vested in share-based payment arrangement", "negatedLabel": "Number of RSU's, Exercise" } } }, "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments expired in share-based payment arrangement", "negatedLabel": "Number of RSU's, Expiry" } } }, "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "auth_ref": [ "r167" ], "lang": { "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of other equity instruments outstanding in share-based payment arrangement", "periodEndLabel": "Number of RSU's, ending balance", "periodStartLabel": "Number of RSU's, beginning balance" } } }, "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfOutstandingShareOptions": { "auth_ref": [ "r81", "r85", "r87" ], "lang": { "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement", "periodEndLabel": "Number of stock options, ending balance", "periodStartLabel": "Number of stock options, beginning balance", "verboseLabel": "Number of stock options, Outstanding" } } }, "localname": "NumberOfOutstandingShareOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "auth_ref": [ "r86" ], "lang": { "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of stock options, Exercisable" } } }, "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "auth_ref": [ "r83" ], "lang": { "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options exercised in share-based payment arrangement", "negatedLabel": "Number of stock options, Exercise of options" } } }, "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of share options expired in share-based payment arrangement", "negatedLabel": "Number of stock options, Expiry of options" } } }, "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } }, "en-us": { "role": { "label": "Number of stock options, options granted", "verboseLabel": "Number of stock options, options issued" } } }, "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "decimalItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r156" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "verboseLabel": "Number of share issuance" } } }, "localname": "NumberOfSharesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r20" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "ifrs-full_OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities": { "auth_ref": [ "r124" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to acquire interests in joint ventures (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities. [Refer: Joint ventures [member]]" } }, "en-us": { "role": { "label": "Other cash payments to acquire interests in joint ventures, classified as investing activities", "negatedLabel": "Newly consolidated subsidiary (see Appendix B)" } } }, "localname": "OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncome": { "auth_ref": [ "r4", "r24", "r30", "r69" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Other comprehensive income", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "auth_ref": [ "r17", "r30" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Adjustments arising from translating financial statements of foreign operations" } } }, "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r127" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Lease payments" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromCurrentBorrowings": { "auth_ref": [ "r163" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from current borrowings obtained. [Refer: Current borrowings]" } }, "en-us": { "role": { "label": "Proceeds from receipt of loans" } } }, "localname": "ProceedsFromCurrentBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r163" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Exercise of option", "verboseLabel": "Exercise of options" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "http://a2zas.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "auth_ref": [ "r163" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } }, "en-us": { "role": { "label": "Proceeds from exercise of warrants", "negatedLabel": "Reclassification to Warrant Reserve", "verboseLabel": "Exercise of warrants" } } }, "localname": "ProceedsFromExerciseOfWarrants", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "http://a2zas.com/role/ScheduleOfFairValueHierarchyOfWarrantsDetails", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssuingShares": { "auth_ref": [ "r125" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from issuing shares." } }, "en-us": { "role": { "label": "Issuance of shares and warrants, net" } } }, "localname": "ProceedsFromIssuingShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r106", "r129" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r106", "r129" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "localname": "ProductsAndServicesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r3", "r23", "r52", "r58", "r60", "r100", "r102", "r128", "r132", "r134" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Net loss for the period", "negatedLabel": "Loss", "totalLabel": "Net loss for the period" } } }, "localname": "ProfitLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows", "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss", "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "auth_ref": [ "r26" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss), attributable to owners of parent", "totalLabel": "Net loss attributable to controlling shareholders" } } }, "localname": "ProfitLossAttributableToOwnersOfParent", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r95", "r114", "r115", "r130", "r131" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) before tax", "totalLabel": "Loss before taxes on income" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromOperatingActivities": { "auth_ref": [ "r122", "r161" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from operating activities", "negatedLabel": "Segment loss", "totalLabel": "Operating loss" } } }, "localname": "ProfitLossFromOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss", "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossOfCombinedEntity": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Business combinations [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) of combined entity as if combination occurred at beginning of period", "negatedLabel": "Profit (loss) of combined entity as if combination occurred at beginning of period" } } }, "localname": "ProfitLossOfCombinedEntity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r7", "r37" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProportionOfOwnershipInterestInAssociate": { "auth_ref": [ "r40", "r42", "r62" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]" } }, "en-us": { "role": { "label": "Proportion of ownership interest in associate" } } }, "localname": "ProportionOfOwnershipInterestInAssociate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "auth_ref": [ "r40", "r42", "r61" ], "lang": { "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Ownership interest in subsidary" } } }, "localname": "ProportionOfOwnershipInterestInSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r123" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Purchase of property, plant and equipment" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [ "r126" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Repayments of borrowings, classified as financing activities", "negatedLabel": "Repayment of loans" } } }, "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r50" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development costs" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r119", "r120" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 4.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Accumulated deficit", "negatedLabel": "Retained earnings" } } }, "localname": "RetainedEarnings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition", "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r6", "r116" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r28", "r68", "r95", "r98", "r101", "r106", "r107", "r108", "r114", "r115", "r128" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 1.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenues (note 7)", "terseLabel": "Total", "verboseLabel": "Revenues" } } }, "localname": "Revenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss", "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails", "http://a2zas.com/role/ScheduleOfRevenueFromServicesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SalesAndMarketingExpense": { "auth_ref": [ "r161" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss": { "order": 3.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } }, "en-us": { "role": { "label": "Sales and marketing costs" } } }, "localname": "SalesAndMarketingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SegmentsAxis": { "auth_ref": [ "r47", "r78", "r100", "r121", "r133" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Segments [axis]" } } }, "localname": "SegmentsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsMember": { "auth_ref": [ "r47", "r78", "r105", "r121", "r133" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "localname": "SegmentsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfOperatingSegmentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_SharebasedPaymentArrangementsMember": { "auth_ref": [ "r88" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "localname": "SharebasedPaymentArrangementsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "ifrs-full_ShorttermBorrowings": { "auth_ref": [ "r159" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 1.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Short term loan and current portion of long-term loans" } } }, "localname": "ShorttermBorrowings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "auth_ref": [ "r41", "r43", "r73", "r112", "r113" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Associates [axis]" } } }, "localname": "SignificantInvestmentsInAssociatesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r41", "r43", "r72" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/NatureAndContinuanceOfOperationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityAbstract": { "auth_ref": [], "localname": "StatementOfChangesInEquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfChangesInShareholdersEquityDeficit", "http://a2zas.com/role/ScheduleOfOutstandingStockOptionsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetails", "http://a2zas.com/role/ScheduleOfOutstandingWarrantsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical", "http://a2zas.com/role/ScheduleOfWarrantsTransactionsDetailsParenthetical" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r12" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Other accounts payable" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivables": { "auth_ref": [ "r10", "r18" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } }, "en-us": { "role": { "label": "Other accounts receivable" } } }, "localname": "TradeAndOtherCurrentReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "auth_ref": [ "r88" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } } }, "localname": "TypesOfSharebasedPaymentArrangementsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfRsusTransactionsDetails", "http://a2zas.com/role/ShareholdersEquityDetailsNarrative", "http://a2zas.com/role/WarrantsAndOptionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "ifrs-full_WarrantReserve": { "auth_ref": [ "r160" ], "calculation": { "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition": { "order": 2.0, "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity resulting from issuing share purchase warrants, other than those resulting from share-based payment arrangements. [Refer: Reserve of share-based payments]" } }, "en-us": { "role": { "label": "Warrant Reserve" } } }, "localname": "WarrantReserve", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfFinancialPosition" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r83" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Exercise of options" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r84" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, Expiry of options" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r82" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted Average Exercise Price, options granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r81", "r85" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted Average Exercise Price, ending balance", "periodStartLabel": "Weighted Average Exercise Price, beginning balance" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "auth_ref": [ "r89" ], "lang": { "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Share Price" } } }, "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/ScheduleOfStockOptionTransactionsDetailsParenthetical" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r46" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://a2zas.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r1": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r10": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r100": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS08_g20-24__IFRS08_g20-24_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r110": { "IssueDate": "2022-03-24", "Name": "IAS", "Note": "Effective 2023-01-01", "Number": "1", "Paragraph": "82", "Subparagraph": "bc", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_bc&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "82", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_82&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39M&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "4", "Paragraph": "39J", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39J&doctype=Standard&book=b", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r115": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r116": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r117": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r118": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r119": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r12": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r120": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r121": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r122": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "32", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r123": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r124": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r125": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r126": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r127": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r128": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r129": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r13": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r130": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r131": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r132": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r133": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r134": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r135": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r136": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r137": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r138": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r139": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r140": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r141": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r142": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r143": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r144": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r145": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r146": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r147": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r148": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r149": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r150": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r151": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r152": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r153": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r154": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r155": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r156": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r157": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r158": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r159": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r16": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r160": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r161": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r162": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r163": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r164": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r165": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r166": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r167": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r17": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r20": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r30": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_79&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "35", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r40": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r50": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r60": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "21", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Clause": "ix", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r70": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_114&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r80": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r90": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_q_ii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A__IFRS07_g3-5A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 50 0001493152-23-029306-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-029306-xbrl.zip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end